CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: s-block molecular entity
Accession: CHEBI:33674
browse the term
Definition: An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element.
Synonyms: related_synonym: s-block compounds; s-block molecular entities
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NR1I3
nuclear receptor subfamily 1 group I member 3
increases activity multiple interactions
EXP
artemisinin results in increased activity of NR1I3 protein; artemisinin results in increased activity of NR1I3 protein alternative form; artemisinin results in increased activity of NR1I3 protein mutant form androstan-3-ol inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form]; artemisinin inhibits the reaction [androstan-3-ol results in decreased activity of NR1I3 protein alternative form]; artemisinin inhibits the reaction [Imidazoles results in decreased activity of NR1I3 protein alternative form]; Imidazoles inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form]
CTD
PMID:21778469 PMID:27732639
NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NPPA
natriuretic peptide A
affects abundance
EXP
NPPA protein affects the abundance of Epinephrine
CTD
PMID:2951327
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRB1
adrenoceptor beta 1
increases activity
EXP
Norepinephrine results in increased activity of ADRB1 protein
CTD
PMID:10344530
NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
G
ADRB2
adrenoceptor beta 2
multiple interactions
EXP
[Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine
CTD
PMID:2884805
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
NPPA
natriuretic peptide A
increases expression
EXP
Norepinephrine results in increased expression of NPPA protein
CTD
PMID:8952593
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions increases activity
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased activity of PIK3CG protein]; [Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
POMC
proopiomelanocortin
increases response to substance
EXP
POMC protein results in increased susceptibility to Norepinephrine
CTD
PMID:6279499
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
PRKCZ
protein kinase C zeta
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
REN
renin
increases activity
EXP
Norepinephrine results in increased activity of REN protein
CTD
PMID:8952593
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLCG1
phospholipase C gamma 1
decreases activity multiple interactions
EXP
1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein]
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Dithiothreitol metabolite results in increased expression of HSPA5 protein
CTD
PMID:17416481
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP8
caspase 8
increases activity multiple interactions
EXP
4-phenylenediamine results in increased activity of CASP8 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP8 protein]
CTD
PMID:20156547
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
CASP9
caspase 9
multiple interactions increases activity
EXP
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP9 protein]
CTD
PMID:20156547
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLCG1
phospholipase C gamma 1
increases activity
EXP
1-stearoyl-2-arachidonoylphosphatidic acid results in increased activity of PLCG1 protein
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HIF1A
hypoxia inducible factor 1 subunit alpha
increases expression
EXP
15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein
CTD
PMID:17658243
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
increases reduction
EXP
DHRS4 protein results in increased reduction of 16-ketoestrone
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport
EXP
ABCC2 protein affects the transport of Estradiol
CTD
PMID:15507541
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
ESR1
estrogen receptor 1
affects expression
EXP
Estradiol affects the expression of ESR1 protein
CTD
PMID:16483645
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of estradiol-17 beta-glucuronide
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SOD2
superoxide dismutase 2
multiple interactions
EXP
Dihydrotestosterone promotes the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein]
CTD
PMID:16682413
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin
CTD
PMID:20510202
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SCT
secretin
decreases abundance
EXP
SCT protein results in decreased abundance of Lactic Acid
CTD
PMID:2418308
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SOD1
superoxide dismutase 1
affects response to substance
EXP
SOD1 protein affects the susceptibility to Nafenopin
CTD
PMID:6333936
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
P2RY2
purinergic receptor P2Y2
multiple interactions
EXP
[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP]
CTD
PMID:10604969
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
multiple interactions
EXP
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate
CTD
PMID:2579070
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CFTR
CF transmembrane conductance regulator
multiple interactions
EXP
[1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of CFTR protein
CTD
PMID:15161604
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
3-oxocholan-24-oic acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
KCNH2
potassium voltage-gated channel subfamily H member 2
multiple interactions
EXP
Cisapride binds to and results in decreased activity of KCNH2 protein
CTD
PMID:12388285
NCBI chr16:15,009,031...15,041,786
Ensembl chr16:15,009,031...15,041,504
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ALPI
alkaline phosphatase, intestinal
increases chemical synthesis
EXP
ALPI protein results in increased chemical synthesis of nitrophenylphosphate
CTD
PMID:1495895
NCBI chr25:44,107,418...44,110,947
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
P2RY2
purinergic receptor P2Y2
multiple interactions
EXP
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP]
CTD
PMID:10604969
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CFTR
CF transmembrane conductance regulator
decreases activity
EXP
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CFTR protein
CTD
PMID:15496164
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CFTR
CF transmembrane conductance regulator
multiple interactions
EXP
[1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of CFTR protein
CTD
PMID:15161604
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
increases reduction
EXP
DHRS4 protein results in increased reduction of 9-cis-retinal
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
2-acetyltributylcitrate results in increased activity of NR1I2 protein
CTD
PMID:21742782
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
KCNJ3
potassium inwardly rectifying channel subfamily J member 3
multiple interactions
EXP
Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr36:1,354,686...1,496,397
Ensembl chr36:1,354,678...1,493,766
G
KCNJ6
potassium inwardly rectifying channel subfamily J member 6
multiple interactions
EXP
Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr31:32,752,585...33,010,999
Ensembl chr31:32,755,899...32,934,478
G
MAPK14
mitogen-activated protein kinase 14
multiple interactions
EXP
Acetylcholine results in increased phosphorylation of and results in increased activity of MAPK14 protein
CTD
PMID:9688607
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Aspirin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AVP
arginine vasopressin
decreases activity
EXP
Acyclovir results in decreased activity of AVP protein
CTD
PMID:2724137
NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AGT
angiotensinogen
increases abundance
EXP
AGT results in increased abundance of Aldosterone
CTD
PMID:2831029
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
POMC
proopiomelanocortin
increases abundance
EXP
POMC protein results in increased abundance of Aldosterone
CTD
PMID:2831029
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP3
caspase 3
increases activity
EXP
Tretinoin results in increased activity of CASP3 protein
CTD
PMID:16953078
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CLDN1
claudin 1
multiple interactions increases expression
EXP
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA] Tretinoin results in increased expression of CLDN1 mRNA; Tretinoin results in increased expression of CLDN1 protein
CTD
PMID:17035595
NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033
G
CLDN4
claudin 4
increases expression multiple interactions
EXP
Tretinoin results in increased expression of CLDN4 mRNA; Tretinoin results in increased expression of CLDN4 protein CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]
CTD
PMID:17035595
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
CYP26A1
cytochrome P450 family 26 subfamily A member 1
increases degradation multiple interactions
EXP
CYP26A1 protein results in increased degradation of Tretinoin CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD
PMID:17035595
NCBI chr28:7,423,955...7,432,359
Ensembl chr28:7,428,772...7,432,370
G
NOS3
nitric oxide synthase 3
increases expression
EXP
Tretinoin results in increased expression of NOS3 mRNA; Tretinoin results in increased expression of NOS3 protein
CTD
PMID:17267746
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
OCLN
occludin
multiple interactions increases expression
EXP
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA] Tretinoin results in increased expression of OCLN mRNA; Tretinoin results in increased expression of OCLN protein
CTD
PMID:17035595
NCBI chr 2:54,500,299...54,545,430
Ensembl chr 2:54,500,299...54,545,430
G
TJP1
tight junction protein 1
increases expression multiple interactions
EXP
Tretinoin results in increased expression of TJP1 mRNA; Tretinoin results in increased expression of TJP1 protein CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD
PMID:17035595
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLN
phospholamban
affects expression
EXP
Allopurinol affects the expression of PLN mRNA; Allopurinol affects the expression of PLN protein; Allopurinol affects the expression of PLN protein modified form
CTD
PMID:17071724
NCBI chr 1:58,579,095...58,590,541
Ensembl chr 1:58,579,145...58,590,535
G
SLC8A1
solute carrier family 8 member A1
affects expression
EXP
Allopurinol affects the expression of SLC8A1 mRNA; Allopurinol affects the expression of SLC8A1 protein
CTD
PMID:17071724
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC8A1
solute carrier family 8 member A1
decreases activity
EXP
Amiodarone results in decreased activity of SLC8A1 protein
CTD
PMID:15288574
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
increases expression
EXP
Amlodipine results in increased expression of REN protein
CTD
PMID:10218729
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRB1
adrenoceptor beta 1
multiple interactions
EXP
amosulalol binds to and results in decreased activity of ADRB1 protein
CTD
PMID:6129981
NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
G
ADRB2
adrenoceptor beta 2
multiple interactions
EXP
amosulalol binds to and results in decreased activity of ADRB2 protein
CTD
PMID:6129981
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
IL6
interleukin 6
multiple interactions increases expression
EXP
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein]
CTD
PMID:24105867
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
increases expression multiple interactions
EXP
Amphotericin B results in increased expression of PRKACG protein N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein]
CTD
PMID:24105867
NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146
G
REN
renin
decreases secretion
EXP
Amphotericin B results in decreased secretion of REN protein
CTD
PMID:7391978
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
TNF
tumor necrosis factor
increases expression
EXP
Amphotericin B results in increased expression of TNF protein
CTD
PMID:24105867
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
P2RY2
purinergic receptor P2Y2
multiple interactions
EXP
[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]
CTD
PMID:10604969
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[Chlorodiphenyl (54% Chlorine) binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein
CTD
PMID:24389113
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
EXP
[Chlorodiphenyl (54% Chlorine) binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein
CTD
PMID:24389113
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
Arsenic results in increased phosphorylation of MAPK1 protein
CTD
PMID:29306782
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
Arsenic results in increased phosphorylation of MAPK3 protein
CTD
PMID:29306782
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein
CTD
PMID:23236503
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein
CTD
PMID:23236503
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
SLC9A1
solute carrier family 9 member A1
increases expression
EXP
Arsenic Trioxide results in increased expression of SLC9A1 protein
CTD
PMID:23236503
NCBI chr 2:73,054,742...73,103,364
Ensembl chr 2:73,054,742...73,103,364
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
multiple interactions
EXP
Atenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]
CTD
PMID:6103674
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase
multiple interactions
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
SCT
secretin
multiple interactions
EXP
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates]
CTD
PMID:3562434
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
KCNJ3
potassium inwardly rectifying channel subfamily J member 3
multiple interactions
EXP
Barium inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr36:1,354,686...1,496,397
Ensembl chr36:1,354,678...1,493,766
G
KCNJ6
potassium inwardly rectifying channel subfamily J member 6
multiple interactions
EXP
Barium inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr31:32,752,585...33,010,999
Ensembl chr31:32,755,899...32,934,478
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DES
desmin
decreases expression
EXP
benazepril results in decreased expression of DES mRNA
CTD
PMID:20137276
NCBI chr37:25,933,525...25,939,910
Ensembl chr37:25,933,455...25,940,985
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing
EXP
CYP2C11 protein affects the metabolism of Benzyl Alcohol
CTD
PMID:8592870
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
affects metabolic processing
EXP
CYP2E1 protein affects the metabolism of Benzyl Alcohol
CTD
PMID:8592870
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NR1I3
nuclear receptor subfamily 1 group I member 3
increases activity
EXP
Diethylhexyl Phthalate results in increased activity of NR1I3 protein
CTD
PMID:27732639
NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AADAT
aminoadipate aminotransferase
decreases expression
EXP
bisphenol A results in decreased expression of AADAT mRNA
CTD
PMID:38866337
NCBI chr25:20,920,118...20,944,251
Ensembl chr25:20,920,139...20,945,387
G
ABCA8
ATP binding cassette subfamily A member 8
increases expression
EXP
bisphenol A results in increased expression of ABCA8 mRNA
CTD
PMID:38866337
NCBI chr 9:15,420,305...15,497,175
G
ABCA9
ATP binding cassette subfamily A member 9
increases expression
EXP
bisphenol A results in increased expression of ABCA9 mRNA
CTD
PMID:38866337
NCBI chr 9:15,515,462...15,574,890
Ensembl chr 9:15,420,835...15,783,045
G
ABCB4
ATP binding cassette subfamily B member 4
decreases expression
EXP
bisphenol A results in decreased expression of ABCB4 mRNA
CTD
PMID:38866337
NCBI chr14:13,542,610...13,614,334
Ensembl chr14:13,548,462...13,614,571
G
ABCC5
ATP binding cassette subfamily C member 5
increases expression
EXP
bisphenol A results in increased expression of ABCC5 mRNA
CTD
PMID:38866337
NCBI chr34:16,856,624...16,947,844
Ensembl chr34:16,856,633...16,946,422
G
ACACA
acetyl-CoA carboxylase alpha
increases expression
EXP
bisphenol A results in increased expression of ACACA mRNA
CTD
PMID:38866337
NCBI chr 9:36,904,204...37,188,096
Ensembl chr 9:36,905,293...37,187,892
G
ACAD9
acyl-CoA dehydrogenase family member 9
increases expression
EXP
bisphenol A results in increased expression of ACAD9 mRNA
CTD
PMID:38866337
NCBI chr20:3,155,754...3,205,307
Ensembl chr20:3,021,167...3,205,279
G
ACIN1
apoptotic chromatin condensation inducer 1
increases expression
EXP
bisphenol A results in increased expression of ACIN1 mRNA
CTD
PMID:38866337
NCBI chr 8:3,370,469...3,405,710
Ensembl chr 8:3,371,004...3,405,682
G
ACKR2
atypical chemokine receptor 2
increases expression
EXP
bisphenol A results in increased expression of ACKR2 mRNA
CTD
PMID:38866337
NCBI chr23:11,904,020...11,962,291
Ensembl chr23:11,960,981...11,962,135
G
ACP3
acid phosphatase 3
decreases expression
EXP
bisphenol A results in decreased expression of ACP3 mRNA
CTD
PMID:38866337
NCBI chr23:29,294,641...29,353,970
Ensembl chr23:29,294,843...29,343,499
G
ACSBG1
acyl-CoA synthetase bubblegum family member 1
increases expression
EXP
bisphenol A results in increased expression of ACSBG1 mRNA
CTD
PMID:38866337
NCBI chr 3:58,319,222...58,367,087
Ensembl chr 3:58,319,376...58,366,854
G
ACSL1
acyl-CoA synthetase long chain family member 1
increases expression
EXP
bisphenol A results in increased expression of ACSL1 mRNA
CTD
PMID:38866337
NCBI chr16:45,735,675...45,806,235
Ensembl chr16:45,735,703...45,804,970
G
ACTN3
actinin alpha 3
increases expression
EXP
bisphenol A results in increased expression of ACTN3 mRNA
CTD
PMID:38866337
NCBI chr18:50,787,353...50,801,036
Ensembl chr18:50,787,353...50,801,197
G
ACVR2A
activin A receptor type 2A
increases expression
EXP
bisphenol A results in increased expression of ACVR2A mRNA
CTD
PMID:38866337
NCBI chr19:49,642,429...49,726,720
Ensembl chr19:49,641,219...49,723,420
G
ADA
adenosine deaminase
decreases expression
EXP
bisphenol A results in decreased expression of ADA mRNA
CTD
PMID:38866337
NCBI chr24:32,083,786...32,119,810
Ensembl chr24:32,083,931...32,111,160
G
ADGRG4
adhesion G protein-coupled receptor G4
decreases expression
EXP
bisphenol A results in decreased expression of ADGRG4 mRNA
CTD
PMID:38866337
NCBI chr X:106,700,740...106,784,092
Ensembl chr X:106,680,887...106,785,009
G
ADGRG6
adhesion G protein-coupled receptor G6
decreases expression
EXP
bisphenol A results in decreased expression of ADGRG6 mRNA
CTD
PMID:38866337
NCBI chr 1:33,967,783...34,106,950
Ensembl chr 1:33,969,268...34,104,228
G
ADHFE1
alcohol dehydrogenase iron containing 1
increases expression
EXP
bisphenol A results in increased expression of ADHFE1 mRNA
CTD
PMID:38866337
NCBI chr29:16,019,183...16,054,060
Ensembl chr29:16,019,246...16,050,535
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
increases expression
EXP
bisphenol A results in increased expression of ADIPOQ mRNA
CTD
PMID:38866337
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
AGBL4
AGBL carboxypeptidase 4
increases expression
EXP
bisphenol A results in increased expression of AGBL4 mRNA
CTD
PMID:38866337
NCBI chr15:11,056,440...12,435,428
Ensembl chr15:11,056,447...12,435,448
G
AGFG2
ArfGAP with FG repeats 2
increases expression
EXP
bisphenol A results in increased expression of AGFG2 mRNA
CTD
PMID:38866337
NCBI chr 6:9,122,324...9,143,858
Ensembl chr 6:9,122,298...9,143,774
G
AHCYL1
adenosylhomocysteinase like 1
increases expression
EXP
bisphenol A results in increased expression of AHCYL1 mRNA
CTD
PMID:38866337
NCBI chr 6:41,945,224...41,983,917
Ensembl chr 6:41,946,974...41,985,643
G
AHCYL2
adenosylhomocysteinase like 2
increases expression
EXP
bisphenol A results in increased expression of AHCYL2 mRNA
CTD
PMID:38866337
NCBI chr14:7,347,173...7,509,113
Ensembl chr14:7,350,102...7,509,157
G
AIF1L
allograft inflammatory factor 1 like
decreases expression
EXP
bisphenol A results in decreased expression of AIF1L mRNA
CTD
PMID:38866337
NCBI chr 9:52,944,925...52,966,953
Ensembl chr 9:52,947,570...52,966,894
G
AIFM1
apoptosis inducing factor mitochondria associated 1
increases expression
EXP
bisphenol A results in increased expression of AIFM1 mRNA
CTD
PMID:38866337
NCBI chr X:101,275,027...101,307,551
Ensembl chr X:101,275,017...101,307,367
G
AK1
adenylate kinase 1
decreases expression
EXP
bisphenol A results in decreased expression of AK1 mRNA
CTD
PMID:38866337
NCBI chr 9:55,539,179...55,548,132
Ensembl chr 9:55,539,260...55,548,132
G
AK5
adenylate kinase 5
decreases expression
EXP
bisphenol A results in decreased expression of AK5 mRNA
CTD
PMID:38866337
NCBI chr 6:69,282,997...69,520,903
Ensembl chr 6:69,284,288...69,521,020
G
AKAP8
A-kinase anchoring protein 8
increases expression
EXP
bisphenol A results in increased expression of AKAP8 mRNA
CTD
PMID:38866337
NCBI chr20:46,800,917...46,817,397
Ensembl chr20:46,800,872...46,817,397
G
AKIRIN1
akirin 1
decreases expression
EXP
bisphenol A results in decreased expression of AKIRIN1 mRNA
CTD
PMID:38866337
NCBI chr15:3,759,559...3,771,651
Ensembl chr15:3,763,374...3,771,551
G
ALAS1
5'-aminolevulinate synthase 1
increases expression
EXP
bisphenol A results in increased expression of ALAS1 mRNA
CTD
PMID:38866337
NCBI chr20:37,552,813...37,566,417
Ensembl chr20:37,552,814...37,566,638
G
ALCAM
activated leukocyte cell adhesion molecule
increases expression
EXP
bisphenol A results in increased expression of ALCAM mRNA
CTD
PMID:38866337
NCBI chr33:10,983,363...11,195,170
Ensembl chr33:10,983,363...11,370,085
G
ALDH18A1
aldehyde dehydrogenase 18 family member A1
decreases expression
EXP
bisphenol A results in decreased expression of ALDH18A1 mRNA
CTD
PMID:38866337
NCBI chr28:9,101,578...9,148,063
Ensembl chr28:9,102,282...9,147,992
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
decreases expression
EXP
bisphenol A results in decreased expression of ALDH1L2 mRNA
CTD
PMID:38866337
NCBI chr10:33,310,523...33,365,677
Ensembl chr10:33,310,558...33,365,228
G
ALDH7A1
aldehyde dehydrogenase 7 family member A1
increases expression
EXP
bisphenol A results in increased expression of ALDH7A1 mRNA
CTD
PMID:38866337
NCBI chr11:15,828,581...15,878,556
Ensembl chr11:15,815,936...15,878,516
G
ALKBH2
alkB homolog 2, alpha-ketoglutarate dependent dioxygenase
increases expression
EXP
bisphenol A results in increased expression of ALKBH2 mRNA
CTD
PMID:38866337
NCBI chr26:17,911,892...17,918,911
Ensembl chr26:17,911,763...17,917,788
G
ALS2
alsin Rho guanine nucleotide exchange factor ALS2
increases expression
EXP
bisphenol A results in increased expression of ALS2 mRNA
CTD
PMID:38866337
NCBI chr37:10,755,595...10,825,073
Ensembl chr37:10,756,515...10,812,292
G
AMMECR1
AMMECR nuclear protein 1
increases expression
EXP
bisphenol A results in increased expression of AMMECR1 mRNA
CTD
PMID:38866337
NCBI chr X:83,401,728...83,517,565
Ensembl chr X:83,406,049...83,517,498
G
ANGPT4
angiopoietin 4
increases expression
EXP
bisphenol A results in increased expression of ANGPT4 mRNA
CTD
PMID:38866337
NCBI chr24:20,021,625...20,068,805
Ensembl chr24:20,022,322...20,064,023
G
ANKRD50
ankyrin repeat domain containing 50
increases expression
EXP
bisphenol A results in increased expression of ANKRD50 mRNA
CTD
PMID:38866337
NCBI chr19:15,876,656...15,907,899
Ensembl chr19:15,876,566...15,903,238
G
ANKRD66
ankyrin repeat domain 66
increases expression
EXP
bisphenol A results in increased expression of ANKRD66 mRNA
CTD
PMID:38866337
NCBI chr12:14,919,258...14,933,438
G
ANTXR2
ANTXR cell adhesion molecule 2
increases expression
EXP
bisphenol A results in increased expression of ANTXR2 mRNA
CTD
PMID:38866337
NCBI chr32:4,143,407...4,302,194
Ensembl chr32:4,148,310...4,302,071
G
AOC2
amine oxidase copper containing 2
increases expression
EXP
bisphenol A results in increased expression of AOC2 mRNA
CTD
PMID:38866337
NCBI chr 9:20,180,005...20,185,863
Ensembl chr 9:20,180,205...20,185,103
G
AOPEP
aminopeptidase O (putative)
decreases expression
EXP
bisphenol A results in decreased expression of AOPEP mRNA
CTD
PMID:38866337
NCBI chr 1:71,770,687...72,009,374
Ensembl chr 1:71,677,068...72,009,395
G
AP1G1
adaptor related protein complex 1 subunit gamma 1
increases expression
EXP
bisphenol A results in increased expression of AP1G1 mRNA
CTD
PMID:38866337
NCBI chr 5:77,512,865...77,589,136
Ensembl chr 5:77,432,517...77,565,801
G
AP3M2
adaptor related protein complex 3 subunit mu 2
increases expression
EXP
bisphenol A results in increased expression of AP3M2 mRNA
CTD
PMID:38866337
NCBI chr16:23,500,988...23,518,193
Ensembl chr16:23,454,325...23,518,193
G
AP3S2
adaptor related protein complex 3 subunit sigma 2
decreases expression
EXP
bisphenol A results in decreased expression of AP3S2 mRNA
CTD
PMID:38866337
NCBI chr 3:52,807,462...52,865,290
Ensembl chr 3:52,807,462...52,865,245
G
APBB2
amyloid beta precursor protein binding family B member 2
increases expression
EXP
bisphenol A results in increased expression of APBB2 mRNA
CTD
PMID:38866337
NCBI chr 3:71,454,814...71,830,482
Ensembl chr 3:71,454,585...71,826,749
G
APEX2
apurinic/apyrimidinic endodeoxyribonuclease 2
increases expression
EXP
bisphenol A results in increased expression of APEX2 mRNA
CTD
PMID:38866337
NCBI chr X:46,692,667...46,703,309
Ensembl chr X:46,693,191...46,702,195
G
APLP2
amyloid beta precursor like protein 2
increases expression
EXP
bisphenol A results in increased expression of APLP2 mRNA
CTD
PMID:38866337
NCBI chr 5:4,704,155...4,786,011
Ensembl chr 5:4,705,491...4,786,079
G
APMAP
adipocyte plasma membrane associated protein
increases expression
EXP
bisphenol A results in increased expression of APMAP mRNA
CTD
PMID:38866337
NCBI chr23:1,148,662...1,183,997
Ensembl chr23:1,150,778...1,184,003
G
APOB
apolipoprotein B
decreases expression
EXP
bisphenol A results in decreased expression of APOB mRNA
CTD
PMID:38866337
NCBI chr17:15,877,937...15,916,032
Ensembl chr17:15,878,244...15,915,135
G
AQR
aquarius intron-binding spliceosomal factor
increases expression
EXP
bisphenol A results in increased expression of AQR mRNA
CTD
PMID:38866337
NCBI chr30:2,571,359...2,670,715
Ensembl chr30:2,571,554...2,670,597
G
ARFGEF2
ADP ribosylation factor guanine nucleotide exchange factor 2
increases expression
EXP
bisphenol A results in increased expression of ARFGEF2 mRNA
CTD
PMID:38866337
NCBI chr24:35,648,650...35,744,815
Ensembl chr24:35,648,431...35,744,584
G
ARHGDIB
Rho GDP dissociation inhibitor beta
decreases expression
EXP
bisphenol A results in decreased expression of ARHGDIB mRNA
CTD
PMID:38866337
NCBI chr27:31,662,817...31,681,951
Ensembl chr27:31,662,925...31,681,642
G
ARHGDIG
Rho GDP dissociation inhibitor gamma
decreases expression
EXP
bisphenol A results in decreased expression of ARHGDIG mRNA
CTD
PMID:38866337
NCBI chr 6:40,222,014...40,225,037
Ensembl chr 6:40,221,103...40,223,115
G
ARMH4
armadillo like helical domain containing 4
increases expression
EXP
bisphenol A results in increased expression of ARMH4 mRNA
CTD
PMID:38866337
NCBI chr 8:33,411,953...33,575,083
Ensembl chr 8:33,412,665...33,551,054
G
ARNT
aryl hydrocarbon receptor nuclear translocator
increases expression
EXP
bisphenol A results in increased expression of ARNT mRNA
CTD
PMID:38866337
Ensembl chr17:59,941,353...60,010,867 Ensembl chr17:59,941,353...60,010,867
G
ARRB1
arrestin beta 1
increases expression
EXP
bisphenol A results in increased expression of ARRB1 mRNA
CTD
PMID:38866337
NCBI chr21:23,261,020...23,304,448
Ensembl chr21:23,235,711...23,297,786
G
ASB9
ankyrin repeat and SOCS box containing 9
decreases expression
EXP
bisphenol A results in decreased expression of ASB9 mRNA
CTD
PMID:38866337
NCBI chr X:11,505,941...11,533,335
Ensembl chr X:11,505,941...11,533,135
G
ASH2L
ASH2 like, histone lysine methyltransferase complex subunit
increases expression
EXP
bisphenol A results in increased expression of ASH2L mRNA
CTD
PMID:38866337
NCBI chr16:27,334,419...27,366,994
Ensembl chr16:27,334,420...27,366,950
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
EXP
bisphenol A results in decreased expression of ASNS mRNA
CTD
PMID:38866337
NCBI chr14:22,718,020...22,734,109
Ensembl chr14:22,718,042...22,734,054
G
ATOSA
atos homolog A
increases expression
EXP
bisphenol A results in increased expression of FAM214A mRNA
CTD
PMID:38866337
NCBI chr30:18,221,930...18,308,390
Ensembl chr30:18,221,987...18,306,807
G
BATF3
basic leucine zipper ATF-like transcription factor 3
decreases expression
EXP
bisphenol A results in decreased expression of BATF3 mRNA
CTD
PMID:38866337
NCBI chr 7:10,843,859...10,854,269
Ensembl chr 7:10,843,850...10,857,847
G
BCAT1
branched chain amino acid transaminase 1
decreases expression
EXP
bisphenol A results in decreased expression of BCAT1 mRNA
CTD
PMID:38866337
NCBI chr27:22,536,297...22,643,350
Ensembl chr27:22,535,254...22,636,959
G
BCL2L2
BCL2 like 2
increases expression
EXP
bisphenol A results in increased expression of BCL2L2 mRNA
CTD
PMID:38866337
NCBI chr 8:3,569,335...3,573,922
Ensembl chr 8:3,569,399...3,586,070
G
BLID
BH3-like motif containing, cell death inducer
decreases expression
EXP
bisphenol A results in decreased expression of BLID mRNA
CTD
PMID:38866337
NCBI chr 5:11,989,993...12,083,555
G
BMP4
bone morphogenetic protein 4
increases expression
EXP
bisphenol A results in increased expression of BMP4 mRNA
CTD
PMID:38866337
NCBI chr 8:29,997,563...30,254,307
Ensembl chr 8:29,997,569...30,004,557
G
BMPR1B
bone morphogenetic protein receptor type 1B
decreases expression
EXP
bisphenol A results in decreased expression of BMPR1B mRNA
CTD
PMID:38866337
NCBI chr32:17,761,555...17,978,056
Ensembl chr32:17,870,904...18,016,444
G
BNIP3
BCL2 interacting protein 3
decreases expression
EXP
bisphenol A results in decreased expression of BNIP3 mRNA
CTD
PMID:38866337
NCBI chr28:40,037,681...40,050,499
Ensembl chr28:40,038,643...40,049,797
G
BSDC1
BSD domain containing 1
increases expression
EXP
bisphenol A results in increased expression of BSDC1 mRNA
CTD
PMID:38866337
NCBI chr 2:68,848,324...68,874,321
Ensembl chr 2:68,848,550...68,873,520
G
BSPRY
B-box and SPRY domain containing
increases expression
EXP
bisphenol A results in increased expression of BSPRY mRNA
CTD
PMID:38866337
NCBI chr11:67,702,949...67,726,809
Ensembl chr11:67,704,845...67,726,155
G
BTBD7
BTB domain containing 7
increases expression
EXP
bisphenol A results in increased expression of BTBD7 mRNA
CTD
PMID:38866337
NCBI chr 8:62,437,825...62,547,419
Ensembl chr 8:62,441,752...62,522,836
G
BTG1
BTG anti-proliferation factor 1
increases expression
EXP
bisphenol A results in increased expression of BTG1 mRNA
CTD
PMID:38866337
NCBI chr15:32,646,520...32,648,222
Ensembl chr15:32,647,472...32,647,762
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
increases expression
EXP
bisphenol A results in increased expression of BUB1B mRNA
CTD
PMID:38866337
NCBI chr30:7,361,982...7,410,162
Ensembl chr30:7,322,912...7,438,052
G
BVES
blood vessel epicardial substance
decreases expression
EXP
bisphenol A results in decreased expression of BVES mRNA
CTD
PMID:38866337
NCBI chr12:62,542,274...62,581,110
Ensembl chr12:62,545,666...62,579,548
G
C10H12orf75
chromosome 10 C12orf75 homolog
decreases expression
EXP
bisphenol A results in decreased expression of C10H12ORF75 mRNA
CTD
PMID:38866337
NCBI chr10:33,093,491...33,100,926
G
C13H8orf82
chromosome 13 C8orf82 homolog
decreases expression
EXP
bisphenol A results in decreased expression of C13H8ORF82 mRNA
CTD
PMID:38866337
G
C1QTNF2
C1q and TNF related 2
decreases expression
EXP
bisphenol A results in decreased expression of C1QTNF2 mRNA
CTD
PMID:38866337
NCBI chr 4:50,352,245...50,372,412
Ensembl chr 4:50,367,910...50,372,597
G
C1QTNF3
C1q and TNF related 3
decreases expression
EXP
bisphenol A results in decreased expression of C1QTNF3 mRNA
CTD
PMID:38866337
NCBI chr 4:73,787,706...73,817,410
G
C20H19orf44
chromosome 20 C19orf44 homolog
increases expression
EXP
bisphenol A results in increased expression of C20H19ORF44 mRNA
CTD
PMID:38866337
NCBI chr20:46,019,750...46,039,201
Ensembl chr20:46,020,441...46,037,713
G
C26H12orf43
chromosome 26 C12orf43 homolog
increases expression
EXP
bisphenol A results in increased expression of C26H12ORF43 mRNA
CTD
PMID:38866337
NCBI chr26:16,826,481...16,835,832
Ensembl chr26:16,826,489...16,835,796
G
C28H10orf90
chromosome 28 C10orf90 homolog
decreases expression
EXP
bisphenol A results in decreased expression of C28H10ORF90 mRNA
CTD
PMID:38866337
NCBI chr28:35,514,489...35,721,091
Ensembl chr28:35,515,286...35,720,509
G
C30H15orf48
chromosome 30 C15orf48 homolog
decreases expression
EXP
bisphenol A results in decreased expression of C30H15ORF48 mRNA
CTD
PMID:38866337
Ensembl chr30:11,795,781...11,800,915 Ensembl chr30:11,795,781...11,800,915
G
C5AR2
complement C5a receptor 2
increases expression
EXP
bisphenol A results in increased expression of C5AR2 mRNA
CTD
PMID:38866337
NCBI chr 1:108,644,195...108,652,628
Ensembl chr 1:108,644,945...108,645,958
G
C7
complement C7
increases expression
EXP
bisphenol A results in increased expression of C7 mRNA
CTD
PMID:38866337
NCBI chr 4:68,450,660...68,502,753
Ensembl chr 4:68,451,578...68,513,386
G
CA12
carbonic anhydrase 12
decreases expression
EXP
bisphenol A results in decreased expression of CA12 mRNA
CTD
PMID:38866337
NCBI chr30:27,903,460...27,957,162
Ensembl chr30:27,905,837...27,957,742
G
CA9
carbonic anhydrase 9
decreases expression
EXP
bisphenol A results in decreased expression of CA9 mRNA
CTD
PMID:38866337
NCBI chr11:52,205,619...52,211,281
Ensembl chr11:52,205,668...52,211,267
G
CALU
calumenin
decreases expression
EXP
bisphenol A results in decreased expression of CALU mRNA
CTD
PMID:38866337
NCBI chr14:7,869,946...7,899,302
Ensembl chr14:7,872,076...7,925,078
G
CANX
calnexin
increases expression
EXP
bisphenol A results in increased expression of CANX mRNA
CTD
PMID:38866337
NCBI chr11:1,966,612...1,998,620
Ensembl chr11:1,927,888...1,998,604
G
CARMIL1
capping protein regulator and myosin 1 linker 1
increases expression
EXP
bisphenol A results in increased expression of CARMIL1 mRNA
CTD
PMID:38866337
NCBI chr35:23,268,438...23,581,794
Ensembl chr35:23,268,723...23,581,403
G
CATSPER3
cation channel sperm associated 3
increases expression
EXP
bisphenol A results in increased expression of CATSPER3 mRNA
CTD
PMID:38866337
NCBI chr11:23,018,770...23,057,945
Ensembl chr11:23,021,663...23,052,820
G
CAV1
caveolin 1
decreases expression
EXP
bisphenol A results in decreased expression of CAV1 mRNA
CTD
PMID:38866337
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
G
CCDC141
coiled-coil domain containing 141
increases expression
EXP
bisphenol A results in increased expression of CCDC141 mRNA
CTD
PMID:38866337
NCBI chr36:22,437,363...22,626,200
Ensembl chr36:22,492,052...22,625,957
G
CCDC170
coiled-coil domain containing 170
decreases expression
EXP
bisphenol A results in decreased expression of CCDC170 mRNA
CTD
PMID:38866337
NCBI chr 1:41,858,005...41,932,286
Ensembl chr 1:41,858,020...41,932,260
G
CCL2
C-C motif chemokine ligand 2
decreases expression
EXP
bisphenol A results in decreased expression of CCL2 mRNA
CTD
PMID:38866337
NCBI chr 9:39,008,187...39,009,932
G
CCL4
chemokine (C-C motif) ligand 4
decreases expression
EXP
bisphenol A results in decreased expression of CCL4 mRNA
CTD
PMID:38866337
NCBI chr 9:37,681,342...37,682,691
Ensembl chr 9:37,676,966...37,710,209
G
CCL8
C-C motif chemokine ligand 8
decreases expression
EXP
bisphenol A results in decreased expression of CCL8 mRNA
CTD
PMID:38866337
NCBI chr 9:38,949,184...38,950,702
Ensembl chr 9:38,948,184...38,950,803
G
CCR4
C-C motif chemokine receptor 4
decreases expression
EXP
bisphenol A results in decreased expression of CCR4 mRNA
CTD
PMID:38866337
NCBI chr23:3,844,072...3,847,770
Ensembl chr23:3,844,173...3,845,255
G
CD109
CD109 molecule
increases expression
EXP
bisphenol A results in increased expression of CD109 mRNA
CTD
PMID:38866337
NCBI chr12:35,712,589...35,839,153
Ensembl chr12:35,712,271...35,839,044
G
CD36
CD36 molecule (CD36 blood group)
increases expression
EXP
bisphenol A results in increased expression of CD36 mRNA
CTD
PMID:38866337
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD3G
CD3 gamma subunit of T-cell receptor complex
increases expression
EXP
bisphenol A results in increased expression of CD3G mRNA
CTD
PMID:38866337
NCBI chr 5:15,379,788...15,391,271
Ensembl chr 5:15,380,633...15,391,214
G
CD40
CD40 molecule
decreases expression
EXP
bisphenol A results in decreased expression of CD40 mRNA
CTD
PMID:38866337
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CD55
CD55 molecule
increases expression
EXP
bisphenol A results in increased expression of CD55 mRNA
CTD
PMID:38866337
NCBI chr 7:6,361,037...6,396,063
Ensembl chr 7:6,360,964...6,386,226
G
CD72
CD72 molecule
decreases expression
EXP
bisphenol A results in decreased expression of CD72 mRNA
CTD
PMID:38866337
NCBI chr11:52,170,893...52,179,035
Ensembl chr11:52,170,893...52,178,301
G
CD74
CD74 molecule
decreases expression
EXP
bisphenol A results in decreased expression of CD74 mRNA
CTD
PMID:38866337
NCBI chr 4:58,689,745...58,698,421
Ensembl chr 4:58,689,752...58,698,151
G
CDC42EP3
CDC42 effector protein 3
decreases expression
EXP
bisphenol A results in decreased expression of CDC42EP3 mRNA
CTD
PMID:38866337
NCBI chr17:29,949,452...29,973,008
Ensembl chr17:29,950,210...29,973,008
G
CDK8
cyclin dependent kinase 8
decreases expression
EXP
bisphenol A results in decreased expression of CDK8 mRNA
CTD
PMID:38866337
NCBI chr25:13,043,949...13,179,752
Ensembl chr25:13,045,343...13,179,656
G
CDKN1C
cyclin dependent kinase inhibitor 1C
increases expression
EXP
bisphenol A results in increased expression of CDKN1C mRNA
CTD
PMID:38866337
NCBI chr18:46,860,636...46,861,697
G
CDPF1
cysteine rich DPF motif domain containing 1
increases expression
EXP
bisphenol A results in increased expression of CDPF1 mRNA
CTD
PMID:38866337
NCBI chr10:19,928,742...19,950,129
Ensembl chr10:19,929,142...19,932,650
G
CDYL
chromodomain Y like
decreases expression
EXP
bisphenol A results in decreased expression of CDYL mRNA
CTD
PMID:38866337
NCBI chr35:4,844,757...5,074,967
Ensembl chr35:4,844,779...5,073,670
G
CELF2
CUGBP Elav-like family member 2
increases expression
EXP
bisphenol A results in increased expression of CELF2 mRNA
CTD
PMID:38866337
NCBI chr 2:25,003,810...25,818,264
Ensembl chr 2:25,004,580...25,520,136
G
CENPS
centromere protein S
decreases expression
EXP
bisphenol A results in decreased expression of CENPS mRNA
CTD
PMID:38866337
NCBI chr 2:85,379,378...85,389,175
G
CEP68
centrosomal protein 68
increases expression
EXP
bisphenol A results in increased expression of CEP68 mRNA
CTD
PMID:38866337
NCBI chr10:64,545,010...64,561,481
Ensembl chr10:64,538,166...64,561,684
G
CEP89
centrosomal protein 89
decreases expression
EXP
bisphenol A results in decreased expression of CEP89 mRNA
CTD
PMID:38866337
NCBI chr 1:119,124,042...119,197,394
Ensembl chr 1:119,123,933...119,197,338
G
CFAP119
cilia and flagella associated protein 119
increases expression
EXP
bisphenol A results in increased expression of CCDC189 mRNA
CTD
PMID:38866337
NCBI chr 6:17,414,722...17,419,011
Ensembl chr 6:17,414,809...17,418,848
G
CFAP53
cilia and flagella associated protein 53
increases expression
EXP
bisphenol A results in increased expression of CFAP53 mRNA
CTD
PMID:38866337
NCBI chr 7:78,612,226...78,649,518
Ensembl chr 7:78,597,746...78,651,472
G
CGREF1
cell growth regulator with EF-hand domain 1
decreases expression
EXP
bisphenol A results in decreased expression of CGREF1 mRNA
CTD
PMID:38866337
NCBI chr17:21,093,664...21,106,797
G
CHKA
choline kinase alpha
increases expression
EXP
bisphenol A results in increased expression of CHKA mRNA
CTD
PMID:38866337
NCBI chr18:49,717,512...49,784,653
Ensembl chr18:49,745,437...49,781,882
G
CHN1
chimerin 1
decreases expression
EXP
bisphenol A results in decreased expression of CHN1 mRNA
CTD
PMID:38866337
NCBI chr36:18,785,470...18,990,409
Ensembl chr36:18,786,073...18,980,993
G
CHRDL1
chordin like 1
increases expression
EXP
bisphenol A results in increased expression of CHRDL1 mRNA
CTD
PMID:38866337
NCBI chr X:83,816,131...83,936,497
Ensembl chr X:83,817,880...83,936,949
G
CIART
circadian associated repressor of transcription
increases expression
EXP
bisphenol A results in increased expression of CIART mRNA
CTD
PMID:38866337
NCBI chr17:59,524,715...59,529,535
Ensembl chr17:59,525,987...59,529,402
G
CIDEA
cell death inducing DFFA like effector a
increases expression
EXP
bisphenol A results in increased expression of CIDEA mRNA
CTD
PMID:38866337
NCBI chr 7:77,685,383...77,703,320
Ensembl chr 7:77,684,863...77,702,934
G
CIDEC
cell death inducing DFFA like effector c
increases expression
EXP
bisphenol A results in increased expression of CIDEC mRNA
CTD
PMID:38866337
NCBI chr20:8,386,334...8,402,076
Ensembl chr20:8,386,415...8,401,774
G
CILK1
ciliogenesis associated kinase 1
increases expression
EXP
bisphenol A results in increased expression of CILK1 mRNA
CTD
PMID:38866337
NCBI chr12:20,453,322...20,511,463
Ensembl chr12:20,450,834...20,511,673
G
CIPC
CLOCK interacting pacemaker
increases expression
EXP
bisphenol A results in increased expression of CIPC mRNA
CTD
PMID:38866337
NCBI chr 8:49,926,494...49,947,006
Ensembl chr 8:49,926,978...49,945,326
G
CITED1
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1
increases expression
EXP
bisphenol A results in increased expression of CITED1 mRNA
CTD
PMID:38866337
NCBI chr X:56,327,104...56,332,608
Ensembl chr X:56,327,182...56,332,047
G
CLCC1
chloride channel CLIC like 1
decreases expression
EXP
bisphenol A results in decreased expression of CLCC1 mRNA
CTD
PMID:38866337
NCBI chr 6:42,807,432...42,829,317
Ensembl chr 6:42,807,064...42,829,273
G
CLDN1
claudin 1
increases expression
EXP
bisphenol A results in increased expression of CLDN1 mRNA
CTD
PMID:38866337
NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033
G
CLMP
CXADR like membrane protein
decreases expression
EXP
bisphenol A results in decreased expression of CLMP mRNA
CTD
PMID:38866337
NCBI chr 5:11,255,054...11,289,578
Ensembl chr 5:11,267,038...11,286,682
G
CLSPN
claspin
increases expression
EXP
bisphenol A results in increased expression of CLSPN mRNA
CTD
PMID:38866337
NCBI chr15:6,400,084...6,430,295
Ensembl chr15:6,400,062...6,430,279
G
CMA1
chymase 1
decreases expression
EXP
bisphenol A results in decreased expression of CMA1 mRNA
CTD
PMID:38866337
NCBI chr 8:4,438,244...4,441,189
Ensembl chr 8:4,438,244...4,441,189
G
CNIH1
cornichon family AMPA receptor auxiliary protein 1
decreases expression
EXP
bisphenol A results in decreased expression of CNIH1 mRNA
CTD
PMID:38866337
NCBI chr 8:30,365,010...30,379,356
Ensembl chr 8:30,359,499...30,408,357
G
CNN1
calponin 1
decreases expression
EXP
bisphenol A results in decreased expression of CNN1 mRNA
CTD
PMID:38866337
NCBI chr20:49,830,859...49,837,432
Ensembl chr20:49,831,265...49,837,385
G
COLEC12
collectin subfamily member 12
increases expression
EXP
bisphenol A results in increased expression of COLEC12 mRNA
CTD
PMID:38866337
NCBI chr 7:67,192,191...67,373,524
Ensembl chr 7:67,193,626...67,372,755
G
COX19
cytochrome c oxidase assembly factor COX19
increases expression
EXP
bisphenol A results in increased expression of COX19 mRNA
CTD
PMID:38866337
NCBI chr 6:15,897,702...15,908,020
Ensembl chr 6:15,897,774...15,904,998
G
CPEB4
cytoplasmic polyadenylation element binding protein 4
increases expression
EXP
bisphenol A results in increased expression of CPEB4 mRNA
CTD
PMID:38866337
NCBI chr 4:38,604,065...38,665,200
Ensembl chr 4:38,607,948...38,664,821
G
CPM
carboxypeptidase M
decreases expression
EXP
bisphenol A results in decreased expression of CPM mRNA
CTD
PMID:38866337
NCBI chr10:10,968,830...10,999,887
G
CPQ
carboxypeptidase Q
decreases expression
EXP
bisphenol A results in decreased expression of CPQ mRNA
CTD
PMID:38866337
NCBI chr29:41,058,641...41,461,567
Ensembl chr29:41,058,306...41,461,563
G
CPXM1
carboxypeptidase X, M14 family member 1
increases expression
EXP
bisphenol A results in increased expression of CPXM1 mRNA
CTD
PMID:38866337
NCBI chr24:18,453,874...18,460,350
Ensembl chr24:18,453,712...18,461,738
G
CRABP2
cellular retinoic acid binding protein 2
decreases expression
EXP
bisphenol A results in decreased expression of CRABP2 mRNA
CTD
PMID:38866337
NCBI chr 7:41,277,580...41,282,158
Ensembl chr 7:41,277,644...41,281,833
G
CRB3
crumbs cell polarity complex component 3
decreases expression
EXP
bisphenol A results in decreased expression of CRB3 mRNA
CTD
PMID:38866337
NCBI chr20:53,717,844...53,722,127
Ensembl chr20:53,718,103...53,720,381
G
CRYBG3
crystallin beta-gamma domain containing 3
increases expression
EXP
bisphenol A results in increased expression of CRYBG3 mRNA
CTD
PMID:38866337
NCBI chr33:4,864,458...4,967,707
Ensembl chr33:4,864,458...4,966,440
G
CSF2
colony stimulating factor 2
decreases expression
EXP
bisphenol A results in decreased expression of CSF2 mRNA
CTD
PMID:38866337
NCBI chr11:20,342,880...20,346,959
Ensembl chr11:20,344,648...20,346,959
G
CSNK1G1
casein kinase 1 gamma 1
increases expression
EXP
bisphenol A results in increased expression of CSNK1G1 mRNA
CTD
PMID:38866337
NCBI chr30:28,661,726...28,832,193
Ensembl chr30:28,654,200...28,788,801
G
CTCF
CCCTC-binding factor
increases expression
EXP
bisphenol A results in increased expression of CTCF mRNA
CTD
PMID:38866337
NCBI chr 5:81,808,512...81,863,811
Ensembl chr 5:81,809,393...81,858,655
G
CTHRC1
collagen triple helix repeat containing 1
decreases expression
EXP
bisphenol A results in decreased expression of CTHRC1 mRNA
CTD
PMID:38866337
NCBI chr13:4,801,049...4,811,565
Ensembl chr13:4,805,577...4,811,282
G
CTNS
cystinosin, lysosomal cystine transporter
increases expression
EXP
bisphenol A results in increased expression of CTNS mRNA
CTD
PMID:38866337
NCBI chr 9:47,474,488...47,490,951
Ensembl chr 9:47,473,901...47,490,252
G
CTR9
CTR9 homolog, Paf1/RNA polymerase II complex component
increases expression
EXP
bisphenol A results in increased expression of CTR9 mRNA
CTD
PMID:38866337
NCBI chr21:33,915,804...33,949,597
Ensembl chr21:33,915,772...33,949,103
G
CXCL12
C-X-C motif chemokine ligand 12
increases expression
EXP
bisphenol A results in increased expression of CXCL12 mRNA
CTD
PMID:38866337
NCBI chr28:2,895,916...2,903,543
G
CXCL8
C-X-C motif chemokine ligand 8
decreases expression
EXP
bisphenol A results in decreased expression of CXCL8 mRNA
CTD
PMID:38866337
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CYB5D1
cytochrome b5 domain containing 1
increases expression
EXP
bisphenol A results in increased expression of CYB5D1 mRNA
CTD
PMID:38866337
NCBI chr 5:32,714,130...32,721,719
G
CYGB
cytoglobin
increases expression
EXP
bisphenol A results in increased expression of CYGB mRNA
CTD
PMID:38866337
NCBI chr 9:4,191,114...4,201,438
Ensembl chr 9:4,184,959...4,200,164
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
increases expression
EXP
bisphenol A results in increased expression of CYP27A1 mRNA
CTD
PMID:38866337
NCBI chr37:25,366,475...25,401,978
Ensembl chr37:25,366,472...25,401,509
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
decreases expression
EXP
bisphenol A results in decreased expression of CYP2J2 mRNA
CTD
PMID:38866337
NCBI chr 5:49,942,241...49,986,603
Ensembl chr 5:49,942,193...49,984,617
G
CYP2U1
cytochrome P450 family 2 subfamily U member 1
increases expression
EXP
bisphenol A results in increased expression of CYP2U1 mRNA
CTD
PMID:38866337
NCBI chr32:28,426,250...28,445,399
Ensembl chr32:28,438,173...28,444,383
G
CYSRT1
cysteine rich tail 1
decreases expression
EXP
bisphenol A results in decreased expression of CYSRT1 mRNA
CTD
PMID:38866337
NCBI chr 9:48,447,774...48,449,765
G
DAZAP2
DAZ associated protein 2
increases expression
EXP
bisphenol A results in increased expression of DAZAP2 mRNA
CTD
PMID:38866337
NCBI chr27:3,617,346...3,621,592
Ensembl chr27:3,615,726...3,621,587
G
DBNDD2
dysbindin domain containing 2
decreases expression
EXP
bisphenol A results in decreased expression of DBNDD2 mRNA
CTD
PMID:38866337
NCBI chr24:32,661,966...32,701,789
Ensembl chr24:32,697,708...32,700,203
G
DCLK1
doublecortin like kinase 1
decreases expression
EXP
bisphenol A results in decreased expression of DCLK1 mRNA
CTD
PMID:38866337
NCBI chr25:4,441,945...4,783,542
Ensembl chr25:4,345,771...4,778,047
G
DCPS
decapping enzyme, scavenger
decreases expression
EXP
bisphenol A results in decreased expression of DCPS mRNA
CTD
PMID:38866337
NCBI chr 5:8,168,887...8,212,582
Ensembl chr 5:8,172,313...8,212,832
G
DCX
doublecortin
increases expression
EXP
bisphenol A results in increased expression of DCX mRNA
CTD
PMID:38866337
NCBI chr X:84,408,762...84,541,157
Ensembl chr X:84,408,895...84,517,827
G
DDAH1
dimethylarginine dimethylaminohydrolase 1
decreases expression
EXP
bisphenol A results in decreased expression of DDAH1 mRNA
CTD
PMID:38866337
NCBI chr 6:62,548,852...62,683,687
Ensembl chr 6:62,549,152...62,683,729
G
DDIT4L
DNA damage inducible transcript 4 like
increases expression
EXP
bisphenol A results in increased expression of DDIT4L mRNA
CTD
PMID:38866337
NCBI chr32:22,062,630...22,067,364
Ensembl chr32:22,064,393...22,068,562
G
DDRGK1
DDRGK domain containing 1
increases expression
EXP
bisphenol A results in increased expression of DDRGK1 mRNA
CTD
PMID:38866337
NCBI chr24:18,085,865...18,098,868
Ensembl chr24:18,084,725...18,097,157
G
DEF6
DEF6 guanine nucleotide exchange factor
increases expression
EXP
bisphenol A results in increased expression of DEF6 mRNA
CTD
PMID:38866337
NCBI chr12:4,463,512...4,483,544
Ensembl chr12:4,463,913...4,483,556
G
DENND2A
DENN domain containing 2A
increases expression
EXP
bisphenol A results in increased expression of DENND2A mRNA
CTD
PMID:38866337
NCBI chr16:8,377,389...8,479,791
Ensembl chr16:8,376,316...8,478,890
G
DENND5A
DENN domain containing 5A
increases expression
EXP
bisphenol A results in increased expression of DENND5A mRNA
CTD
PMID:38866337
NCBI chr21:32,465,278...32,573,381
Ensembl chr21:32,370,913...32,574,588
G
DHDH
dihydrodiol dehydrogenase
increases expression
EXP
bisphenol A results in increased expression of DHDH mRNA
CTD
PMID:38866337
NCBI chr 1:107,434,363...107,445,068
Ensembl chr 1:107,434,323...107,445,107
G
DHRS2
dehydrogenase/reductase 2
decreases expression
EXP
bisphenol A results in decreased expression of DHRS2 mRNA
CTD
PMID:38866337
NCBI chr 8:3,820,269...3,847,217
Ensembl chr 8:3,836,476...3,845,916
G
DHRS9
dehydrogenase/reductase 9
increases expression
EXP
bisphenol A results in increased expression of DHRS9 mRNA
CTD
PMID:38866337
NCBI chr36:13,859,935...13,881,432
Ensembl chr36:13,866,959...13,880,179
G
DIO1
iodothyronine deiodinase 1
decreases expression
EXP
bisphenol A results in decreased expression of DIO1 mRNA
CTD
PMID:38866337
NCBI chr 5:55,081,894...55,098,560
Ensembl chr 5:55,082,604...55,098,529
G
DKK1
dickkopf WNT signaling pathway inhibitor 1
decreases expression
EXP
bisphenol A results in decreased expression of DKK1 mRNA
CTD
PMID:38866337
NCBI chr26:35,697,428...35,701,596
Ensembl chr26:35,697,618...35,701,496
G
DKK2
dickkopf WNT signaling pathway inhibitor 2
increases expression
EXP
bisphenol A results in increased expression of DKK2 mRNA
CTD
PMID:38866337
NCBI chr32:27,548,877...27,647,039
Ensembl chr32:27,550,833...27,713,838
G
DLA-DOB
major histocompatibility complex, class II, DO beta
increases expression
EXP
bisphenol A results in increased expression of DLA-DOB mRNA
CTD
PMID:38866337
NCBI chr12:2,376,957...2,384,179
Ensembl chr12:2,378,126...2,432,303
G
DLST
dihydrolipoamide S-succinyltransferase
increases expression
EXP
bisphenol A results in increased expression of DLST mRNA
CTD
PMID:38866337
NCBI chr 8:48,003,730...48,025,001
Ensembl chr 8:48,002,211...48,024,999
G
DMXL2
Dmx like 2
increases expression
EXP
bisphenol A results in increased expression of DMXL2 mRNA
CTD
PMID:38866337
NCBI chr30:17,156,077...17,308,641
Ensembl chr30:17,156,791...17,308,803
G
DNAAF8
dynein axonemal assembly factor 8
increases expression
EXP
bisphenol A results in increased expression of DNAAF8 mRNA
CTD
PMID:38866337
NCBI chr 6:36,665,193...36,678,860
Ensembl chr 6:36,665,455...36,678,680
G
DNAJB13
DnaJ heat shock protein family (Hsp40) member B13
increases expression
EXP
bisphenol A results in increased expression of DNAJB13 mRNA
CTD
PMID:38866337
NCBI chr21:24,314,242...24,326,605
Ensembl chr21:24,314,248...24,338,253
G
DNAJB5
DnaJ heat shock protein family (Hsp40) member B5
decreases expression
EXP
bisphenol A results in decreased expression of DNAJB5 mRNA
CTD
PMID:38866337
NCBI chr11:51,587,728...51,596,911
Ensembl chr11:51,587,295...51,595,839
G
DNAJC13
DnaJ heat shock protein family (Hsp40) member C13
increases expression
EXP
bisphenol A results in increased expression of DNAJC13 mRNA
CTD
PMID:38866337
NCBI chr23:29,389,120...29,506,339
Ensembl chr23:29,389,979...29,506,343
G
DNAJC17
DnaJ heat shock protein family (Hsp40) member C17
decreases expression
EXP
bisphenol A results in decreased expression of DNAJC17 mRNA
CTD
PMID:38866337
NCBI chr30:7,904,519...7,945,222
Ensembl chr30:7,904,517...7,945,125
G
DNAL4
dynein axonemal light chain 4
increases expression
EXP
bisphenol A results in increased expression of DNAL4 mRNA
CTD
PMID:38866337
NCBI chr10:26,023,706...26,037,883
Ensembl chr10:26,030,850...26,035,690
G
DOCK9
dedicator of cytokinesis 9
increases expression
EXP
bisphenol A results in increased expression of DOCK9 mRNA
CTD
PMID:38866337
NCBI chr22:48,880,335...49,159,395
Ensembl chr22:48,880,972...49,159,711
G
DSE
dermatan sulfate epimerase
decreases expression
EXP
bisphenol A results in decreased expression of DSE mRNA
CTD
PMID:38866337
NCBI chr 1:56,787,809...56,868,037
Ensembl chr 1:56,787,256...56,867,716
G
DSEL
dermatan sulfate epimerase like
decreases expression
EXP
bisphenol A results in decreased expression of DSEL mRNA
CTD
PMID:38866337
NCBI chr 1:10,344,468...10,366,936
G
DSTYK
dual serine/threonine and tyrosine protein kinase
increases expression
EXP
bisphenol A results in increased expression of DSTYK mRNA
CTD
PMID:38866337
NCBI chr38:1,669,721...1,716,407
Ensembl chr38:1,669,726...1,716,254
G
DUSP13B
dual specificity phosphatase 13B
decreases expression
EXP
bisphenol A results in decreased expression of DUSP13 mRNA
CTD
PMID:38866337
NCBI chr 4:25,360,291...25,373,299
Ensembl chr 4:25,360,294...25,373,238
G
DUSP14
dual specificity phosphatase 14
decreases expression
EXP
bisphenol A results in decreased expression of DUSP14 mRNA
CTD
PMID:38866337
NCBI chr 9:37,253,305...37,277,320
Ensembl chr 9:37,276,084...37,276,680
G
DUSP6
dual specificity phosphatase 6
increases expression
EXP
bisphenol A results in increased expression of DUSP6 mRNA
CTD
PMID:38866337
NCBI chr15:30,322,472...30,327,221
Ensembl chr15:30,323,697...30,326,508
G
DYNC2H1
dynein cytoplasmic 2 heavy chain 1
increases expression
EXP
bisphenol A results in increased expression of DYNC2H1 mRNA
CTD
PMID:38866337
NCBI chr 5:28,566,604...28,727,416
Ensembl chr 5:28,388,664...28,727,334
G
DYNLT2
dynein light chain Tctex-type 2
increases expression
EXP
bisphenol A results in increased expression of DYNLT2 mRNA
CTD
PMID:38866337
G
DYNLT4
dynein light chain Tctex-type 4
increases expression
EXP
bisphenol A results in increased expression of DYNLT4 mRNA
CTD
PMID:38866337
NCBI chr15:15,516,950...15,519,137
Ensembl chr15:15,518,369...15,519,028
G
EBF1
EBF transcription factor 1
increases expression
EXP
bisphenol A results in increased expression of EBF1 mRNA
CTD
PMID:38866337
NCBI chr 4:51,378,314...51,765,768
Ensembl chr 4:51,379,233...51,763,035
G
ECHDC2
enoyl-CoA hydratase domain containing 2
increases expression
EXP
bisphenol A results in increased expression of ECHDC2 mRNA
CTD
PMID:38866337
NCBI chr 5:55,972,116...55,991,573
Ensembl chr 5:55,972,004...55,991,531
G
EDN1
endothelin 1
decreases expression
EXP
bisphenol A results in decreased expression of EDN1 mRNA
CTD
PMID:38866337
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
EDNRA
endothelin receptor type A
decreases expression
EXP
bisphenol A results in decreased expression of EDNRA mRNA
CTD
PMID:38866337
NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463
G
EEF2K
eukaryotic elongation factor 2 kinase
increases expression
EXP
bisphenol A results in increased expression of EEF2K mRNA
CTD
PMID:38866337
NCBI chr 6:23,368,296...23,433,853
Ensembl chr 6:23,371,546...23,433,929
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
increases expression
EXP
bisphenol A results in increased expression of EFEMP1 mRNA
CTD
PMID:38866337
NCBI chr10:56,632,801...56,694,872
Ensembl chr10:56,579,899...56,787,187
G
EGLN3
egl-9 family hypoxia inducible factor 3
decreases expression
EXP
bisphenol A results in decreased expression of EGLN3 mRNA
CTD
PMID:38866337
NCBI chr 8:12,873,755...12,901,728
Ensembl chr 8:12,875,387...12,901,709
G
EIF2B5
eukaryotic translation initiation factor 2B subunit epsilon
increases expression
EXP
bisphenol A results in increased expression of EIF2B5 mRNA
CTD
PMID:38866337
NCBI chr34:17,038,163...17,047,390
Ensembl chr34:17,038,203...17,046,928
G
EIF5B
eukaryotic translation initiation factor 5B
increases expression
EXP
bisphenol A results in increased expression of EIF5B mRNA
CTD
PMID:38866337
NCBI chr10:43,247,536...43,342,754
Ensembl chr10:43,244,704...43,342,575
G
ELK4
ETS transcription factor ELK4
increases expression
EXP
bisphenol A results in increased expression of ELK4 mRNA
CTD
PMID:38866337
NCBI chr38:2,069,829...2,085,381
Ensembl chr38:2,078,008...2,125,069
G
ELOB
elongin B
decreases expression
EXP
bisphenol A results in decreased expression of ELOB mRNA
CTD
PMID:38866337
NCBI chr 6:38,311,082...38,314,502
Ensembl chr 6:38,311,082...38,314,508
G
ELOVL7
ELOVL fatty acid elongase 7
decreases expression
EXP
bisphenol A results in decreased expression of ELOVL7 mRNA
CTD
PMID:38866337
NCBI chr 2:47,406,323...47,482,113
Ensembl chr 2:47,296,656...47,482,064
G
EMC9
ER membrane protein complex subunit 9
increases expression
EXP
bisphenol A results in increased expression of EMC9 mRNA
CTD
PMID:38866337
NCBI chr 8:4,133,997...4,136,144
Ensembl chr 8:4,134,020...4,136,290
G
EML1
EMAP like 1
increases expression
EXP
bisphenol A results in increased expression of EML1 mRNA
CTD
PMID:38866337
NCBI chr 8:68,139,741...68,295,363
Ensembl chr 8:68,216,857...68,294,080
G
EMP1
epithelial membrane protein 1
decreases expression
EXP
bisphenol A results in decreased expression of EMP1 mRNA
CTD
PMID:38866337
NCBI chr27:33,177,874...33,199,048
Ensembl chr27:33,179,576...33,206,634
G
ENO1
enolase 1
decreases expression
EXP
bisphenol A results in decreased expression of ENO1 mRNA
CTD
PMID:38866337
NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
G
ENO3
enolase 3
decreases expression
EXP
bisphenol A results in decreased expression of ENO3 mRNA
CTD
PMID:38866337
NCBI chr 5:31,662,284...31,667,498
Ensembl chr 5:31,662,285...31,834,968
G
ENPP5
ectonucleotide pyrophosphatase/phosphodiesterase family member 5
increases expression
EXP
bisphenol A results in increased expression of ENPP5 mRNA
CTD
PMID:38866337
NCBI chr12:14,376,278...14,387,883
Ensembl chr12:14,377,565...14,385,171
G
ENTPD3
ectonucleoside triphosphate diphosphohydrolase 3
decreases expression
EXP
bisphenol A results in decreased expression of ENTPD3 mRNA
CTD
PMID:38866337
NCBI chr23:9,858,328...9,891,244
Ensembl chr23:9,858,764...9,890,483
G
EPB42
erythrocyte membrane protein band 4.2
increases expression
EXP
bisphenol A results in increased expression of EPB42 mRNA
CTD
PMID:38866337
NCBI chr30:10,065,352...10,085,021
Ensembl chr30:10,065,469...10,084,976
G
EPHX2
epoxide hydrolase 2
increases expression
EXP
bisphenol A results in increased expression of EPHX2 mRNA
CTD
PMID:38866337
NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
G
ERAP1
endoplasmic reticulum aminopeptidase 1
increases expression
EXP
bisphenol A results in increased expression of ERAP1 mRNA
CTD
PMID:38866337
NCBI chr 3:12,879,823...12,920,710
Ensembl chr 3:12,879,477...12,919,634
G
EREG
epiregulin
decreases expression
EXP
bisphenol A results in decreased expression of EREG mRNA
CTD
PMID:38866337
NCBI chr13:62,857,325...62,877,831
Ensembl chr13:62,856,709...62,877,760
G
ERLIN2
ER lipid raft associated 2
increases expression
EXP
bisphenol A results in increased expression of ERLIN2 mRNA
CTD
PMID:38866337
NCBI chr16:27,622,549...27,639,807
Ensembl chr16:27,625,417...27,639,202
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
decreases expression
EXP
bisphenol A results in decreased expression of ERO1A mRNA
CTD
PMID:38866337
NCBI chr 8:28,864,642...28,913,864
Ensembl chr 8:28,864,925...28,914,368
G
EXTL3
exostosin like glycosyltransferase 3
increases expression
EXP
bisphenol A results in increased expression of EXTL3 mRNA
CTD
PMID:38866337
NCBI chr25:28,788,803...28,833,964
Ensembl chr25:28,790,506...28,937,647
G
F11R
F11 receptor
increases expression
EXP
bisphenol A results in increased expression of F11R mRNA
CTD
PMID:38866337
NCBI chr38:21,433,819...21,456,722
Ensembl chr38:21,451,952...21,454,959
G
F13A1
coagulation factor XIII A chain
decreases expression
EXP
bisphenol A results in decreased expression of F13A1 mRNA
CTD
PMID:38866337
NCBI chr35:6,186,750...6,347,522
Ensembl chr35:6,187,235...6,349,773
G
F2RL1
F2R like trypsin receptor 1
decreases expression
EXP
bisphenol A results in decreased expression of F2RL1 mRNA
CTD
PMID:38866337
NCBI chr 3:29,801,119...29,810,006
Ensembl chr 3:29,800,211...29,810,180
G
F3
coagulation factor III, tissue factor
decreases expression
EXP
bisphenol A results in decreased expression of F3 mRNA
CTD
PMID:38866337
NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
G
FABP4
fatty acid binding protein 4
increases expression
EXP
bisphenol A results in increased expression of FABP4 mRNA
CTD
PMID:38866337
NCBI chr29:28,651,550...28,656,255
Ensembl chr29:28,652,146...28,656,228
G
FABP5
fatty acid binding protein 5
increases expression
EXP
bisphenol A results in increased expression of FABP5 mRNA
CTD
PMID:38866337
NCBI chr29:28,488,818...28,492,698
G
FAH
fumarylacetoacetate hydrolase
decreases expression
EXP
bisphenol A results in decreased expression of FAH mRNA
CTD
PMID:38866337
NCBI chr 3:57,300,422...57,326,546
Ensembl chr 3:57,300,441...57,326,486
G
FAM107A
family with sequence similarity 107 member A
increases expression
EXP
bisphenol A results in increased expression of FAM107A mRNA
CTD
PMID:38866337
NCBI chr20:32,047,132...32,099,815
Ensembl chr20:32,047,625...32,097,585
G
FAM13C
family with sequence similarity 13 member C
decreases expression
EXP
bisphenol A results in decreased expression of FAM13C mRNA
CTD
PMID:38866337
NCBI chr 4:11,461,024...11,607,901
Ensembl chr 4:11,452,422...11,608,088
G
FAM180A
family with sequence similarity 180 member A
increases expression
EXP
bisphenol A results in increased expression of FAM180A mRNA
CTD
PMID:38866337
NCBI chr16:12,523,407...12,535,510
Ensembl chr16:12,523,467...12,535,885
G
FAM228B
family with sequence similarity 228, member B
increases expression
EXP
bisphenol A results in increased expression of FAM228B mRNA
CTD
PMID:38866337
NCBI chr17:18,579,700...18,615,602
G
FAM229A
family with sequence similarity 229 member A
increases expression
EXP
bisphenol A results in increased expression of FAM229A mRNA
CTD
PMID:38866337
NCBI chr 2:68,876,345...68,877,498
Ensembl chr 2:68,874,679...68,877,498
G
FAM234B
family with sequence similarity 234 member B
increases expression
EXP
bisphenol A results in increased expression of FAM234B mRNA
CTD
PMID:38866337
NCBI chr27:33,302,816...33,337,751
Ensembl chr27:33,305,231...33,337,577
G
FAM72A
family with sequence similarity 72 member A
decreases expression
EXP
bisphenol A results in decreased expression of FAM72A mRNA
CTD
PMID:38866337
NCBI chr38:2,495,180...2,505,313
G
FAM98A
family with sequence similarity 98 member A
increases expression
EXP
bisphenol A results in increased expression of FAM98A mRNA
CTD
PMID:38866337
NCBI chr17:26,671,254...26,687,808
Ensembl chr17:26,671,948...26,688,447
G
FANK1
fibronectin type III and ankyrin repeat domains 1
decreases expression
EXP
bisphenol A results in decreased expression of FANK1 mRNA
CTD
PMID:38866337
NCBI chr28:35,042,045...35,152,282
Ensembl chr28:35,095,689...35,152,276
G
FAXDC2
fatty acid hydroxylase domain containing 2
increases expression
EXP
bisphenol A results in increased expression of FAXDC2 mRNA
CTD
PMID:38866337
NCBI chr 4:54,962,585...54,988,756
Ensembl chr 4:54,970,733...54,991,204
G
FBH1
F-box DNA helicase 1
increases expression
EXP
bisphenol A results in increased expression of FBH1 mRNA
CTD
PMID:38866337
NCBI chr 2:30,047,994...30,095,761
Ensembl chr 2:30,048,567...30,095,696
G
FBLL1
fibrillarin like 1
increases expression
EXP
bisphenol A results in increased expression of FBLL1 mRNA
CTD
PMID:38866337
NCBI chr 4:43,214,112...43,216,772
G
FBXO21
F-box protein 21
increases expression
EXP
bisphenol A results in increased expression of FBXO21 mRNA
CTD
PMID:38866337
NCBI chr26:13,722,301...13,769,273
Ensembl chr26:13,725,137...13,769,234
G
FBXW12
F-box and WD repeat domain containing 12
decreases expression
EXP
bisphenol A results in decreased expression of FBXW12 mRNA
CTD
PMID:38866337
NCBI chr20:40,696,434...40,711,177
Ensembl chr20:40,696,502...40,710,720
G
FBXW2
F-box and WD repeat domain containing 2
increases expression
EXP
bisphenol A results in increased expression of FBXW2 mRNA
CTD
PMID:38866337
NCBI chr11:73,825,191...73,848,361
Ensembl chr11:73,824,590...73,849,249
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
increases expression
EXP
bisphenol A results in increased expression of FDFT1 mRNA
CTD
PMID:38866337
NCBI chr25:26,060,031...26,093,515
Ensembl chr25:26,060,386...26,093,582
G
FFAR3
free fatty acid receptor 3
increases expression
EXP
bisphenol A results in increased expression of FFAR3 mRNA
CTD
PMID:38866337
NCBI chr 1:117,251,604...117,257,048
G
FGD6
FYVE, RhoGEF and PH domain containing 6
increases expression
EXP
bisphenol A results in increased expression of FGD6 mRNA
CTD
PMID:38866337
NCBI chr15:35,050,993...35,162,421
Ensembl chr15:35,055,469...35,162,224
G
FGL1
fibrinogen like 1
increases expression
EXP
bisphenol A results in increased expression of FGL1 mRNA
CTD
PMID:38866337
NCBI chr16:41,161,314...41,191,282
Ensembl chr16:41,161,394...41,179,791
G
FHOD3
formin homology 2 domain containing 3
decreases expression
EXP
bisphenol A results in decreased expression of FHOD3 mRNA
CTD
PMID:38866337
NCBI chr 7:53,477,273...53,933,532
Ensembl chr 7:53,478,930...53,934,331
G
FICD
FIC domain protein adenylyltransferase
decreases expression
EXP
bisphenol A results in decreased expression of FICD mRNA
CTD
PMID:38866337
NCBI chr26:18,347,393...18,353,081
Ensembl chr26:18,348,526...18,353,665
G
FKBP11
FKBP prolyl isomerase 11
decreases expression
EXP
bisphenol A results in decreased expression of FKBP11 mRNA
CTD
PMID:38866337
NCBI chr27:5,636,643...5,639,521
Ensembl chr27:5,636,627...5,639,509
G
FKBP5
FKBP prolyl isomerase 5
increases expression
EXP
bisphenol A results in increased expression of FKBP5 mRNA
CTD
PMID:38866337
NCBI chr12:4,724,668...4,833,691
Ensembl chr12:4,727,497...4,833,323
G
FRMD3
FERM domain containing 3
increases expression
EXP
bisphenol A results in increased expression of FRMD3 mRNA
CTD
PMID:38866337
NCBI chr 1:75,893,014...76,183,234
Ensembl chr 1:75,893,008...76,183,228
G
FRYL
FRY like transcription coactivator
increases expression
EXP
bisphenol A results in increased expression of FRYL mRNA
CTD
PMID:38866337
NCBI chr13:44,307,293...44,565,449
Ensembl chr13:44,307,859...44,527,170
G
FXYD4
FXYD domain containing ion transport regulator 4
decreases expression
EXP
bisphenol A results in decreased expression of FXYD4 mRNA
CTD
PMID:38866337
NCBI chr28:3,685,057...3,690,388
Ensembl chr28:3,685,151...3,687,652
G
FZD6
frizzled class receptor 6
decreases expression
EXP
bisphenol A results in decreased expression of FZD6 mRNA
CTD
PMID:38866337
NCBI chr13:4,732,541...4,771,294
Ensembl chr13:4,733,017...4,772,115
G
GADD45B
growth arrest and DNA damage inducible beta
decreases expression
EXP
bisphenol A results in decreased expression of GADD45B mRNA
CTD
PMID:38866337
NCBI chr20:56,627,915...56,629,960
Ensembl chr20:56,628,485...56,629,730
G
GAP43
growth associated protein 43
decreases expression
EXP
bisphenol A results in decreased expression of GAP43 mRNA
CTD
PMID:38866337
NCBI chr33:19,668,491...19,770,509
Ensembl chr33:19,656,835...19,770,408
G
GAPVD1
GTPase activating protein and VPS9 domains 1
increases expression
EXP
bisphenol A results in increased expression of GAPVD1 mRNA
CTD
PMID:38866337
NCBI chr 9:57,751,988...57,836,526
Ensembl chr 9:57,756,234...57,802,174
G
GAR1
GAR1 ribonucleoprotein
increases expression
EXP
bisphenol A results in increased expression of GAR1 mRNA
CTD
PMID:38866337
NCBI chr32:29,995,710...30,004,545
Ensembl chr32:29,996,148...30,004,536
G
GARS1
glycyl-tRNA synthetase 1
decreases expression
EXP
bisphenol A results in decreased expression of GARS1 mRNA
CTD
PMID:38866337
NCBI chr14:43,308,274...43,351,999
Ensembl chr14:43,308,152...43,396,487
G
GCNT1
glucosaminyl (N-acetyl) transferase 1
decreases expression
EXP
bisphenol A results in decreased expression of GCNT1 mRNA
CTD
PMID:38866337
NCBI chr 1:81,985,519...82,017,420
G
GCNT4
glucosaminyl (N-acetyl) transferase 4
decreases expression
EXP
bisphenol A results in decreased expression of GCNT4 mRNA
CTD
PMID:38866337
NCBI chr 3:31,198,656...31,222,523
Ensembl chr 3:31,217,562...31,218,926
G
GDA
guanine deaminase
increases expression
EXP
bisphenol A results in increased expression of GDA mRNA
CTD
PMID:38866337
NCBI chr 1:85,506,598...85,586,212
Ensembl chr 1:85,444,917...85,586,163
G
GEMIN5
gem nuclear organelle associated protein 5
increases expression
EXP
bisphenol A results in increased expression of GEMIN5 mRNA
CTD
PMID:38866337
NCBI chr 4:54,894,747...54,934,869
Ensembl chr 4:54,894,784...54,934,986
G
GGA2
golgi associated, gamma adaptin ear containing, ARF binding protein 2
increases expression
EXP
bisphenol A results in increased expression of GGA2 mRNA
CTD
PMID:38866337
NCBI chr 6:22,309,565...22,342,469
Ensembl chr 6:22,309,537...22,341,632
G
GLB1L
galactosidase beta 1 like
increases expression
EXP
bisphenol A results in increased expression of GLB1L mRNA
CTD
PMID:38866337
NCBI chr37:25,783,837...25,793,968
Ensembl chr37:25,783,816...25,792,589
G
GLCE
glucuronic acid epimerase
increases expression
EXP
bisphenol A results in increased expression of GLCE mRNA
CTD
PMID:38866337
NCBI chr30:33,093,318...33,208,754
Ensembl chr30:33,110,947...33,206,095
G
GLS
glutaminase
decreases expression
EXP
bisphenol A results in decreased expression of GLS mRNA
CTD
PMID:38866337
NCBI chr37:1,433,640...1,508,347
Ensembl chr37:1,433,398...1,508,146
G
GLS2
glutaminase 2
increases expression
EXP
bisphenol A results in increased expression of GLS2 mRNA
CTD
PMID:38866337
NCBI chr10:722,105...737,857
Ensembl chr10:722,202...737,753
G
GLUL
glutamate-ammonia ligase
increases expression
EXP
bisphenol A results in increased expression of GLUL mRNA
CTD
PMID:38866337
NCBI chr 7:15,730,898...15,740,241
Ensembl chr 7:15,730,898...15,740,241
G
GMPR
guanosine monophosphate reductase
decreases expression
EXP
bisphenol A results in decreased expression of GMPR mRNA
CTD
PMID:38866337
NCBI chr35:15,400,937...15,449,157
Ensembl chr35:15,401,003...15,448,022
G
GNG2
G protein subunit gamma 2
decreases expression
EXP
bisphenol A results in decreased expression of GNG2 mRNA
CTD
PMID:38866337
NCBI chr 8:28,080,699...28,194,464
Ensembl chr 8:28,049,195...28,191,358
G
GNG3
G protein subunit gamma 3
increases expression
EXP
bisphenol A results in increased expression of GNG3 mRNA
CTD
PMID:38866337
NCBI chr18:53,958,798...53,960,363
Ensembl chr18:53,958,804...53,960,284
G
GNG8
G protein subunit gamma 8
decreases expression
EXP
bisphenol A results in decreased expression of GNG8 mRNA
CTD
PMID:38866337
NCBI chr 1:109,266,884...109,268,515
Ensembl chr 1:109,268,056...109,268,453
G
GNGT1
G protein subunit gamma transducin 1
decreases expression
EXP
bisphenol A results in decreased expression of GNGT1 mRNA
CTD
PMID:38866337
NCBI chr14:19,081,676...19,420,261
Ensembl chr14:19,415,510...19,420,255
G
GNMT
glycine N-methyltransferase
increases expression
EXP
bisphenol A results in increased expression of GNMT mRNA
CTD
PMID:38866337
NCBI chr12:11,500,363...11,503,075
Ensembl chr12:11,500,392...11,503,481
G
GOLGA2
golgin A2
increases expression
EXP
bisphenol A results in increased expression of GOLGA2 mRNA
CTD
PMID:38866337
NCBI chr 9:55,234,836...55,251,698
G
GOLIM4
golgi integral membrane protein 4
increases expression
EXP
bisphenol A results in increased expression of GOLIM4 mRNA
CTD
PMID:38866337
NCBI chr34:32,800,297...32,879,065
Ensembl chr34:32,801,676...32,879,515
G
GPD1L
glycerol-3-phosphate dehydrogenase 1 like
increases expression
EXP
bisphenol A results in increased expression of GPD1L mRNA
CTD
PMID:38866337
NCBI chr23:12,568,914...12,631,903
Ensembl chr23:12,522,398...12,632,447
G
GPNMB
glycoprotein nmb
increases expression
EXP
bisphenol A results in increased expression of GPNMB mRNA
CTD
PMID:38866337
NCBI chr14:36,919,184...36,947,023
Ensembl chr14:36,919,296...36,946,643
G
GPR137B
G protein-coupled receptor 137B
increases expression
EXP
bisphenol A results in increased expression of GPR137B mRNA
CTD
PMID:38866337
NCBI chr 4:3,819,338...3,864,690
Ensembl chr 4:3,825,602...3,864,780
G
GPR20
G protein-coupled receptor 20
increases expression
EXP
bisphenol A results in increased expression of GPR20 mRNA
CTD
PMID:38866337
NCBI chr13:35,820,979...35,835,553
G
GPR85
G protein-coupled receptor 85
decreases expression
EXP
bisphenol A results in decreased expression of GPR85 mRNA
CTD
PMID:38866337
NCBI chr14:52,567,685...52,572,600
Ensembl chr14:52,569,632...52,570,744
G
GREM1
gremlin 1, DAN family BMP antagonist
decreases expression
EXP
bisphenol A results in decreased expression of GREM1 mRNA
CTD
PMID:38866337
NCBI chr30:2,219,535...2,231,868
Ensembl chr30:2,222,898...2,225,418
G
GSAP
gamma-secretase activating protein
decreases expression
EXP
bisphenol A results in decreased expression of GSAP mRNA
CTD
PMID:38866337
NCBI chr18:17,406,903...17,479,429
Ensembl chr18:17,407,532...17,484,688
G
GSS
glutathione synthetase
increases expression
EXP
bisphenol A results in increased expression of GSS mRNA
CTD
PMID:38866337
NCBI chr24:23,973,807...24,000,281
Ensembl chr24:23,901,045...23,997,286
G
GSTT2B
glutathione S-transferase theta 2B
increases expression
EXP
bisphenol A results in increased expression of GSTT2B mRNA
CTD
PMID:38866337
NCBI chr26:28,573,435...28,580,846
G
GTF3C4
general transcription factor IIIC subunit 4
increases expression
EXP
bisphenol A results in increased expression of GTF3C4 mRNA
CTD
PMID:38866337
NCBI chr 9:51,602,025...51,630,139
Ensembl chr 9:51,606,235...51,630,637
G
GYPC
glycophorin C
increases expression
EXP
bisphenol A results in increased expression of GYPC mRNA
CTD
PMID:38866337
NCBI chr19:23,946,413...23,988,970
Ensembl chr19:23,946,494...23,988,415
G
H1-5
H1.5 linker histone, cluster member
increases expression
EXP
bisphenol A results in increased expression of H1-5 mRNA
CTD
PMID:38866337
NCBI chr35:25,045,883...25,046,775
Ensembl chr35:25,046,023...25,046,703
G
H2AC13
H2A clustered histone 13
increases expression
EXP
bisphenol A results in increased expression of H2AC11 mRNA
CTD
PMID:38866337
NCBI chr35:25,000,243...25,001,749
Ensembl chr35:25,000,401...25,000,793
G
H2AC19
H2A clustered histone 19
decreases expression
EXP
bisphenol A results in decreased expression of H2AC15 mRNA
CTD
PMID:38866337
NCBI chr17:59,156,821...59,157,523
Ensembl chr17:59,147,111...59,147,503
G
H2AC25
H2A clustered histone 25
increases expression
EXP
bisphenol A results in increased expression of H2AC25 mRNA
CTD
PMID:38866337
NCBI chr14:604,444...605,584
Ensembl chr14:604,505...604,897
G
HACD1
3-hydroxyacyl-CoA dehydratase 1
decreases expression
EXP
bisphenol A results in decreased expression of HACD1 mRNA
CTD
PMID:38866337
NCBI chr 2:19,362,488...19,383,090
Ensembl chr 2:19,362,403...19,383,090
G
HACD2
3-hydroxyacyl-CoA dehydratase 2
decreases expression
EXP
bisphenol A results in decreased expression of HACD2 mRNA
CTD
PMID:38866337
NCBI chr33:26,530,221...26,643,477
Ensembl chr33:26,533,114...26,637,035
G
HAUS8
HAUS augmin like complex subunit 8
decreases expression
EXP
bisphenol A results in decreased expression of HAUS8 mRNA
CTD
PMID:38866337
NCBI chr20:45,600,120...45,622,569
Ensembl chr20:45,600,135...45,622,566
G
HCAR1
hydroxycarboxylic acid receptor 1
increases expression
EXP
bisphenol A results in increased expression of HCAR1 mRNA
CTD
PMID:38866337
NCBI chr26:6,734,818...6,735,906
Ensembl chr26:6,734,818...6,735,906
G
HCAR2
hydroxycarboxylic acid receptor 2
increases expression
EXP
bisphenol A results in increased expression of HCAR2 mRNA
CTD
PMID:38866337
NCBI chr26:6,748,415...6,750,509
G
HCN3
hyperpolarization activated cyclic nucleotide gated potassium channel 3
increases expression
EXP
bisphenol A results in increased expression of HCN3 mRNA
CTD
PMID:38866337
NCBI chr 7:42,272,756...42,282,770
Ensembl chr 7:42,273,571...42,282,595
G
HDHD3
haloacid dehalogenase like hydrolase domain containing 3
decreases expression
EXP
bisphenol A results in decreased expression of HDHD3 mRNA
CTD
PMID:38866337
NCBI chr11:67,729,133...67,731,956
Ensembl chr11:67,729,275...67,730,030
G
HEATR1
HEAT repeat containing 1
increases expression
EXP
bisphenol A results in increased expression of HEATR1 mRNA
CTD
PMID:38866337
NCBI chr 4:3,501,191...3,547,212
Ensembl chr 4:3,501,571...3,547,100
G
HECTD1
HECT domain E3 ubiquitin protein ligase 1
increases expression
EXP
bisphenol A results in increased expression of HECTD1 mRNA
CTD
PMID:38866337
NCBI chr 8:10,399,183...10,493,074
Ensembl chr 8:10,400,604...10,491,247
G
HEPHL1
hephaestin like 1
decreases expression
EXP
bisphenol A results in decreased expression of HEPHL1 mRNA
CTD
PMID:38866337
NCBI chr21:6,720,472...6,813,946
Ensembl chr21:6,716,562...6,814,486
G
HIF3A
hypoxia inducible factor 3 subunit alpha
increases expression
EXP
bisphenol A results in increased expression of HIF3A mRNA
CTD
PMID:38866337
NCBI chr 1:109,479,456...109,504,271
Ensembl chr 1:109,479,128...109,504,274
G
HILPDA
hypoxia inducible lipid droplet associated
decreases expression
EXP
bisphenol A results in decreased expression of HILPDA mRNA
CTD
PMID:38866337
NCBI chr14:7,957,811...7,959,878
G
HLF
HLF transcription factor, PAR bZIP family member
increases expression
EXP
bisphenol A results in increased expression of HLF mRNA
CTD
PMID:38866337
NCBI chr 9:30,321,090...30,380,480
Ensembl chr 9:30,327,495...30,377,175
G
HMG20A
high mobility group 20A
increases expression
EXP
bisphenol A results in increased expression of HMG20A mRNA
CTD
PMID:38866337
NCBI chr30:38,839,520...38,916,952
Ensembl chr30:38,845,415...38,864,148
G
HMGA2
high mobility group AT-hook 2
increases expression
EXP
bisphenol A results in increased expression of HMGA2 mRNA
CTD
PMID:38866337
NCBI chr10:8,348,101...8,491,435
G
HMGB3
high mobility group box 3
increases expression
EXP
bisphenol A results in increased expression of HMGB3 mRNA
CTD
PMID:38866337
NCBI chr X:119,152,166...119,159,803
Ensembl chr X:119,155,786...119,159,814
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
bisphenol A results in increased expression of HMGCS1 mRNA
CTD
PMID:38866337
NCBI chr 4:66,633,706...66,654,005
Ensembl chr 4:66,633,572...66,652,196
G
HNF4A
hepatocyte nuclear factor 4 alpha
increases expression
EXP
bisphenol A results in increased expression of HNF4A mRNA
CTD
PMID:38866337
NCBI chr24:31,847,864...31,908,337
Ensembl chr24:31,847,961...31,905,916
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
EXP
bisphenol A results in increased expression of HNRNPA2B1 mRNA
CTD
PMID:38866337
NCBI chr14:39,498,805...39,509,034
Ensembl chr14:39,500,897...39,508,952
G
HNRNPA3
heterogeneous nuclear ribonucleoprotein A3
increases expression
EXP
bisphenol A results in increased expression of HNRNPA3 mRNA
CTD
PMID:38866337
NCBI chr36:20,974,541...20,983,972
Ensembl chr36:20,974,648...20,980,137
G
HNRNPH2
heterogeneous nuclear ribonucleoprotein H2
increases expression
EXP
bisphenol A results in increased expression of HNRNPH2 mRNA
CTD
PMID:38866337
NCBI chr X:75,320,505...75,326,651
Ensembl chr X:75,324,481...75,325,830
G
HOMEZ
homeobox and leucine zipper encoding
decreases expression
EXP
bisphenol A results in decreased expression of HOMEZ mRNA
CTD
PMID:38866337
NCBI chr 8:3,545,434...3,558,923
Ensembl chr 8:3,545,472...3,558,440
G
HOXA1
homeobox A1
increases expression
EXP
bisphenol A results in increased expression of HOXA1 mRNA
CTD
PMID:38866337
NCBI chr14:40,267,033...40,272,212
Ensembl chr14:40,267,528...40,269,681
G
HOXA2
homeobox A2
increases expression
EXP
bisphenol A results in increased expression of HOXA2 mRNA
CTD
PMID:38866337
NCBI chr14:40,273,992...40,276,975
Ensembl chr14:40,274,469...40,276,239
G
HOXA3
homeobox A3
increases expression
EXP
bisphenol A results in increased expression of HOXA3 mRNA
CTD
PMID:38866337
NCBI chr14:40,280,866...40,326,559
Ensembl chr14:40,280,861...40,296,147
G
HOXA9
homeobox A9
increases expression
EXP
bisphenol A results in increased expression of HOXA9 mRNA
CTD
PMID:38866337
NCBI chr14:40,336,829...40,340,533
Ensembl chr14:40,337,999...40,339,923
G
HOXD8
homeobox D8
increases expression
EXP
bisphenol A results in increased expression of HOXD8 mRNA
CTD
PMID:38866337
NCBI chr36:19,938,916...19,941,092
G
HPS5
HPS5 biogenesis of lysosomal organelles complex 2 subunit 2
increases expression
EXP
bisphenol A results in increased expression of HPS5 mRNA
CTD
PMID:38866337
NCBI chr21:40,725,089...40,770,665
Ensembl chr21:40,726,274...40,770,112
G
HRCT1
histidine rich carboxyl terminus 1
increases expression
EXP
bisphenol A results in increased expression of HRCT1 mRNA
CTD
PMID:38866337
NCBI chr11:52,420,070...52,421,097
Ensembl chr11:52,420,011...52,420,629
G
HSD17B4
hydroxysteroid 17-beta dehydrogenase 4
increases expression
EXP
bisphenol A results in increased expression of HSD17B4 mRNA
CTD
PMID:38866337
NCBI chr11:8,717,182...8,810,716
Ensembl chr11:8,717,349...8,824,594
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
increases expression
EXP
bisphenol A results in increased expression of HSD17B7 mRNA
CTD
PMID:38866337
NCBI chr38:19,975,935...19,999,077
Ensembl chr38:19,977,086...19,999,010
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
bisphenol A results in increased expression of HSP90AA1 mRNA
CTD
PMID:38866337
NCBI chr 8:70,091,203...70,096,107
Ensembl chr 8:70,092,217...70,095,243
G
HSPA8
heat shock protein family A (Hsp70) member 8
increases expression
EXP
bisphenol A results in increased expression of HSPA8 mRNA
CTD
PMID:38866337
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
G
HSPA9
heat shock protein family A (Hsp70) member 9
increases expression
EXP
bisphenol A results in increased expression of HSPA9 mRNA
CTD
PMID:38866337
NCBI chr11:26,122,917...26,142,458
Ensembl chr11:26,121,499...26,142,434
G
HTATSF1
HIV-1 Tat specific factor 1
increases expression
EXP
bisphenol A results in increased expression of HTATSF1 mRNA
CTD
PMID:38866337
NCBI chr X:106,848,455...106,866,540
Ensembl chr X:106,848,455...106,866,540
G
HVCN1
hydrogen voltage gated channel 1
increases expression
EXP
bisphenol A results in increased expression of HVCN1 mRNA
CTD
PMID:38866337
NCBI chr26:8,437,032...8,474,831
Ensembl chr26:8,419,269...8,466,523
G
ID1
inhibitor of DNA binding 1
increases expression
EXP
bisphenol A results in increased expression of ID1 mRNA
CTD
PMID:38866337
NCBI chr24:21,094,339...21,096,276
Ensembl chr24:21,094,755...21,096,276
G
ID4
inhibitor of DNA binding 4, HLH protein
increases expression
EXP
bisphenol A results in increased expression of ID4 mRNA
CTD
PMID:38866337
NCBI chr35:18,358,518...18,360,767
Ensembl chr35:18,357,826...18,359,011 Ensembl chr35:18,357,826...18,359,011
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
increases expression
EXP
bisphenol A results in increased expression of IDH1 mRNA
CTD
PMID:38866337
NCBI chr37:16,512,027...16,531,269
Ensembl chr37:16,512,770...16,531,219
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
decreases expression
EXP
bisphenol A results in decreased expression of IDH2 mRNA
CTD
PMID:38866337
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
G
IFNAR2
interferon alpha and beta receptor subunit 2
decreases expression
EXP
bisphenol A results in decreased expression of IFNAR2 mRNA
CTD
PMID:38866337
NCBI chr31:27,860,094...27,891,361
G
IFT122
intraflagellar transport 122
increases expression
EXP
bisphenol A results in increased expression of IFT122 mRNA
CTD
PMID:38866337
NCBI chr20:5,644,002...5,716,702
Ensembl chr20:5,644,089...5,715,906
G
IFT70B
intraflagellar transport 70B
decreases expression
EXP
bisphenol A results in decreased expression of IFT70B mRNA
CTD
PMID:38866337
NCBI chr36:21,270,467...21,273,878
G
IGFBP3
insulin like growth factor binding protein 3
increases expression
EXP
bisphenol A results in increased expression of IGFBP3 mRNA
CTD
PMID:38866337
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
G
IKZF2
IKAROS family zinc finger 2
increases expression
EXP
bisphenol A results in increased expression of IKZF2 mRNA
CTD
PMID:38866337
NCBI chr37:20,508,647...20,662,549
Ensembl chr37:20,516,239...20,661,298
G
IL10RB
interleukin 10 receptor subunit beta
decreases expression
EXP
bisphenol A results in decreased expression of IL10RB mRNA
CTD
PMID:38866337
NCBI chr31:28,791,541...28,815,163
Ensembl chr31:27,892,394...27,915,637
G
IL11
interleukin 11
decreases expression
EXP
bisphenol A results in decreased expression of IL11 mRNA
CTD
PMID:38866337
NCBI chr 1:102,311,960...102,319,102
Ensembl chr 1:102,316,105...102,318,653
G
IL13RA1
interleukin 13 receptor subunit alpha 1
decreases expression
EXP
bisphenol A results in decreased expression of IL13RA1 mRNA
CTD
PMID:38866337
NCBI chr X:90,925,497...90,981,855
Ensembl chr X:90,924,801...90,979,963
G
IL18R1
interleukin 18 receptor 1
increases expression
EXP
bisphenol A results in increased expression of IL18R1 mRNA
CTD
PMID:38866337
NCBI chr10:40,614,336...40,653,300
Ensembl chr10:40,615,312...40,653,454
G
IL1R1
interleukin 1 receptor type 1
increases expression
EXP
bisphenol A results in increased expression of IL1R1 mRNA
CTD
PMID:38866337
NCBI chr10:40,825,986...40,897,898
Ensembl chr10:40,827,377...40,897,596
G
IL1RL1
interleukin 1 receptor like 1
increases expression
EXP
bisphenol A results in increased expression of IL1RL1 mRNA
CTD
PMID:38866337
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
G
IL37
interleukin 37
decreases expression
EXP
bisphenol A results in decreased expression of IL37 mRNA
CTD
PMID:38866337
NCBI chr17:36,964,857...37,101,005
Ensembl chr17:36,977,063...37,100,801
G
INHBA
inhibin subunit beta A
decreases expression
EXP
bisphenol A results in decreased expression of INHBA mRNA
CTD
PMID:38866337
NCBI chr18:8,272,978...8,288,432
Ensembl chr18:8,272,872...8,283,794
G
INO80C
INO80 complex subunit C
decreases expression
EXP
bisphenol A results in decreased expression of INO80C mRNA
CTD
PMID:38866337
NCBI chr 7:54,569,954...54,586,902
Ensembl chr 7:54,569,972...54,586,782
G
INSIG1
insulin induced gene 1
increases expression
EXP
bisphenol A results in increased expression of INSIG1 mRNA
CTD
PMID:38866337
NCBI chr16:18,260,456...18,271,855
Ensembl chr16:18,259,935...18,271,378
G
INTS6L
integrator complex subunit 6 like
decreases expression
EXP
bisphenol A results in decreased expression of INTS6L mRNA
CTD
PMID:38866337
NCBI chr X:105,996,058...106,052,347
Ensembl chr X:105,995,434...106,080,535
G
IRAK2
interleukin 1 receptor associated kinase 2
decreases expression
EXP
bisphenol A results in decreased expression of IRAK2 mRNA
CTD
PMID:38866337
NCBI chr20:8,133,987...8,197,009
Ensembl chr20:8,134,970...8,196,910
G
ISG15
ISG15 ubiquitin like modifier
decreases expression
EXP
bisphenol A results in decreased expression of ISG15 mRNA
CTD
PMID:38866337
NCBI chr 5:56,230,879...56,237,354
Ensembl chr 5:56,236,318...56,404,695
G
ITGB1BP2
integrin subunit beta 1 binding protein 2
decreases expression
EXP
bisphenol A results in decreased expression of ITGB1BP2 mRNA
CTD
PMID:38866337
NCBI chr X:55,632,566...55,652,801
Ensembl chr X:55,633,060...55,636,868
G
IZUMO4
IZUMO family member 4
decreases expression
EXP
bisphenol A results in decreased expression of IZUMO4 mRNA
CTD
PMID:38866337
NCBI chr20:56,933,644...56,936,171
Ensembl chr20:56,933,646...56,936,163
G
JAK1
Janus kinase 1
increases expression
EXP
bisphenol A results in increased expression of JAK1 mRNA
CTD
PMID:38866337
NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
G
JAZF1
JAZF zinc finger 1
decreases expression
EXP
bisphenol A results in decreased expression of JAZF1 mRNA
CTD
PMID:38866337
NCBI chr14:40,939,680...41,275,981
Ensembl chr14:40,941,677...41,234,384
G
KAZALD1
Kazal type serine peptidase inhibitor domain 1
increases expression
EXP
bisphenol A results in increased expression of KAZALD1 mRNA
CTD
PMID:38866337
NCBI chr28:13,741,085...13,745,426
Ensembl chr28:13,742,322...13,745,119
G
KCNE4
potassium voltage-gated channel subfamily E regulatory subunit 4
decreases expression
EXP
bisphenol A results in decreased expression of KCNE4 mRNA
CTD
PMID:38866337
NCBI chr37:28,994,797...28,998,596
Ensembl chr37:28,996,105...28,996,990
G
KCNIP1
potassium voltage-gated channel interacting protein 1
decreases expression
EXP
bisphenol A results in decreased expression of KCNIP1 mRNA
CTD
PMID:38866337
NCBI chr 4:41,220,128...41,566,841
Ensembl chr 4:41,223,369...41,431,510
G
KCNJ15
potassium inwardly rectifying channel subfamily J member 15
decreases expression
EXP
bisphenol A results in decreased expression of KCNJ15 mRNA
CTD
PMID:38866337
NCBI chr31:33,314,061...33,388,165
Ensembl chr31:33,384,630...33,386,885
G
KCNK16
potassium two pore domain channel subfamily K member 16
decreases expression
EXP
bisphenol A results in decreased expression of KCNK16 mRNA
CTD
PMID:38866337
NCBI chr12:8,210,498...8,232,269
Ensembl chr12:8,224,518...8,232,758
G
KCTD1
potassium channel tetramerization domain containing 1
increases expression
EXP
bisphenol A results in increased expression of KCTD1 mRNA
CTD
PMID:38866337
NCBI chr 7:62,119,658...62,214,365
Ensembl chr 7:62,118,600...62,213,593
G
KCTD13
potassium channel tetramerization domain containing 13
increases expression
EXP
bisphenol A results in increased expression of KCTD13 mRNA
CTD
PMID:38866337
NCBI chr 6:17,945,541...17,959,421
Ensembl chr 6:17,946,062...17,959,232
G
KCTD7
potassium channel tetramerization domain containing 7
increases expression
EXP
bisphenol A results in increased expression of KCTD7 mRNA
CTD
PMID:38866337
G
KDELR2
KDEL endoplasmic reticulum protein retention receptor 2
decreases expression
EXP
bisphenol A results in decreased expression of KDELR2 mRNA
CTD
PMID:38866337
NCBI chr 6:11,796,586...11,815,765
Ensembl chr 6:11,798,377...11,815,760
G
KDM5A
lysine demethylase 5A
increases expression
EXP
bisphenol A results in increased expression of KDM5A mRNA
CTD
PMID:38866337
NCBI chr27:42,364,606...42,447,839
Ensembl chr27:42,360,456...42,447,821
G
KHK
ketohexokinase
increases expression
EXP
bisphenol A results in increased expression of KHK mRNA
CTD
PMID:38866337
NCBI chr17:21,079,907...21,092,510
Ensembl chr17:21,079,907...21,092,510
G
KIDINS220
kinase D interacting substrate 220
increases expression
EXP
bisphenol A results in increased expression of KIDINS220 mRNA
CTD
PMID:38866337
NCBI chr17:5,983,208...6,077,609
Ensembl chr17:5,982,938...6,071,165
G
KLF1
KLF transcription factor 1
decreases expression
EXP
bisphenol A results in decreased expression of KLF1 mRNA
CTD
PMID:38866337
NCBI chr20:49,295,097...49,298,668
Ensembl chr20:49,295,195...49,298,602
G
KLF3
KLF transcription factor 3
increases expression
EXP
bisphenol A results in increased expression of KLF3 mRNA
CTD
PMID:38866337
NCBI chr 3:73,627,112...73,663,702
Ensembl chr 3:73,629,312...73,664,182
G
KLHL12
kelch like family member 12
increases expression
EXP
bisphenol A results in increased expression of KLHL12 mRNA
CTD
PMID:38866337
NCBI chr 7:256,814...284,132
G
KLK14
kallikrein related peptidase 14
decreases expression
EXP
bisphenol A results in decreased expression of KLK14 mRNA
CTD
PMID:38866337
NCBI chr 1:105,811,435...105,816,625
Ensembl chr 1:105,812,224...105,816,625
G
KNCN
kinocilin
decreases expression
EXP
bisphenol A results in decreased expression of KNCN mRNA
CTD
PMID:38866337
NCBI chr15:13,900,881...13,907,964
Ensembl chr15:13,903,036...13,907,967
G
KPNA6
karyopherin subunit alpha 6
increases expression
EXP
bisphenol A results in increased expression of KPNA6 mRNA
CTD
PMID:38866337
NCBI chr 2:69,025,409...69,078,635
Ensembl chr 2:69,030,228...69,077,912
G
KRT16
keratin 16
increases expression
EXP
bisphenol A results in increased expression of KRT16 mRNA
CTD
PMID:38866337
NCBI chr 9:21,167,714...21,170,650
G
KRT7
keratin 7
decreases expression
EXP
bisphenol A results in decreased expression of KRT7 mRNA
CTD
PMID:38866337
NCBI chr27:2,812,709...2,827,451
G
LACTB
lactamase beta
increases expression
EXP
bisphenol A results in increased expression of LACTB mRNA
CTD
PMID:38866337
NCBI chr30:27,720,255...27,738,213
Ensembl chr30:27,719,821...27,737,959
G
LAMC2
laminin subunit gamma 2
increases expression
EXP
bisphenol A results in increased expression of LAMC2 mRNA
CTD
PMID:38866337
NCBI chr 7:16,543,541...16,625,304
Ensembl chr 7:16,569,086...16,624,085
G
LATS2
large tumor suppressor kinase 2
increases expression
EXP
bisphenol A results in increased expression of LATS2 mRNA
CTD
PMID:38866337
NCBI chr25:17,110,620...17,169,826
Ensembl chr25:17,110,637...17,169,291
G
LBH
LBH regulator of WNT signaling pathway
increases expression
EXP
bisphenol A results in increased expression of LBH mRNA
CTD
PMID:38866337
NCBI chr17:23,939,135...23,969,611
Ensembl chr17:23,938,772...24,022,140
G
LCN8
lipocalin 8
increases expression
EXP
bisphenol A results in increased expression of LCN8 mRNA
CTD
PMID:38866337
NCBI chr 9:48,789,948...48,796,002
Ensembl chr 9:48,769,526...48,794,188
G
LCNL1
lipocalin like 1
decreases expression
EXP
bisphenol A results in decreased expression of LCNL1 mRNA
CTD
PMID:38866337
NCBI chr 9:48,643,845...48,647,187
G
LCP1
lymphocyte cytosolic protein 1
decreases expression
EXP
bisphenol A results in decreased expression of LCP1 mRNA
CTD
PMID:38866337
NCBI chr22:4,955,453...5,059,654
Ensembl chr22:4,992,347...5,059,636
G
LENG9
leukocyte receptor cluster member 9
increases expression
EXP
bisphenol A results in increased expression of LENG9 mRNA
CTD
PMID:38866337
NCBI chr 1:102,842,997...102,844,194
G
LEP
leptin
decreases expression
EXP
bisphenol A results in decreased expression of LEP mRNA
CTD
PMID:38866337
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
LEPR
leptin receptor
decreases expression
EXP
bisphenol A results in decreased expression of LEPR mRNA
CTD
PMID:38866337
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LGALS12
galectin 12
increases expression
EXP
bisphenol A results in increased expression of LGALS12 mRNA
CTD
PMID:38866337
NCBI chr18:53,428,894...53,446,767
Ensembl chr18:53,437,562...53,447,013
G
LGR4
leucine rich repeat containing G protein-coupled receptor 4
increases expression
EXP
bisphenol A results in increased expression of LGR4 mRNA
CTD
PMID:38866337
NCBI chr21:47,952,019...47,995,530
Ensembl chr21:47,952,890...47,996,288
G
LHFPL6
LHFPL tetraspan subfamily member 6
increases expression
EXP
bisphenol A results in increased expression of LHFPL6 mRNA
CTD
PMID:38866337
NCBI chr25:1,567,799...1,805,030
Ensembl chr25:1,567,335...1,804,535
G
LIN7A
lin-7 homolog A, crumbs cell polarity complex component
decreases expression
EXP
bisphenol A results in decreased expression of LIN7A mRNA
CTD
PMID:38866337
NCBI chr15:23,101,524...23,186,343
Ensembl chr15:23,111,944...23,187,354
G
LMO2
LIM domain only 2
increases expression
EXP
bisphenol A results in increased expression of LMO2 mRNA
CTD
PMID:38866337
G
LOC100687713
BUB3-interacting and GLEBS motif-containing protein ZNF207
increases expression
EXP
bisphenol A results in increased expression of ZNF207 mRNA
CTD
PMID:38866337
NCBI chr11:1,027,387...1,029,505
G
LONRF3
LON peptidase N-terminal domain and ring finger 3
increases expression
EXP
bisphenol A results in increased expression of LONRF3 mRNA
CTD
PMID:38866337
NCBI chr X:91,105,938...91,146,468
Ensembl chr X:91,106,496...91,141,790
G
LPIN1
lipin 1
increases expression
EXP
bisphenol A results in increased expression of LPIN1 mRNA
CTD
PMID:38866337
NCBI chr17:8,348,860...8,480,447
Ensembl chr17:8,348,886...8,478,863
G
LRBA
LPS responsive beige-like anchor protein
increases expression
EXP
bisphenol A results in increased expression of LRBA mRNA
CTD
PMID:38866337
NCBI chr15:48,273,866...48,996,546
Ensembl chr15:48,274,881...48,995,697
G
LRIG3
leucine rich repeats and immunoglobulin like domains 3
increases expression
EXP
bisphenol A results in increased expression of LRIG3 mRNA
CTD
PMID:38866337
NCBI chr10:2,723,836...2,772,630
Ensembl chr10:2,724,951...2,772,636
G
LRIT3
leucine rich repeat, Ig-like and transmembrane domains 3
decreases expression
EXP
bisphenol A results in decreased expression of LRIT3 mRNA
CTD
PMID:38866337
NCBI chr32:30,024,765...30,044,845
Ensembl chr32:30,026,897...30,041,996
G
LRP12
LDL receptor related protein 12
decreases expression
EXP
bisphenol A results in decreased expression of LRP12 mRNA
CTD
PMID:38866337
NCBI chr13:5,670,932...5,754,076
Ensembl chr13:5,674,649...5,744,740
G
LRP6
LDL receptor related protein 6
increases expression
EXP
bisphenol A results in increased expression of LRP6 mRNA
CTD
PMID:38866337
NCBI chr27:34,003,334...34,166,334
Ensembl chr27:34,003,539...34,161,437
G
LRRC59
leucine rich repeat containing 59
decreases expression
EXP
bisphenol A results in decreased expression of LRRC59 mRNA
CTD
PMID:38866337
NCBI chr 9:26,350,300...26,364,021
Ensembl chr 9:26,351,734...26,364,082
G
LRRN4CL
LRRN4 C-terminal like
increases expression
EXP
bisphenol A results in increased expression of LRRN4CL mRNA
CTD
PMID:38866337
NCBI chr18:53,971,590...53,973,958
Ensembl chr18:53,972,490...53,973,203
G
LST1
leukocyte specific transcript 1
increases expression
EXP
bisphenol A results in increased expression of LST1 mRNA
CTD
PMID:38866337
NCBI chr12:1,084,739...1,086,182
G
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
decreases expression
EXP
bisphenol A results in decreased expression of LYVE1 mRNA
CTD
PMID:38866337
NCBI chr21:33,716,138...33,727,470
Ensembl chr21:33,716,581...33,727,297
G
MAN1A1
mannosidase alpha class 1A member 1
increases expression
EXP
bisphenol A results in increased expression of MAN1A1 mRNA
CTD
PMID:38866337
NCBI chr 1:59,106,834...59,274,936
Ensembl chr 1:59,109,366...59,275,399
G
MAOA
monoamine oxidase A
increases expression
EXP
bisphenol A results in increased expression of MAOA mRNA
CTD
PMID:38866337
NCBI chr X:37,678,933...37,744,757
Ensembl chr X:37,677,493...37,744,757
G
MAP10
microtubule associated protein 10
increases expression
EXP
bisphenol A results in increased expression of MAP10 mRNA
CTD
PMID:38866337
NCBI chr 4:6,867,323...6,870,177
Ensembl chr 4:6,867,326...6,870,063
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases expression
EXP
bisphenol A results in increased expression of MAP2K6 mRNA
CTD
PMID:38866337
NCBI chr 9:15,840,714...15,962,400
Ensembl chr 9:15,840,983...15,952,026
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
increases expression
EXP
bisphenol A results in increased expression of MAP3K5 mRNA
CTD
PMID:38866337
NCBI chr 1:29,107,813...29,306,437
Ensembl chr 1:29,108,591...29,306,503
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
increases expression
EXP
bisphenol A results in increased expression of MAP4K4 mRNA
CTD
PMID:38866337
NCBI chr10:41,088,020...41,276,801
Ensembl chr10:41,089,371...41,276,891
G
MAPK13
mitogen-activated protein kinase 13
decreases expression
EXP
bisphenol A results in decreased expression of MAPK13 mRNA
CTD
PMID:38866337
NCBI chr12:5,239,783...5,248,197
Ensembl chr12:5,239,750...5,248,196
G
MARF1
meiosis regulator and mRNA stability factor 1
increases expression
EXP
bisphenol A results in increased expression of MARF1 mRNA
CTD
PMID:38866337
NCBI chr 6:28,194,771...28,231,908
Ensembl chr 6:28,041,318...28,262,184
G
MAT2A
methionine adenosyltransferase 2A
increases expression
EXP
bisphenol A results in increased expression of MAT2A mRNA
CTD
PMID:38866337
NCBI chr17:39,525,635...39,532,512
Ensembl chr17:39,525,626...39,532,512
G
MBOAT2
membrane bound O-acyltransferase domain containing 2
decreases expression
EXP
bisphenol A results in decreased expression of MBOAT2 mRNA
CTD
PMID:38866337
NCBI chr17:6,090,746...6,217,139
Ensembl chr17:6,094,900...6,213,142
G
MC1R
melanocortin 1 receptor
increases expression
EXP
bisphenol A results in increased expression of MC1R mRNA
CTD
PMID:38866337
NCBI chr 5:63,694,296...63,695,249
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
increases expression
EXP
bisphenol A results in increased expression of MCL1 mRNA
CTD
PMID:38866337
NCBI chr17:59,759,605...59,763,111
Ensembl chr17:59,759,605...59,763,111
G
MCUR1
mitochondrial calcium uniporter regulator 1
increases expression
EXP
bisphenol A results in increased expression of MCUR1 mRNA
CTD
PMID:38866337
NCBI chr35:13,188,002...13,229,444
G
MDH2
malate dehydrogenase 2
increases expression
EXP
bisphenol A results in increased expression of MDH2 mRNA
CTD
PMID:38866337
NCBI chr 6:7,389,266...7,405,311
G
ME3
malic enzyme 3
decreases expression
EXP
bisphenol A results in decreased expression of ME3 mRNA
CTD
PMID:38866337
NCBI chr21:12,813,052...13,105,805
Ensembl chr21:12,813,047...13,105,804
G
MED13
mediator complex subunit 13
increases expression
EXP
bisphenol A results in increased expression of MED13 mRNA
CTD
PMID:38866337
NCBI chr 9:34,638,892...34,742,235
Ensembl chr 9:34,641,601...34,738,352
G
MEIS1
Meis homeobox 1
increases expression
EXP
bisphenol A results in increased expression of MEIS1 mRNA
CTD
PMID:38866337
NCBI chr10:65,765,498...65,898,714
Ensembl chr10:65,683,560...65,897,573
G
MERTK
MER proto-oncogene, tyrosine kinase
increases expression
EXP
bisphenol A results in increased expression of MERTK mRNA
CTD
PMID:38866337
NCBI chr17:36,336,787...36,445,796
Ensembl chr17:36,336,861...36,445,380
G
METTL1
methyltransferase 1, tRNA methylguanosine
decreases expression
EXP
bisphenol A results in decreased expression of METTL1 mRNA
CTD
PMID:38866337
NCBI chr10:1,831,088...1,833,818
Ensembl chr10:1,831,091...1,833,868
G
MFAP1
microfibril associated protein 1
increases expression
EXP
bisphenol A results in increased expression of MFAP1 mRNA
CTD
PMID:38866337
NCBI chr30:10,545,987...10,559,507
Ensembl chr30:10,546,369...10,559,414
G
MGRH
mas-related G-protein coupled receptor member X2
decreases expression
EXP
bisphenol A results in decreased expression of MGRH mRNA
CTD
PMID:38866337
NCBI chr18:47,212,903...47,215,195
G
MIF
macrophage migration inhibitory factor
decreases expression
EXP
bisphenol A results in decreased expression of MIF mRNA
CTD
PMID:38866337
G
MINAR2
membrane integral NOTCH2 associated receptor 2
decreases expression
EXP
bisphenol A results in decreased expression of MINAR2 mRNA
CTD
PMID:38866337
NCBI chr11:18,506,042...18,531,187
Ensembl chr11:18,507,059...18,524,589
G
MIR29C-1
microRNA mir-29c-1
decreases expression
EXP
bisphenol A results in decreased expression of MIR29C-1 mRNA
CTD
PMID:38866337
NCBI chr 7:6,588,010...6,588,067
G
MLLT11
MLLT11 transcription factor 7 cofactor
decreases expression
EXP
bisphenol A results in decreased expression of MLLT11 mRNA
CTD
PMID:38866337
NCBI chr17:60,142,411...60,153,650
Ensembl chr17:60,152,378...60,152,650
G
MMP13
matrix metallopeptidase 13
decreases expression
EXP
bisphenol A results in decreased expression of MMP13 mRNA
CTD
PMID:38866337
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
G
MOB3B
MOB kinase activator 3B
increases expression
EXP
bisphenol A results in increased expression of MOB3B mRNA
CTD
PMID:38866337
NCBI chr11:45,456,049...45,574,034
Ensembl chr11:45,460,901...45,574,034
G
MON2
MON2 homolog, regulator of endosome-to-Golgi trafficking
increases expression
EXP
bisphenol A results in increased expression of MON2 mRNA
CTD
PMID:38866337
NCBI chr10:5,670,388...5,776,533
Ensembl chr10:5,670,388...5,774,134
G
MPEG1
macrophage expressed 1
decreases expression
EXP
bisphenol A results in decreased expression of MPEG1 mRNA
CTD
PMID:38866337
NCBI chr18:37,530,895...37,535,334
Ensembl chr18:37,531,032...37,533,179
G
MPLKIP
M-phase specific PLK1 interacting protein
decreases expression
EXP
bisphenol A results in decreased expression of MPLKIP mRNA
CTD
PMID:38866337
NCBI chr18:9,766,369...9,768,831
Ensembl chr18:9,765,972...9,768,833
G
MRM3
mitochondrial rRNA methyltransferase 3
increases expression
EXP
bisphenol A results in increased expression of MRM3 mRNA
CTD
PMID:38866337
NCBI chr 9:45,004,382...45,011,834
Ensembl chr 9:45,005,145...45,011,811
G
MT1E
metallothionein 1E
increases expression
EXP
bisphenol A results in increased expression of MT1E mRNA
CTD
PMID:38866337
G
MTARC1
mitochondrial amidoxime reducing component 1
increases expression
EXP
bisphenol A results in increased expression of MTARC1 mRNA
CTD
PMID:38866337
NCBI chr38:15,460,548...15,490,941
Ensembl chr38:15,463,548...15,532,241
G
MTARC2
mitochondrial amidoxime reducing component 2
increases expression
EXP
bisphenol A results in increased expression of MTARC2 mRNA
CTD
PMID:38866337
NCBI chr38:15,426,884...15,451,701
Ensembl chr38:15,426,666...15,451,136
G
MTURN
maturin, neural progenitor differentiation regulator homolog
increases expression
EXP
bisphenol A results in increased expression of MTURN mRNA
CTD
PMID:38866337
NCBI chr14:42,890,343...42,928,985
Ensembl chr14:42,899,944...42,930,117
G
MX2
MX dynamin like GTPase 2
decreases expression
EXP
bisphenol A results in decreased expression of MX2 mRNA
CTD
PMID:38866337
NCBI chr31:35,860,596...35,883,607
Ensembl chr31:35,860,590...35,951,350
G
MYBPH
myosin binding protein H
increases expression
EXP
bisphenol A results in increased expression of MYBPH mRNA
CTD
PMID:38866337
NCBI chr 7:34,181...44,479
Ensembl chr 7:36,428...43,803
G
MYL5
myosin light chain 5
increases expression
EXP
bisphenol A results in increased expression of MYL5 mRNA
CTD
PMID:38866337
NCBI chr 3:91,738,518...91,743,619
Ensembl chr 3:91,738,523...91,744,297
G
MYL6B
myosin light chain 6B
decreases expression
EXP
bisphenol A results in decreased expression of MYL6B mRNA
CTD
PMID:38866337
NCBI chr10:472,415...476,738
Ensembl chr10:472,515...476,719
G
MYOM1
myomesin 1
decreases expression
EXP
bisphenol A results in decreased expression of MYOM1 mRNA
CTD
PMID:38866337
NCBI chr 7:69,703,057...69,837,987
Ensembl chr 7:69,703,540...69,857,740
G
NAA10
N-alpha-acetyltransferase 10, NatA catalytic subunit
decreases expression
EXP
bisphenol A results in decreased expression of NAA10 mRNA
CTD
PMID:38866337
NCBI chr X:121,777,658...121,782,097
Ensembl chr X:121,727,573...121,788,860
G
NADK
NAD kinase
increases expression
EXP
bisphenol A results in increased expression of NADK mRNA
CTD
PMID:38866337
NCBI chr 5:56,743,920...56,774,578
Ensembl chr 5:56,745,869...56,774,529
G
NANS
N-acetylneuraminate synthase
decreases expression
EXP
bisphenol A results in decreased expression of NANS mRNA
CTD
PMID:38866337
NCBI chr11:55,286,290...55,310,904
Ensembl chr11:55,243,854...55,350,194
G
NAT9
N-acetyltransferase 9
decreases expression
EXP
bisphenol A results in decreased expression of NAT9 mRNA
CTD
PMID:38866337
NCBI chr 9:5,655,178...5,660,068
Ensembl chr 9:5,655,125...5,660,046
G
NCL
nucleolin
increases expression
EXP
bisphenol A results in increased expression of NCL mRNA
CTD
PMID:38866337
NCBI chr25:43,330,524...43,384,909
Ensembl chr25:43,330,799...43,384,258
G
NCOR1
nuclear receptor corepressor 1
increases expression
EXP
bisphenol A results in increased expression of NCOR1 mRNA
CTD
PMID:38866337
NCBI chr 5:39,687,530...39,837,003
Ensembl chr 5:39,687,543...39,836,464
G
NDRG2
NDRG family member 2
increases expression
EXP
bisphenol A results in increased expression of NDRG2 mRNA
CTD
PMID:38866337
NCBI chr15:18,106,651...18,115,026
Ensembl chr15:18,106,654...18,113,970
G
NDUFAF8
NADH:ubiquinone oxidoreductase complex assembly factor 8
increases expression
EXP
bisphenol A results in increased expression of NDUFAF8 mRNA
CTD
PMID:38866337
NCBI chr 9:851,903...854,005
Ensembl chr 9:851,923...854,005
G
NDUFV3
NADH:ubiquinone oxidoreductase subunit V3
decreases expression
EXP
bisphenol A results in decreased expression of NDUFV3 mRNA
CTD
PMID:38866337
NCBI chr31:37,118,201...37,131,035
Ensembl chr31:37,118,247...37,130,810
G
NEK2
NIMA related kinase 2
decreases expression
EXP
bisphenol A results in decreased expression of NEK2 mRNA
CTD
PMID:38866337
NCBI chr 7:10,039,617...10,052,511
Ensembl chr 7:10,040,187...10,052,512
G
NEK9
NIMA related kinase 9
increases expression
EXP
bisphenol A results in increased expression of NEK9 mRNA
CTD
PMID:38866337
NCBI chr 8:48,180,203...48,218,430
Ensembl chr 8:48,183,071...48,257,646
G
NFATC2IP
nuclear factor of activated T cells 2 interacting protein
increases expression
EXP
bisphenol A results in increased expression of NFATC2IP mRNA
CTD
PMID:38866337
NCBI chr 6:18,433,421...18,444,148
Ensembl chr 6:18,432,809...18,443,922
G
NFIA
nuclear factor I A
increases expression
EXP
bisphenol A results in increased expression of NFIA mRNA
CTD
PMID:38866337
NCBI chr 5:48,489,521...49,064,867
Ensembl chr 5:48,496,773...49,064,848
G
NGF
nerve growth factor
decreases expression
EXP
bisphenol A results in decreased expression of NGF mRNA
CTD
PMID:38866337
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NIM1K
NIM1 serine/threonine protein kinase
increases expression
EXP
bisphenol A results in increased expression of NIM1K mRNA
CTD
PMID:38866337
NCBI chr 4:66,662,920...66,726,675
Ensembl chr 4:66,662,951...66,705,908
G
NIN
ninein
increases expression
EXP
bisphenol A results in increased expression of NIN mRNA
CTD
PMID:38866337
NCBI chr 8:27,100,740...27,199,269
Ensembl chr 8:27,104,262...27,189,463
G
NIPAL2
NIPA like domain containing 2
decreases expression
EXP
bisphenol A results in decreased expression of NIPAL2 mRNA
CTD
PMID:38866337
NCBI chr13:427,216...493,861
Ensembl chr13:428,752...493,817
G
NIPAL3
NIPA like domain containing 3
increases expression
EXP
bisphenol A results in increased expression of NIPAL3 mRNA
CTD
PMID:38866337
NCBI chr 2:75,182,820...75,236,487
Ensembl chr 2:75,184,578...75,232,897
G
NKX3-2
NK3 homeobox 2
increases expression
EXP
bisphenol A results in increased expression of NKX3-2 mRNA
CTD
PMID:38866337
NCBI chr 3:66,543,046...66,546,779
Ensembl chr 3:66,543,046...66,545,580
G
NMB
neuromedin B
decreases expression
EXP
bisphenol A results in decreased expression of NMB mRNA
CTD
PMID:38866337
NCBI chr 3:53,927,891...53,931,129
Ensembl chr 3:53,927,900...53,931,069
G
NMS
neuromedin S
decreases expression
EXP
bisphenol A results in decreased expression of NMS mRNA
CTD
PMID:38866337
NCBI chr10:42,260,542...42,310,397
Ensembl chr10:42,260,540...42,274,613
G
NOLC1
nucleolar and coiled-body phosphoprotein 1
increases expression
EXP
bisphenol A results in increased expression of NOLC1 mRNA
CTD
PMID:38866337
NCBI chr28:14,686,001...14,699,082
Ensembl chr28:14,686,090...14,697,980
G
NONO
non-POU domain containing octamer binding
increases expression
EXP
bisphenol A results in increased expression of NONO mRNA
CTD
PMID:38866337
NCBI chr X:55,618,032...55,632,237
Ensembl chr X:55,618,095...55,631,388
G
NOX4
NADPH oxidase 4
decreases expression
EXP
bisphenol A results in decreased expression of NOX4 mRNA
CTD
PMID:38866337
NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
G
NPAT
nuclear protein, coactivator of histone transcription
increases expression
EXP
bisphenol A results in increased expression of NPAT mRNA
CTD
PMID:38866337
NCBI chr 5:24,297,419...24,360,461
Ensembl chr 5:24,296,653...24,346,935
G
NPB
neuropeptide B
decreases expression
EXP
bisphenol A results in decreased expression of NPB mRNA
CTD
PMID:38866337
NCBI chr 9:390,493...392,339
Ensembl chr 9:391,781...392,314
G
NPNT
nephronectin
increases expression
EXP
bisphenol A results in increased expression of NPNT mRNA
CTD
PMID:38866337
NCBI chr32:26,706,147...26,781,792
Ensembl chr32:26,705,476...26,781,275
G
NPTX2
neuronal pentraxin 2
decreases expression
EXP
bisphenol A results in decreased expression of NPTX2 mRNA
CTD
PMID:38866337
NCBI chr 6:10,805,564...10,816,587
Ensembl chr 6:10,806,696...10,816,572
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
bisphenol A results in increased expression of NQO1 mRNA
CTD
PMID:38866337
NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
G
NR4A2
nuclear receptor subfamily 4 group A member 2
increases expression
EXP
bisphenol A results in increased expression of NR4A2 mRNA
CTD
PMID:38866337
NCBI chr36:2,546,237...2,554,559
Ensembl chr36:2,547,421...2,552,780
G
NREP
neuronal regeneration related protein
decreases expression
EXP
bisphenol A results in decreased expression of NREP mRNA
CTD
PMID:38866337
NCBI chr 3:997,142...1,025,215
Ensembl chr 3:997,234...1,024,087
G
NRP1
neuropilin 1
increases expression
EXP
bisphenol A results in increased expression of NRP1 mRNA
CTD
PMID:38866337
NCBI chr 2:3,416,062...3,553,929
Ensembl chr 2:3,413,821...3,552,483
G
NSDHL
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
decreases expression
EXP
bisphenol A results in decreased expression of NSDHL mRNA
CTD
PMID:38866337
NCBI chr X:120,720,118...120,754,573
Ensembl chr X:120,720,183...120,754,143
G
NT5C1B
5'-nucleotidase, cytosolic IB
increases expression
EXP
bisphenol A results in increased expression of NT5C1B mRNA
CTD
PMID:38866337
NCBI chr17:13,848,736...13,870,933
G
NTRK2
neurotrophic receptor tyrosine kinase 2
increases expression
EXP
bisphenol A results in increased expression of NTRK2 mRNA
CTD
PMID:38866337
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
NUP93
nucleoporin 93
increases expression
EXP
bisphenol A results in increased expression of NUP93 mRNA
CTD
PMID:38866337
NCBI chr 2:59,465,482...59,573,871
Ensembl chr 2:59,465,487...59,574,033
G
NVL
nuclear VCP like
increases expression
EXP
bisphenol A results in increased expression of NVL mRNA
CTD
PMID:38866337
NCBI chr 7:40,041,692...40,131,984
Ensembl chr 7:40,041,394...40,131,823
G
NWD1
NACHT and WD repeat domain containing 1
decreases expression
EXP
bisphenol A results in decreased expression of NWD1 mRNA
CTD
PMID:38866337
NCBI chr20:45,792,745...45,854,889
Ensembl chr20:45,794,306...45,852,100
G
NXPH2
neurexophilin 2
increases expression
EXP
bisphenol A results in increased expression of NXPH2 mRNA
CTD
PMID:38866337
NCBI chr19:41,316,391...41,321,165
Ensembl chr19:41,318,149...41,318,904
G
OCRL
OCRL inositol polyphosphate-5-phosphatase
increases expression
EXP
bisphenol A results in increased expression of OCRL mRNA
CTD
PMID:38866337
NCBI chr X:100,760,302...100,817,673
Ensembl chr X:100,757,373...100,831,500
G
OGA
O-GlcNAcase
increases expression
EXP
bisphenol A results in increased expression of OGA mRNA
CTD
PMID:38866337
NCBI chr28:14,376,824...14,405,409
Ensembl chr28:14,373,452...14,404,541
G
OGFOD2
2-oxoglutarate and iron dependent oxygenase domain containing 2
increases expression
EXP
bisphenol A results in increased expression of OGFOD2 mRNA
CTD
PMID:38866337
NCBI chr26:6,525,655...6,530,333
Ensembl chr26:6,526,304...6,530,286
G
OLFML1
olfactomedin like 1
increases expression
EXP
bisphenol A results in increased expression of OLFML1 mRNA
CTD
PMID:38866337
NCBI chr21:31,136,218...31,162,405
Ensembl chr21:30,986,521...31,162,414
G
OOEP
oocyte expressed protein
decreases expression
EXP
bisphenol A results in decreased expression of OOEP mRNA
CTD
PMID:38866337
NCBI chr12:35,431,562...35,449,540
Ensembl chr12:35,448,015...35,449,511
G
OR4D9D
olfactory receptor family 4 subfamily D member 9D
decreases expression
EXP
bisphenol A results in decreased expression of OR4D9D mRNA
CTD
PMID:38866337
NCBI chr18:37,212,362...37,215,456
Ensembl chr18:37,214,518...37,215,453
G
OR4S7
olfactory receptor family 4 subfamily S member 7
decreases expression
EXP
bisphenol A results in decreased expression of OR4S7 mRNA
CTD
PMID:38866337
NCBI chr18:41,570,757...41,571,773
Ensembl chr18:41,570,757...41,571,773
G
OR5AN1
olfactory receptor family 5 subfamily AN member 1
decreases expression
EXP
bisphenol A results in decreased expression of OR5AN1 mRNA
CTD
PMID:38866337
NCBI chr18:37,329,690...37,330,628
Ensembl chr18:37,329,690...37,330,744
G
OR5AN5P
olfactory receptor family 5 subfamily AN member 5, pseudogene
decreases expression
EXP
bisphenol A results in decreased expression of OR5AN5P mRNA
CTD
PMID:38866337
G
OR6Q1
olfactory receptor family 6 subfamily Q member 1
decreases expression
EXP
bisphenol A results in decreased expression of OR6AE1 mRNA
CTD
PMID:38866337
NCBI chr18:38,284,202...38,285,308
Ensembl chr18:38,284,202...38,285,155
G
OSR1
odd-skipped related transcription factor 1
increases expression
EXP
bisphenol A results in increased expression of OSR1 mRNA
CTD
PMID:38866337
NCBI chr17:14,508,543...14,515,657
Ensembl chr17:14,509,333...14,589,228
G
PAK1
p21 (RAC1) activated kinase 1
decreases expression
EXP
bisphenol A results in decreased expression of PAK1 mRNA
CTD
PMID:38866337
NCBI chr21:21,341,530...21,409,535
Ensembl chr21:21,265,484...21,408,416
G
PANK2
pantothenate kinase 2
increases expression
EXP
bisphenol A results in increased expression of PANK2 mRNA
CTD
PMID:38866337
NCBI chr24:17,461,406...17,475,248
Ensembl chr24:17,463,447...17,490,360
G
PARD3
par-3 family cell polarity regulator
increases expression
EXP
bisphenol A results in increased expression of PARD3 mRNA
CTD
PMID:38866337
NCBI chr 2:2,252,262...2,791,459
Ensembl chr 2:2,076,502...2,789,886
G
PARP15
poly(ADP-ribose) polymerase family member 15
decreases expression
EXP
bisphenol A results in decreased expression of PARP15 mRNA
CTD
PMID:38866337
NCBI chr33:25,689,618...25,737,179
Ensembl chr33:25,700,353...25,735,540
G
PARP2
poly(ADP-ribose) polymerase 2
increases expression
EXP
bisphenol A results in increased expression of PARP2 mRNA
CTD
PMID:38866337
NCBI chr15:17,705,966...17,716,743
Ensembl chr15:17,705,975...17,716,094
G
PCDH20
protocadherin 20
increases expression
EXP
bisphenol A results in increased expression of PCDH20 mRNA
CTD
PMID:38866337
NCBI chr22:17,150,498...17,156,091
Ensembl chr22:17,151,913...17,155,892
G
PCK1
phosphoenolpyruvate carboxykinase 1
increases expression
EXP
bisphenol A results in increased expression of PCK1 mRNA
CTD
PMID:38866337
NCBI chr24:42,538,858...42,544,200
Ensembl chr24:42,538,882...42,544,198
G
PCSK1
proprotein convertase subtilisin/kexin type 1
decreases expression
EXP
bisphenol A results in decreased expression of PCSK1 mRNA
CTD
PMID:38866337
NCBI chr 3:13,233,342...13,276,921
Ensembl chr 3:13,233,594...13,274,094
G
PDCD7
programmed cell death 7
increases expression
EXP
bisphenol A results in increased expression of PDCD7 mRNA
CTD
PMID:38866337
NCBI chr30:29,498,290...29,510,991
Ensembl chr30:29,475,498...29,510,575
G
PDGFRA
platelet derived growth factor receptor alpha
increases expression
EXP
bisphenol A results in increased expression of PDGFRA mRNA
CTD
PMID:38866337
NCBI chr13:46,729,722...46,775,828
Ensembl chr13:46,730,703...46,773,278
G
PDK4
pyruvate dehydrogenase kinase 4
increases expression
EXP
bisphenol A results in increased expression of PDK4 mRNA
CTD
PMID:38866337
NCBI chr14:20,825,861...20,839,290
Ensembl chr14:20,827,831...20,839,256
G
PDLIM5
PDZ and LIM domain 5
decreases expression
EXP
bisphenol A results in decreased expression of PDLIM5 mRNA
CTD
PMID:38866337
NCBI chr32:17,294,023...17,505,212
Ensembl chr32:17,294,073...17,502,409
G
PEG3
paternally expressed 3
increases expression
EXP
bisphenol A results in increased expression of PEG3 mRNA
CTD
PMID:38866337
NCBI chr 1:101,091,161...101,123,552
Ensembl chr 1:101,098,669...101,121,032
G
PELI1
pellino E3 ubiquitin protein ligase 1
increases expression
EXP
bisphenol A results in increased expression of PELI1 mRNA
CTD
PMID:38866337
NCBI chr10:63,727,905...63,863,599
Ensembl chr10:63,729,604...63,743,303
G
PFDN2
prefoldin subunit 2
decreases expression
EXP
bisphenol A results in decreased expression of PFDN2 mRNA
CTD
PMID:38866337
NCBI chr38:21,355,622...21,367,623
Ensembl chr38:21,355,678...21,367,619
G
PFKFB2
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
increases expression
EXP
bisphenol A results in increased expression of PFKFB2 mRNA
CTD
PMID:38866337
NCBI chr 7:6,193,519...6,220,034
Ensembl chr 7:6,196,656...6,218,397
G
PFN4
profilin family member 4
decreases expression
EXP
bisphenol A results in decreased expression of PFN4 mRNA
CTD
PMID:38866337
NCBI chr17:18,571,201...18,579,593
Ensembl chr17:18,573,445...18,578,818
G
PGAM1
phosphoglycerate mutase 1
decreases expression
EXP
bisphenol A results in decreased expression of PGAM1 mRNA
CTD
PMID:38866337
NCBI chr28:10,720,235...10,727,709
Ensembl chr28:10,720,094...10,930,286
G
PGK1
phosphoglycerate kinase 1
decreases expression
EXP
bisphenol A results in decreased expression of PGK1 mRNA
CTD
PMID:38866337
NCBI chr X:60,374,743...60,396,244
Ensembl chr X:60,374,754...60,423,947
G
PGR
progesterone receptor
decreases expression
EXP
bisphenol A results in decreased expression of PGR mRNA
CTD
PMID:38866337
NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
G
PHKA1
phosphorylase kinase regulatory subunit alpha 1
increases expression
EXP
bisphenol A results in increased expression of PHKA1 mRNA
CTD
PMID:38866337
NCBI chr X:56,579,538...56,758,293
Ensembl chr X:56,581,435...56,757,905
G
PIAS1
protein inhibitor of activated STAT 1
increases expression
EXP
bisphenol A results in increased expression of PIAS1 mRNA
CTD
PMID:38866337
NCBI chr30:32,116,363...32,232,530
Ensembl chr30:32,119,311...32,228,945
G
PIF1
PIF1 5'-to-3' DNA helicase
increases expression
EXP
bisphenol A results in increased expression of PIF1 mRNA
CTD
PMID:38866337
NCBI chr30:29,223,507...29,232,584
Ensembl chr30:29,157,119...29,232,043
G
PIK3IP1
phosphoinositide-3-kinase interacting protein 1
increases expression
EXP
bisphenol A results in increased expression of PIK3IP1 mRNA
CTD
PMID:38866337
NCBI chr26:24,243,195...24,255,335
Ensembl chr26:24,244,772...24,255,131
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
EXP
bisphenol A results in increased expression of PIK3R1 mRNA
CTD
PMID:38866337
NCBI chr 2:53,447,802...53,527,563
Ensembl chr 2:53,448,286...53,524,970
G
PIKFYVE
phosphoinositide kinase, FYVE-type zinc finger containing
increases expression
EXP
bisphenol A results in increased expression of PIKFYVE mRNA
CTD
PMID:38866337
NCBI chr37:16,537,095...16,620,427
Ensembl chr37:16,541,562...16,619,554
G
PIP4K2C
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
increases expression
EXP
bisphenol A results in increased expression of PIP4K2C mRNA
CTD
PMID:38866337
NCBI chr10:1,670,076...1,680,975
Ensembl chr10:1,672,380...1,680,840
G
PJA1
praja ring finger ubiquitin ligase 1
decreases expression
EXP
bisphenol A results in decreased expression of PJA1 mRNA
CTD
PMID:38866337
NCBI chr X:53,608,459...53,614,270
G
PKD2
polycystin 2, transient receptor potential cation channel
increases expression
EXP
bisphenol A results in increased expression of PKD2 mRNA
CTD
PMID:38866337
NCBI chr32:11,383,441...11,437,603
Ensembl chr32:11,383,424...11,435,438
G
PKDREJ
polycystin family receptor for egg jelly
increases expression
EXP
bisphenol A results in increased expression of PKDREJ mRNA
CTD
PMID:38866337
NCBI chr10:19,914,217...19,921,766
Ensembl chr10:19,914,721...19,920,822
G
PKP2
plakophilin 2
decreases expression
EXP
bisphenol A results in decreased expression of PKP2 mRNA
CTD
PMID:38866337
NCBI chr27:16,023,186...16,109,978
Ensembl chr27:16,023,224...16,109,603
G
PLAA
phospholipase A2 activating protein
increases expression
EXP
bisphenol A results in increased expression of PLAA mRNA
CTD
PMID:38866337
NCBI chr11:45,121,423...45,159,093
Ensembl chr11:45,121,588...45,159,098
G
PLAGL1
PLAG1 like zinc finger 1
decreases expression
EXP
bisphenol A results in decreased expression of PLAGL1 mRNA
CTD
PMID:38866337
NCBI chr 1:35,418,470...35,529,230
Ensembl chr 1:35,419,577...35,528,530
G
PLD4
phospholipase D family member 4
increases expression
EXP
bisphenol A results in increased expression of PLD4 mRNA
CTD
PMID:38866337
NCBI chr 8:72,410,076...72,417,681
Ensembl chr 8:72,416,637...72,417,384
G
PLEKHA2
pleckstrin homology domain containing A2
decreases expression
EXP
bisphenol A results in decreased expression of PLEKHA2 mRNA
CTD
PMID:38866337
NCBI chr16:26,570,466...26,644,971
Ensembl chr16:26,572,641...26,629,495
G
PLIN1
perilipin 1
increases expression
EXP
bisphenol A results in increased expression of PLIN1 mRNA
CTD
PMID:38866337
NCBI chr 3:52,657,178...52,670,573
Ensembl chr 3:52,658,427...52,671,196
G
PLOD2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
decreases expression
EXP
bisphenol A results in decreased expression of PLOD2 mRNA
CTD
PMID:38866337
NCBI chr23:41,290,183...41,382,917
Ensembl chr23:41,290,567...41,382,807
G
PLSCR4
phospholipid scramblase 4
increases expression
EXP
bisphenol A results in increased expression of PLSCR4 mRNA
CTD
PMID:38866337
NCBI chr23:41,415,151...41,453,727
Ensembl chr23:41,415,079...41,450,001
G
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
decreases expression
EXP
bisphenol A results in decreased expression of PMAIP1 mRNA
CTD
PMID:38866337
NCBI chr 1:16,469,793...16,472,910
Ensembl chr 1:16,469,793...16,472,910
G
PMEL
premelanosome protein
increases expression
EXP
bisphenol A results in increased expression of PMEL mRNA
CTD
PMID:38866337
NCBI chr10:292,595...327,618
Ensembl chr10:292,597...300,098
G
PNCK
pregnancy up-regulated nonubiquitous CaM kinase
decreases expression
EXP
bisphenol A results in decreased expression of PNCK mRNA
CTD
PMID:38866337
NCBI chr X:121,489,041...121,491,356
Ensembl chr X:121,489,040...121,491,431
G
PNMA8A
PNMA family member 8A
increases expression
EXP
bisphenol A results in increased expression of PNMA8A mRNA
CTD
PMID:38866337
NCBI chr 1:109,401,900...109,405,955
G
POC1B
POC1 centriolar protein B
increases expression
EXP
bisphenol A results in increased expression of POC1B mRNA
CTD
PMID:38866337
NCBI chr15:30,388,351...30,481,294
Ensembl chr15:30,382,033...30,483,135
G
POLA1
DNA polymerase alpha 1, catalytic subunit
increases expression
EXP
bisphenol A results in increased expression of POLA1 mRNA
CTD
PMID:38866337
NCBI chr X:20,227,808...20,537,893
Ensembl chr X:20,227,886...20,537,902
G
POLR1B
RNA polymerase I subunit B
increases expression
EXP
bisphenol A results in increased expression of POLR1B mRNA
CTD
PMID:38866337
NCBI chr17:36,774,472...36,798,900
Ensembl chr17:36,774,541...36,797,525
G
POLR2L
RNA polymerase II, I and III subunit L
increases expression
EXP
bisphenol A results in increased expression of POLR2L mRNA
CTD
PMID:38866337
NCBI chr18:45,201,194...45,203,825
G
POLR3B
RNA polymerase III subunit B
increases expression
EXP
bisphenol A results in increased expression of POLR3B mRNA
CTD
PMID:38866337
NCBI chr10:32,202,188...32,309,775
Ensembl chr10:32,202,190...32,309,614
G
POSTN
periostin
decreases expression
EXP
bisphenol A results in decreased expression of POSTN mRNA
CTD
PMID:38866337
NCBI chr25:3,167,319...3,208,970
Ensembl chr25:3,167,359...3,208,411
G
PPARG
peroxisome proliferator activated receptor gamma
increases expression
EXP
bisphenol A results in increased expression of PPARG mRNA
CTD
PMID:38866337
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PPFIA1
PTPRF interacting protein alpha 1
increases expression
EXP
bisphenol A results in increased expression of PPFIA1 mRNA
CTD
PMID:38866337
NCBI chr18:47,974,109...48,060,331
Ensembl chr18:47,975,441...48,058,377
G
PPFIBP2
PPFIA binding protein 2
increases expression
EXP
bisphenol A results in increased expression of PPFIBP2 mRNA
CTD
PMID:38866337
NCBI chr21:31,165,386...31,335,231
Ensembl chr21:31,165,194...31,334,973
G
PPM1B
protein phosphatase, Mg2+/Mn2+ dependent 1B
increases expression
EXP
bisphenol A results in increased expression of PPM1B mRNA
CTD
PMID:38866337
NCBI chr10:46,590,110...46,680,792
Ensembl chr10:46,590,079...46,665,866
G
PPM1D
protein phosphatase, Mg2+/Mn2+ dependent 1D
increases expression
EXP
bisphenol A results in increased expression of PPM1D mRNA
CTD
PMID:38866337
NCBI chr 9:35,856,277...35,914,096
Ensembl chr 9:35,856,765...35,913,884
G
PPM1J
protein phosphatase, Mg2+/Mn2+ dependent 1J
increases expression
EXP
bisphenol A results in increased expression of PPM1J mRNA
CTD
PMID:38866337
NCBI chr17:62,858,620...62,863,869
Ensembl chr17:62,858,338...62,863,884
G
PPP1R14A
protein phosphatase 1 regulatory inhibitor subunit 14A
decreases expression
EXP
bisphenol A results in decreased expression of PPP1R14A mRNA
CTD
PMID:38866337
NCBI chr 1:114,739,823...114,743,663
Ensembl chr 1:114,740,117...114,741,910
G
PPP1R1A
protein phosphatase 1 regulatory inhibitor subunit 1A
decreases expression
EXP
bisphenol A results in decreased expression of PPP1R1A mRNA
CTD
PMID:38866337
NCBI chr27:766,757...770,994
Ensembl chr27:766,338...771,598
G
PPP1R3B
protein phosphatase 1 regulatory subunit 3B
decreases expression
EXP
bisphenol A results in decreased expression of PPP1R3B mRNA
CTD
PMID:38866337
NCBI chr16:35,372,928...35,384,640
Ensembl chr16:35,372,859...35,381,921
G
PPP2R1B
protein phosphatase 2 scaffold subunit Abeta
increases expression
EXP
bisphenol A results in increased expression of PPP2R1B mRNA
CTD
PMID:38866337
NCBI chr 5:21,323,956...21,356,835
Ensembl chr 5:21,322,059...21,394,193
G
PPP2R5A
protein phosphatase 2 regulatory subunit B'alpha
increases expression
EXP
bisphenol A results in increased expression of PPP2R5A mRNA
CTD
PMID:38866337
NCBI chr 7:10,502,959...10,566,475
Ensembl chr 7:10,502,930...10,565,404
G
PPP4R3A
protein phosphatase 4 regulatory subunit 3A
increases expression
EXP
bisphenol A results in increased expression of PPP4R3A mRNA
CTD
PMID:38866337
NCBI chr 8:62,304,805...62,344,232
Ensembl chr 8:62,305,947...62,344,147
G
PPTC7
protein phosphatase targeting COQ7
increases expression
EXP
bisphenol A results in increased expression of PPTC7 mRNA
CTD
PMID:38866337
NCBI chr26:8,345,690...8,383,902
Ensembl chr26:8,349,453...8,383,617
G
PRELID3A
PRELI domain containing 3A
increases expression
EXP
bisphenol A results in increased expression of PRELID3A mRNA
CTD
PMID:38866337
NCBI chr 7:77,826,003...77,873,568
Ensembl chr 7:77,832,134...77,836,987
G
PRKAG2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
EXP
bisphenol A results in decreased expression of PRKAG2 mRNA
CTD
PMID:38866337
NCBI chr16:15,521,304...15,786,237
Ensembl chr16:15,522,111...15,785,854
G
PRKCZ
protein kinase C zeta
increases expression
EXP
bisphenol A results in increased expression of PRKCZ mRNA
CTD
PMID:38866337
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
increases expression
EXP
bisphenol A results in increased expression of PRKDC mRNA
CTD
PMID:38866337
NCBI chr29:24,904...243,926
Ensembl chr29:35,007...243,895
G
PRLR
prolactin receptor
increases expression
EXP
bisphenol A results in increased expression of PRLR mRNA
CTD
PMID:38866337
NCBI chr 4:73,147,919...73,280,970
Ensembl chr 4:73,110,858...73,273,916
G
PRPSAP2
phosphoribosyl pyrophosphate synthetase associated protein 2
decreases expression
EXP
bisphenol A results in decreased expression of PRPSAP2 mRNA
CTD
PMID:38866337
NCBI chr 5:41,118,591...41,167,647
Ensembl chr 5:41,039,015...41,167,568
G
PRR14L
proline rich 14 like
increases expression
EXP
bisphenol A results in increased expression of PRR14L mRNA
CTD
PMID:38866337
NCBI chr26:24,570,777...24,624,151
Ensembl chr26:24,570,880...24,622,166
G
PRSS23
serine protease 23
decreases expression
EXP
bisphenol A results in decreased expression of PRSS23 mRNA
CTD
PMID:38866337
NCBI chr21:12,792,212...12,813,067
Ensembl chr21:12,793,373...12,803,136
G
PRUNE1
prune exopolyphosphatase 1
increases expression
EXP
bisphenol A results in increased expression of PRUNE1 mRNA
CTD
PMID:38866337
NCBI chr17:60,104,724...60,125,899
Ensembl chr17:60,104,958...60,124,900
G
PSAT1
phosphoserine aminotransferase 1
decreases expression
EXP
bisphenol A results in decreased expression of PSAT1 mRNA
CTD
PMID:38866337
NCBI chr 1:80,376,469...80,408,177
Ensembl chr 1:80,377,115...80,408,162
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
bisphenol A results in decreased expression of PTGS2 mRNA
CTD
PMID:38866337
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTHLH
parathyroid hormone like hormone
decreases expression
EXP
bisphenol A results in decreased expression of PTHLH mRNA
CTD
PMID:38866337
NCBI chr27:19,781,557...19,795,078
Ensembl chr27:19,781,557...19,795,078
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
increases expression
EXP
bisphenol A results in increased expression of PTPN13 mRNA
CTD
PMID:38866337
NCBI chr32:10,125,447...10,328,764
Ensembl chr32:10,125,441...10,328,757
G
PXMP4
peroxisomal membrane protein 4
increases expression
EXP
bisphenol A results in increased expression of PXMP4 mRNA
CTD
PMID:38866337
NCBI chr24:22,916,336...22,930,082
Ensembl chr24:22,918,363...22,930,036
G
PYGL
glycogen phosphorylase L
increases expression
EXP
bisphenol A results in increased expression of PYGL mRNA
CTD
PMID:38866337
NCBI chr 8:27,264,778...27,307,977
Ensembl chr 8:27,223,273...27,307,977
G
QPCT
glutaminyl-peptide cyclotransferase
decreases expression
EXP
bisphenol A results in decreased expression of QPCT mRNA
CTD
PMID:38866337
NCBI chr17:29,700,422...29,741,652
Ensembl chr17:29,716,378...29,741,221
G
QRFP
pyroglutamylated RFamide peptide
increases expression
EXP
bisphenol A results in increased expression of QRFP mRNA
CTD
PMID:38866337
NCBI chr 9:53,110,763...53,113,743
Ensembl chr 9:53,112,586...53,112,996
G
RAB6A
RAB6A, member RAS oncogene family
decreases expression
EXP
bisphenol A results in decreased expression of RAB6A mRNA
CTD
PMID:38866337
NCBI chr21:24,489,653...24,578,212
Ensembl chr21:24,492,359...24,576,524
G
RABEP1
rabaptin, RAB GTPase binding effector protein 1
increases expression
EXP
bisphenol A results in increased expression of RABEP1 mRNA
CTD
PMID:38866337
NCBI chr 5:31,390,873...31,442,585
Ensembl chr 5:31,391,576...31,491,506
G
RABGAP1
RAB GTPase activating protein 1
increases expression
EXP
bisphenol A results in increased expression of RABGAP1 mRNA
CTD
PMID:38866337
NCBI chr 9:59,692,621...59,860,392
Ensembl chr 9:59,694,098...59,836,532
G
RAI14
retinoic acid induced 14
decreases expression
EXP
bisphenol A results in decreased expression of RAI14 mRNA
CTD
PMID:38866337
NCBI chr 4:73,460,728...73,599,070
Ensembl chr 4:73,461,523...73,585,173
G
RALGAPA1
Ral GTPase activating protein catalytic subunit alpha 1
increases expression
EXP
bisphenol A results in increased expression of RALGAPA1 mRNA
CTD
PMID:38866337
NCBI chr 8:14,221,516...14,463,481
Ensembl chr 8:14,222,749...14,462,998
G
RALGAPB
Ral GTPase activating protein non-catalytic subunit beta
increases expression
EXP
bisphenol A results in increased expression of RALGAPB mRNA
CTD
PMID:38866337
NCBI chr24:26,948,626...27,032,092
Ensembl chr24:26,961,628...27,070,850
G
RALGPS2
Ral GEF with PH domain and SH3 binding motif 2
decreases expression
EXP
bisphenol A results in decreased expression of RALGPS2 mRNA
CTD
PMID:38866337
NCBI chr 7:20,874,227...21,031,817
Ensembl chr 7:20,879,492...21,005,154
G
RAP2C
RAP2C, member of RAS oncogene family
decreases expression
EXP
bisphenol A results in decreased expression of RAP2C mRNA
CTD
PMID:38866337
NCBI chr X:103,134,752...103,150,900
Ensembl chr X:103,145,635...103,150,934
G
RAPGEF3
Rap guanine nucleotide exchange factor 3
increases expression
EXP
bisphenol A results in increased expression of RAPGEF3 mRNA
CTD
PMID:38866337
NCBI chr27:6,993,452...7,030,372
Ensembl chr27:6,993,452...7,017,316
G
RAPGEF5
Rap guanine nucleotide exchange factor 5
increases expression
EXP
bisphenol A results in increased expression of RAPGEF5 mRNA
CTD
PMID:38866337
NCBI chr14:35,979,393...36,208,849
Ensembl chr14:35,982,444...36,209,214
G
RASSF2
Ras association domain family member 2
increases expression
EXP
bisphenol A results in increased expression of RASSF2 mRNA
CTD
PMID:38866337
NCBI chr24:16,736,786...16,779,910
Ensembl chr24:16,736,962...16,781,569
G
RASSF4
Ras association domain family member 4
decreases expression
EXP
bisphenol A results in decreased expression of RASSF4 mRNA
CTD
PMID:38866337
NCBI chr28:2,450,935...2,473,461
Ensembl chr28:2,452,175...2,482,880
G
RBM11
RNA binding motif protein 11
decreases expression
EXP
bisphenol A results in decreased expression of RBM11 mRNA
CTD
PMID:38866337
NCBI chr31:11,204,273...11,217,526
Ensembl chr31:11,203,207...11,217,509
G
RBM6
RNA binding motif protein 6
increases expression
EXP
bisphenol A results in increased expression of RBM6 mRNA
CTD
PMID:38866337
NCBI chr20:39,235,301...39,359,784
Ensembl chr20:39,235,421...39,334,107
G
RBP4
retinol binding protein 4
decreases expression
EXP
bisphenol A results in decreased expression of RBP4 mRNA
CTD
PMID:38866337
NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
G
RBPJL
recombination signal binding protein for immunoglobulin kappa J region like
increases expression
EXP
bisphenol A results in increased expression of RBPJL mRNA
CTD
PMID:38866337
NCBI chr24:32,615,934...32,625,183
Ensembl chr24:32,612,386...32,624,567
G
RCN1
reticulocalbin 1
decreases expression
EXP
bisphenol A results in decreased expression of RCN1 mRNA
CTD
PMID:38866337
NCBI chr18:35,373,175...35,393,389
Ensembl chr18:35,374,116...35,395,528
G
REPS2
RALBP1 associated Eps domain containing 2
decreases expression
EXP
bisphenol A results in decreased expression of REPS2 mRNA
CTD
PMID:38866337
NCBI chr X:13,088,980...13,320,534
Ensembl chr X:13,088,349...13,307,402
G
RERG
RAS like estrogen regulated growth inhibitor
increases expression
EXP
bisphenol A results in increased expression of RERG mRNA
CTD
PMID:38866337
NCBI chr27:31,413,464...31,526,838
Ensembl chr27:31,417,487...31,525,496
G
RETREG3
reticulophagy regulator family member 3
increases expression
EXP
bisphenol A results in increased expression of RETREG3 mRNA
CTD
PMID:38866337
NCBI chr 9:20,363,729...20,385,580
Ensembl chr 9:20,363,823...20,385,592
G
REV3L
REV3 like, DNA directed polymerase zeta catalytic subunit
increases expression
EXP
bisphenol A results in increased expression of REV3L mRNA
CTD
PMID:38866337
NCBI chr12:67,776,285...67,953,337
Ensembl chr12:67,756,924...67,953,553
G
RHOBTB1
Rho related BTB domain containing 1
increases expression
EXP
bisphenol A results in increased expression of RHOBTB1 mRNA
CTD
PMID:38866337
NCBI chr 4:12,971,624...13,089,520
Ensembl chr 4:12,973,412...13,035,505
G
RHOQ
ras homolog family member Q
decreases expression
EXP
bisphenol A results in decreased expression of RHOQ mRNA
CTD
PMID:38866337
NCBI chr10:48,766,623...48,807,198
Ensembl chr10:48,768,191...48,804,129
G
RHOU
ras homolog family member U
increases expression
EXP
bisphenol A results in increased expression of RHOU mRNA
CTD
PMID:38866337
NCBI chr 4:10,395,033...10,406,239
Ensembl chr 4:10,396,111...10,406,244
G
RIBC2
RIB43A domain with coiled-coils 2
decreases expression
EXP
bisphenol A results in decreased expression of RIBC2 mRNA
CTD
PMID:38866337
NCBI chr10:20,625,423...20,640,266
Ensembl chr10:20,625,447...20,640,468
G
RILPL2
Rab interacting lysosomal protein like 2
increases expression
EXP
bisphenol A results in increased expression of RILPL2 mRNA
CTD
PMID:38866337
NCBI chr26:6,145,571...6,168,750
Ensembl chr26:6,145,937...6,168,625
G
RIMOC1
RAB7A interacting MON1-CCZ1 complex subunit 1
increases expression
EXP
bisphenol A results in increased expression of RIMOC1 mRNA
CTD
PMID:38866337
NCBI chr 4:67,668,727...67,688,509
Ensembl chr 4:67,672,923...67,688,451
G
RMND5A
required for meiotic nuclear division 5 homolog A
increases expression
EXP
bisphenol A results in increased expression of RMND5A mRNA
CTD
PMID:38866337
NCBI chr17:38,408,946...38,472,342
Ensembl chr17:38,412,967...38,472,395
G
RNASEL
ribonuclease L
increases expression
EXP
bisphenol A results in increased expression of RNASEL mRNA
CTD
PMID:38866337
NCBI chr 7:15,978,055...16,001,604
Ensembl chr 7:15,856,151...16,001,569
G
RNASET2
ribonuclease T2
increases expression
EXP
bisphenol A results in increased expression of RNASET2 mRNA
CTD
PMID:38866337
NCBI chr 1:54,779,453...54,820,697
G
RND1
Rho family GTPase 1
decreases expression
EXP
bisphenol A results in decreased expression of RND1 mRNA
CTD
PMID:38866337
NCBI chr27:5,679,629...5,686,657
Ensembl chr27:5,679,658...5,687,428
G
RND3
Rho family GTPase 3
decreases expression
EXP
bisphenol A results in decreased expression of RND3 mRNA
CTD
PMID:38866337
NCBI chr19:51,889,693...51,909,028
Ensembl chr19:51,891,494...51,909,033
G
RNF144B
ring finger protein 144B
decreases expression
EXP
bisphenol A results in decreased expression of RNF144B mRNA
CTD
PMID:38866337
NCBI chr35:17,056,189...17,226,254
Ensembl chr35:17,150,835...17,238,566
G
RNF169
ring finger protein 169
increases expression
EXP
bisphenol A results in increased expression of RNF169 mRNA
CTD
PMID:38866337
NCBI chr21:23,574,478...23,655,305
Ensembl chr21:23,579,370...23,655,290
G
RORB
RAR related orphan receptor B
increases expression
EXP
bisphenol A results in increased expression of RORB mRNA
CTD
PMID:38866337
NCBI chr 1:83,470,569...83,666,200
Ensembl chr 1:83,476,816...83,666,061
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
decreases expression
EXP
bisphenol A results in decreased expression of RRAD mRNA
CTD
PMID:38866337
NCBI chr 5:82,392,608...82,395,574
Ensembl chr 5:82,392,557...82,395,561
G
RRAS2
RAS related 2
decreases expression
EXP
bisphenol A results in decreased expression of RRAS2 mRNA
CTD
PMID:38866337
NCBI chr21:37,037,576...37,119,733
Ensembl chr21:37,038,334...37,112,662
G
RSPO1
R-spondin 1
increases expression
EXP
bisphenol A results in increased expression of RSPO1 mRNA
CTD
PMID:38866337
NCBI chr15:4,857,887...4,876,077
Ensembl chr15:4,856,853...4,876,800
G
RSPO3
R-spondin 3
decreases expression
EXP
bisphenol A results in decreased expression of RSPO3 mRNA
CTD
PMID:38866337
NCBI chr 1:65,858,822...65,936,160
Ensembl chr 1:65,858,794...65,936,322
G
RTF1
RTF1 homolog, Paf1/RNA polymerase II complex component
increases expression
EXP
bisphenol A results in increased expression of RTF1 mRNA
CTD
PMID:38866337
NCBI chr30:8,468,001...8,524,712
Ensembl chr30:8,467,761...8,522,874
G
RUFY1
RUN and FYVE domain containing 1
increases expression
EXP
bisphenol A results in increased expression of RUFY1 mRNA
CTD
PMID:38866337
NCBI chr11:2,062,623...2,127,613
Ensembl chr11:2,052,901...2,127,746
G
RUNDC1
RUN domain containing 1
increases expression
EXP
bisphenol A results in increased expression of RUNDC1 mRNA
CTD
PMID:38866337
NCBI chr 9:20,071,040...20,080,597
Ensembl chr 9:20,072,446...20,080,528
G
S100A10
S100 calcium binding protein A10
increases expression
EXP
bisphenol A results in increased expression of S100A10 mRNA
CTD
PMID:38866337
NCBI chr17:60,984,138...60,994,915
G
SAP30L
SAP30 like
increases expression
EXP
bisphenol A results in increased expression of SAP30L mRNA
CTD
PMID:38866337
NCBI chr 4:55,247,912...55,261,655
Ensembl chr 4:55,252,938...55,262,207
G
SBF2
SET binding factor 2
increases expression
EXP
bisphenol A results in increased expression of SBF2 mRNA
CTD
PMID:38866337
NCBI chr21:33,005,921...33,461,258
Ensembl chr21:33,007,380...33,461,115
G
SCD
stearoyl-CoA desaturase
increases expression
EXP
bisphenol A results in increased expression of SCD mRNA
CTD
PMID:38866337
NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
G
SCUBE2
signal peptide, CUB domain and EGF like domain containing 2
increases expression
EXP
bisphenol A results in increased expression of SCUBE2 mRNA
CTD
PMID:38866337
NCBI chr21:32,370,361...32,435,608
Ensembl chr21:32,370,913...32,574,588
G
SDHA
succinate dehydrogenase complex flavoprotein subunit A
increases expression
EXP
bisphenol A results in increased expression of SDHA mRNA
CTD
PMID:38866337
NCBI chr34:11,935,684...11,965,094
Ensembl chr34:11,935,941...11,965,189
G
SEC16B
SEC16 homolog B, endoplasmic reticulum export factor
decreases expression
EXP
bisphenol A results in decreased expression of SEC16B mRNA
CTD
PMID:38866337
NCBI chr 7:21,683,310...21,739,914
Ensembl chr 7:21,698,411...21,738,954
G
SEMA3C
semaphorin 3C
decreases expression
EXP
bisphenol A results in decreased expression of SEMA3C mRNA
CTD
PMID:38866337
NCBI chr18:20,457,683...20,748,008
Ensembl chr18:20,459,925...20,635,276
G
SEMA3D
semaphorin 3D
decreases expression
EXP
bisphenol A results in decreased expression of SEMA3D mRNA
CTD
PMID:38866337
NCBI chr18:24,254,113...24,429,767
Ensembl chr18:24,262,125...24,394,155
G
SEMA6D
semaphorin 6D
increases expression
EXP
bisphenol A results in increased expression of SEMA6D mRNA
CTD
PMID:38866337
NCBI chr30:13,489,896...14,059,623
Ensembl chr30:14,005,124...14,057,202
G
SENP1
SUMO specific peptidase 1
increases expression
EXP
bisphenol A results in increased expression of SENP1 mRNA
CTD
PMID:38866337
NCBI chr27:6,664,750...6,719,257
Ensembl chr27:6,664,818...6,714,479
G
SEPHS1
selenophosphate synthetase 1
increases expression
EXP
bisphenol A results in increased expression of SEPHS1 mRNA
CTD
PMID:38866337
NCBI chr 2:23,147,303...23,178,808
Ensembl chr 2:23,146,353...23,177,174
G
SEPTIN11
septin 11
increases expression
EXP
bisphenol A results in increased expression of SEPTIN11 mRNA
CTD
PMID:38866337
NCBI chr32:1,553,208...1,608,132
Ensembl chr32:1,475,748...1,607,107
G
SERPINE2
serpin family E member 2
decreases expression
EXP
bisphenol A results in decreased expression of SERPINE2 mRNA
CTD
PMID:38866337
NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228
G
SERPINF1
serpin family F member 1
decreases expression
EXP
bisphenol A results in decreased expression of SERPINF1 mRNA
CTD
PMID:38866337
NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
G
SERPINI1
serpin family I member 1
decreases expression
EXP
bisphenol A results in decreased expression of SERPINI1 mRNA
CTD
PMID:38866337
NCBI chr34:32,553,876...32,624,708
Ensembl chr34:32,553,902...32,624,526
G
SERTAD3
SERTA domain containing 3
increases expression
EXP
bisphenol A results in increased expression of SERTAD3 mRNA
CTD
PMID:38866337
NCBI chr 1:113,258,274...113,264,013
Ensembl chr 1:113,261,354...113,263,899
G
SESN1
sestrin 1
increases expression
EXP
bisphenol A results in increased expression of SESN1 mRNA
CTD
PMID:38866337
NCBI chr12:65,958,995...66,057,369
Ensembl chr12:65,960,066...66,057,035
G
SETD2
SET domain containing 2, histone lysine methyltransferase
increases expression
EXP
bisphenol A results in increased expression of SETD2 mRNA
CTD
PMID:38866337
NCBI chr20:41,675,539...41,800,697
Ensembl chr20:41,675,599...41,800,612
G
SFRP4
secreted frizzled related protein 4
decreases expression
EXP
bisphenol A results in decreased expression of SFRP4 mRNA
CTD
PMID:38866337
NCBI chr18:12,018,049...12,028,123
Ensembl chr18:12,017,978...12,027,788
G
SGK1
serum/glucocorticoid regulated kinase 1
increases expression
EXP
bisphenol A results in increased expression of SGK1 mRNA
CTD
PMID:38866337
NCBI chr 1:27,086,431...27,196,601
Ensembl chr 1:27,087,361...27,196,521
G
SH2D4A
SH2 domain containing 4A
increases expression
EXP
bisphenol A results in increased expression of SH2D4A mRNA
CTD
PMID:38866337
NCBI chr16:22,138,555...22,209,326
Ensembl chr16:22,143,602...22,209,341
G
SH3D19
SH3 domain containing 19
increases expression
EXP
bisphenol A results in increased expression of SH3D19 mRNA
CTD
PMID:38866337
NCBI chr15:49,076,194...49,244,691
Ensembl chr15:49,081,803...49,168,312
G
SHC2
SHC adaptor protein 2
decreases expression
EXP
bisphenol A results in decreased expression of SHC2 mRNA
CTD
PMID:38866337
NCBI chr20:58,001,442...58,023,201
G
SIX4
SIX homeobox 4
decreases expression
EXP
bisphenol A results in decreased expression of SIX4 mRNA
CTD
PMID:38866337
NCBI chr 8:35,735,893...35,748,976
Ensembl chr 8:35,737,058...35,748,893
G
SLC16A12
solute carrier family 16 member 12
decreases expression
EXP
bisphenol A results in decreased expression of SLC16A12 mRNA
CTD
PMID:38866337
NCBI chr28:4,343,773...4,430,653
Ensembl chr28:4,345,546...4,421,234
G
SLC22A3
solute carrier family 22 member 3
increases expression
EXP
bisphenol A results in increased expression of SLC22A3 mRNA
CTD
PMID:38866337
NCBI chr 1:49,407,949...49,496,627
Ensembl chr 1:49,407,966...49,496,620
G
SLC23A2
solute carrier family 23 member 2
increases expression
EXP
bisphenol A results in increased expression of SLC23A2 mRNA
CTD
PMID:38866337
NCBI chr24:16,573,616...16,709,296
Ensembl chr24:16,574,168...16,709,296
G
SLC25A34
solute carrier family 25 member 34
increases expression
EXP
bisphenol A results in increased expression of SLC25A34 mRNA
CTD
PMID:38866337
NCBI chr 2:81,859,294...81,864,808
Ensembl chr 2:81,860,234...81,863,494
G
SLC25A47
solute carrier family 25 member 47
increases expression
EXP
bisphenol A results in increased expression of SLC25A47 mRNA
CTD
PMID:38866337
NCBI chr 8:68,602,525...68,607,364
Ensembl chr 8:68,602,662...68,606,875
G
SLC27A6
solute carrier family 27 member 6
increases expression
EXP
bisphenol A results in increased expression of SLC27A6 mRNA
CTD
PMID:38866337
NCBI chr11:17,899,270...17,968,940
Ensembl chr11:17,899,556...17,968,910
G
SLC38A1
solute carrier family 38 member 1
decreases expression
EXP
bisphenol A results in decreased expression of SLC38A1 mRNA
CTD
PMID:38866337
NCBI chr27:8,110,327...8,179,394
Ensembl chr27:8,130,823...8,174,936
G
SLC40A1
solute carrier family 40 member 1
increases expression
EXP
bisphenol A results in increased expression of SLC40A1 mRNA
CTD
PMID:38866337
NCBI chr37:308,054...329,037
Ensembl chr37:303,104...368,865
G
SLC44A1
solute carrier family 44 member 1
increases expression
EXP
bisphenol A results in increased expression of SLC44A1 mRNA
CTD
PMID:38866337
NCBI chr11:61,120,858...61,313,250
Ensembl chr11:61,120,176...61,312,590
G
SLMAP
sarcolemma associated protein
decreases expression
EXP
bisphenol A results in decreased expression of SLMAP mRNA
CTD
PMID:38866337
NCBI chr20:32,592,576...32,738,515
Ensembl chr20:32,594,417...32,738,823
G
SMAGP
small cell adhesion glycoprotein
decreases expression
EXP
bisphenol A results in decreased expression of SMAGP mRNA
CTD
PMID:38866337
NCBI chr27:3,614,888...3,616,519
Ensembl chr27:3,614,963...3,615,929
G
SMCHD1
structural maintenance of chromosomes flexible hinge domain containing 1
increases expression
EXP
bisphenol A results in increased expression of SMCHD1 mRNA
CTD
PMID:38866337
NCBI chr 7:69,359,286...69,505,067
Ensembl chr 7:69,358,447...69,621,067
G
SMG8
SMG8 nonsense mediated mRNA decay factor
increases expression
EXP
bisphenol A results in increased expression of SMG8 mRNA
CTD
PMID:38866337
NCBI chr 9:33,759,020...33,763,767
Ensembl chr 9:33,759,132...33,935,412
G
SMIM1
small integral membrane protein 1
decreases expression
EXP
bisphenol A results in decreased expression of SMIM1 mRNA
CTD
PMID:38866337
NCBI chr 5:58,281,962...58,285,071
Ensembl chr 5:58,282,347...58,284,616
G
SMIM2
small integral membrane protein 2
increases expression
EXP
bisphenol A results in increased expression of SMIM2 mRNA
CTD
PMID:38866337
NCBI chr22:6,741,203...6,742,866
Ensembl chr22:6,741,504...6,757,691
G
SNRK
SNF related kinase
increases expression
EXP
bisphenol A results in increased expression of SNRK mRNA
CTD
PMID:38866337
NCBI chr23:2,909,311...2,966,098
Ensembl chr23:2,909,298...2,965,508
G
SOCS2
suppressor of cytokine signaling 2
increases expression
EXP
bisphenol A results in increased expression of SOCS2 mRNA
CTD
PMID:38866337
NCBI chr15:33,761,434...33,788,973
Ensembl chr15:33,785,545...33,877,869
G
SP1
Sp1 transcription factor
increases expression
EXP
bisphenol A results in increased expression of SP1 mRNA
CTD
PMID:38866337
NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226
G
SPAAR
small regulatory polypeptide of amino acid response
increases expression
EXP
bisphenol A results in increased expression of SPAAR mRNA
CTD
PMID:38866337
NCBI chr11:52,424,607...52,427,288
Ensembl chr11:52,426,076...52,426,303
G
SPACA9
sperm acrosome associated 9
increases expression
EXP
bisphenol A results in increased expression of SPACA9 mRNA
CTD
PMID:38866337
NCBI chr 9:51,460,359...51,470,612
Ensembl chr 9:51,460,623...51,468,902
G
SPATA20
spermatogenesis associated 20
decreases expression
EXP
bisphenol A results in decreased expression of SPATA20 mRNA
CTD
PMID:38866337
NCBI chr 9:26,468,931...26,476,218
Ensembl chr 9:26,468,208...26,476,211
G
SPATS2L
spermatogenesis associated serine rich 2 like
decreases expression
EXP
bisphenol A results in decreased expression of SPATS2L mRNA
CTD
PMID:38866337
NCBI chr37:9,403,557...9,564,466
Ensembl chr37:9,407,101...9,586,913
G
SPG11
SPG11 vesicle trafficking associated, spatacsin
increases expression
EXP
bisphenol A results in increased expression of SPG11 mRNA
CTD
PMID:38866337
NCBI chr30:11,233,709...11,305,454
Ensembl chr30:11,233,718...11,305,485
G
SPINT3
serine peptidase inhibitor, Kunitz type 3
increases expression
EXP
bisphenol A results in increased expression of SPINT3 mRNA
CTD
PMID:38866337
NCBI chr24:32,721,798...32,724,433
Ensembl chr24:32,721,798...32,724,408
G
SPRY2
sprouty RTK signaling antagonist 2
increases expression
EXP
bisphenol A results in increased expression of SPRY2 mRNA
CTD
PMID:38866337
NCBI chr22:33,366,139...33,371,102
Ensembl chr22:33,366,931...33,367,878
G
SPRYD4
SPRY domain containing 4
increases expression
EXP
bisphenol A results in increased expression of SPRYD4 mRNA
CTD
PMID:38866337
NCBI chr10:720,099...722,139
Ensembl chr10:720,046...722,119
G
SQOR
sulfide quinone oxidoreductase
decreases expression
EXP
bisphenol A results in decreased expression of SQOR mRNA
CTD
PMID:38866337
NCBI chr30:11,956,335...12,004,770
Ensembl chr30:11,956,366...12,004,765
G
SRSF5
serine and arginine rich splicing factor 5
increases expression
EXP
bisphenol A results in increased expression of SRSF5 mRNA
CTD
PMID:38866337
NCBI chr 8:43,514,048...43,519,019
Ensembl chr 8:43,514,076...43,518,481
G
SSH2
slingshot protein phosphatase 2
increases expression
EXP
bisphenol A results in increased expression of SSH2 mRNA
CTD
PMID:38866337
NCBI chr 9:43,726,726...43,907,199
Ensembl chr 9:43,731,635...43,907,220
G
SSR3
signal sequence receptor subunit 3
decreases expression
EXP
bisphenol A results in decreased expression of SSR3 mRNA
CTD
PMID:38866337
NCBI chr23:50,136,591...50,150,424
Ensembl chr23:50,138,909...50,150,415
G
ST6GALNAC5
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
decreases expression
EXP
bisphenol A results in decreased expression of ST6GALNAC5 mRNA
CTD
PMID:38866337
NCBI chr 6:69,706,717...69,867,760
Ensembl chr 6:69,709,114...69,867,648
G
STARD10
StAR related lipid transfer domain containing 10
decreases expression
EXP
bisphenol A results in decreased expression of STARD10 mRNA
CTD
PMID:38866337
NCBI chr21:25,439,189...25,466,614
Ensembl chr21:25,433,208...25,466,583
G
STAT2
signal transducer and activator of transcription 2
increases expression
EXP
bisphenol A results in increased expression of STAT2 mRNA
CTD
PMID:38866337
NCBI chr10:641,543...660,882
Ensembl chr10:642,718...658,546
G
STON1
stonin 1
decreases expression
EXP
bisphenol A results in decreased expression of STON1 mRNA
CTD
PMID:38866337
NCBI chr10:50,421,635...50,470,302
Ensembl chr10:50,436,715...50,467,878
G
STRADA
STE20 related adaptor alpha
decreases expression
EXP
bisphenol A results in decreased expression of STRADA mRNA
CTD
PMID:38866337
NCBI chr 9:11,684,905...11,712,515
Ensembl chr 9:11,684,663...11,712,432
G
STRBP
spermatid perinuclear RNA binding protein
increases expression
EXP
bisphenol A results in increased expression of STRBP mRNA
CTD
PMID:38866337
NCBI chr 9:59,543,172...59,689,035
Ensembl chr 9:59,614,129...59,689,032
G
STRIT1
small transmembrane regulator of ion transport 1
decreases expression
EXP
bisphenol A results in decreased expression of STRIT1 mRNA
CTD
PMID:38866337
NCBI chr23:49,131,218...49,134,728
Ensembl chr23:49,131,221...49,134,942
G
STX11
syntaxin 11
decreases expression
EXP
bisphenol A results in decreased expression of STX11 mRNA
CTD
PMID:38866337
NCBI chr 1:35,600,440...35,645,421
Ensembl chr 1:35,601,133...35,644,819
G
STXBP6
syntaxin binding protein 6
decreases expression
EXP
bisphenol A results in decreased expression of STXBP6 mRNA
CTD
PMID:38866337
NCBI chr 8:4,638,376...4,877,589
Ensembl chr 8:4,641,460...4,877,030
G
SULF2
sulfatase 2
increases expression
EXP
bisphenol A results in increased expression of SULF2 mRNA
CTD
PMID:38866337
NCBI chr24:34,732,000...34,850,347
Ensembl chr24:34,732,037...34,828,569
G
SULT1A1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
increases expression
EXP
bisphenol A results in increased expression of SULT1A1 mRNA
CTD
PMID:38866337
NCBI chr 6:18,176,156...18,179,492
Ensembl chr 6:18,176,355...18,179,489
G
SUMF1
sulfatase modifying factor 1
increases expression
EXP
bisphenol A results in increased expression of SUMF1 mRNA
CTD
PMID:38866337
NCBI chr20:13,093,427...13,190,621
Ensembl chr20:13,092,901...13,299,314
G
SYCE2
synaptonemal complex central element protein 2
increases expression
EXP
bisphenol A results in increased expression of SYCE2 mRNA
CTD
PMID:38866337
NCBI chr20:49,267,985...49,285,986
Ensembl chr20:49,281,773...49,283,880
G
SYNE4
spectrin repeat containing nuclear envelope family member 4
increases expression
EXP
bisphenol A results in increased expression of SYNE4 mRNA
CTD
PMID:38866337
NCBI chr 1:116,676,365...116,686,911
Ensembl chr 1:116,670,841...116,680,515
G
SYTL2
synaptotagmin like 2
decreases expression
EXP
bisphenol A results in decreased expression of SYTL2 mRNA
CTD
PMID:38866337
NCBI chr21:13,639,054...13,756,332
Ensembl chr21:13,688,338...13,755,414
G
TACC3
transforming acidic coiled-coil containing protein 3
increases expression
EXP
bisphenol A results in increased expression of TACC3 mRNA
CTD
PMID:38866337
NCBI chr 3:62,368,641...62,380,898
Ensembl chr 3:62,368,642...62,381,024
G
TAF1
TATA-box binding protein associated factor 1
increases expression
EXP
bisphenol A results in increased expression of TAF1 mRNA
CTD
PMID:38866337
NCBI chr X:55,693,091...55,764,268
Ensembl chr X:55,693,194...55,763,683
G
TAF4B
TATA-box binding protein associated factor 4b
increases expression
EXP
bisphenol A results in increased expression of TAF4B mRNA
CTD
PMID:38866337
NCBI chr 7:62,276,885...62,402,838
Ensembl chr 7:62,278,061...62,402,375
G
TAOK1
TAO kinase 1
increases expression
EXP
bisphenol A results in increased expression of TAOK1 mRNA
CTD
PMID:38866337
NCBI chr 9:43,501,752...43,660,077
Ensembl chr 9:43,559,708...43,651,377
G
TBC1D20
TBC1 domain family member 20
increases expression
EXP
bisphenol A results in increased expression of TBC1D20 mRNA
CTD
PMID:38866337
NCBI chr24:20,400,647...20,419,652
Ensembl chr24:20,400,791...20,419,655
G
TBC1D22B
TBC1 domain family member 22B
increases expression
EXP
bisphenol A results in increased expression of TBC1D22B mRNA
CTD
PMID:38866337
NCBI chr12:6,289,704...6,367,643
Ensembl chr12:6,292,459...6,415,382
G
TBC1D8
TBC1 domain family member 8
increases expression
EXP
bisphenol A results in increased expression of TBC1D8 mRNA
CTD
PMID:38866337
NCBI chr10:41,718,975...41,831,950
Ensembl chr10:41,729,623...41,835,075
G
TBX5
T-box transcription factor 5
increases expression
EXP
bisphenol A results in increased expression of TBX5 mRNA
CTD
PMID:38866337
NCBI chr26:11,462,541...11,549,699
Ensembl chr26:11,463,653...11,506,446
G
TCEA3
transcription elongation factor A3
decreases expression
EXP
bisphenol A results in decreased expression of TCEA3 mRNA
CTD
PMID:38866337
NCBI chr 2:75,998,154...76,040,461
Ensembl chr 2:75,998,214...76,040,413
G
TCEAL3
transcription elongation factor A like 3
decreases expression
EXP
bisphenol A results in decreased expression of TCEAL3 mRNA
CTD
PMID:38866337
NCBI chr X:77,021,480...77,023,881
G
TCEAL4
transcription elongation factor A (SII)-like 4
increases expression
EXP
bisphenol A results in increased expression of TCEAL4 mRNA
CTD
PMID:38866337
NCBI chr X:77,010,138...77,012,431
G
TCP11
t-complex 11
increases expression
EXP
bisphenol A results in increased expression of TCP11 mRNA
CTD
PMID:38866337
NCBI chr12:4,286,863...4,306,152
Ensembl chr12:4,286,876...4,306,273
G
TCTN1
tectonic family member 1
increases expression
EXP
bisphenol A results in increased expression of TCTN1 mRNA
CTD
PMID:38866337
NCBI chr26:8,411,429...8,444,640
Ensembl chr26:8,407,105...8,437,027
G
TCTN3
tectonic family member 3
increases expression
EXP
bisphenol A results in increased expression of TCTN3 mRNA
CTD
PMID:38866337
NCBI chr28:9,155,758...9,181,721
Ensembl chr28:9,156,797...9,181,731
G
TDRP
testis development related protein
decreases expression
EXP
bisphenol A results in decreased expression of TDRP mRNA
CTD
PMID:38866337
NCBI chr25:37,484,952...37,525,672
Ensembl chr25:37,485,566...37,525,726
G
TERF2
telomeric repeat binding factor 2
increases expression
EXP
bisphenol A results in increased expression of TERF2 mRNA
CTD
PMID:38866337
NCBI chr 5:80,278,224...80,305,315
Ensembl chr 5:80,277,505...80,306,342
G
TEX28
testis expressed 28
decreases expression
EXP
bisphenol A results in decreased expression of TEX28 mRNA
CTD
PMID:38866337
NCBI chr X:121,987,726...122,030,718
Ensembl chr X:121,986,906...121,996,306
G
TFDP2
transcription factor Dp-2
increases expression
EXP
bisphenol A results in increased expression of TFDP2 mRNA
CTD
PMID:38866337
NCBI chr23:37,757,858...37,871,632
Ensembl chr23:37,757,685...37,871,612
G
TGFBR2
transforming growth factor beta receptor 2
increases expression
EXP
bisphenol A results in increased expression of TGFBR2 mRNA
CTD
PMID:38866337
NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
G
TGFBR3
transforming growth factor beta receptor 3
increases expression
EXP
bisphenol A results in increased expression of TGFBR3 mRNA
CTD
PMID:38866337
NCBI chr 6:57,025,096...57,220,240
Ensembl chr 6:57,025,112...57,217,121
G
THADA
THADA armadillo repeat containing
increases expression
EXP
bisphenol A results in increased expression of THADA mRNA
CTD
PMID:38866337
NCBI chr10:45,754,873...46,084,496
Ensembl chr10:45,755,985...46,081,896
G
THAP11
THAP domain containing 11
increases expression
EXP
bisphenol A results in increased expression of THAP11 mRNA
CTD
PMID:38866337
NCBI chr 5:81,635,251...81,637,379
Ensembl chr 5:81,635,970...81,636,902
G
THEM5
thioesterase superfamily member 5
decreases expression
EXP
bisphenol A results in decreased expression of THEM5 mRNA
CTD
PMID:38866337
NCBI chr17:60,857,348...60,865,789
Ensembl chr17:60,857,350...60,865,579
G
THOC3
THO complex subunit 3
decreases expression
EXP
bisphenol A results in decreased expression of THOC3 mRNA
CTD
PMID:38866337
NCBI chr 4:37,130,944...37,151,479
Ensembl chr 4:37,057,940...37,199,448 Ensembl chr 4:37,057,940...37,199,448
G
THRAP3
thyroid hormone receptor associated protein 3
increases expression
EXP
bisphenol A results in increased expression of THRAP3 mRNA
CTD
PMID:38866337
NCBI chr15:5,955,469...6,022,442
Ensembl chr15:5,956,316...6,021,875
G
TMC7
transmembrane channel like 7
decreases expression
EXP
bisphenol A results in decreased expression of TMC7 mRNA
CTD
PMID:38866337
NCBI chr 6:25,855,162...25,917,214
Ensembl chr 6:25,855,223...25,907,762
G
TMCO2
transmembrane and coiled-coil domains 2
decreases expression
EXP
bisphenol A results in decreased expression of TMCO2 mRNA
CTD
PMID:38866337
NCBI chr15:2,714,751...2,717,545
Ensembl chr15:2,714,744...2,717,434
G
TMEM138
transmembrane protein 138
decreases expression
EXP
bisphenol A results in decreased expression of TMEM138 mRNA
CTD
PMID:38866337
NCBI chr18:55,033,586...55,040,001
Ensembl chr18:55,033,589...55,039,325
G
TMEM182
transmembrane protein 182
increases expression
EXP
bisphenol A results in increased expression of TMEM182 mRNA
CTD
PMID:38866337
NCBI chr10:40,227,230...40,283,747
Ensembl chr10:40,102,097...40,283,703
G
TMEM200B
transmembrane protein 200B
increases expression
EXP
bisphenol A results in increased expression of TMEM200B mRNA
CTD
PMID:38866337
NCBI chr 2:71,469,123...71,472,913
G
TMEM210
transmembrane protein 210
increases expression
EXP
bisphenol A results in increased expression of TMEM210 mRNA
CTD
PMID:38866337
NCBI chr 9:48,488,897...48,490,044
Ensembl chr 9:48,471,584...48,609,303
G
TMEM30B
transmembrane protein 30B
increases expression
EXP
bisphenol A results in increased expression of TMEM30B mRNA
CTD
PMID:38866337
G
TMEM35A
transmembrane protein 35A
increases expression
EXP
bisphenol A results in increased expression of TMEM35A mRNA
CTD
PMID:38866337
NCBI chr X:75,020,157...75,033,714
Ensembl chr X:75,020,238...75,032,525
G
TMEM42
transmembrane protein 42
increases expression
EXP
bisphenol A results in increased expression of TMEM42 mRNA
CTD
PMID:38866337
NCBI chr20:43,446,963...43,451,241
Ensembl chr20:43,447,894...43,451,751
G
TMEM45A
transmembrane protein 45A
decreases expression
EXP
bisphenol A results in decreased expression of TMEM45A mRNA
CTD
PMID:38866337
NCBI chr33:7,075,693...7,141,013
Ensembl chr33:7,075,752...7,140,982
G
TMEM65
transmembrane protein 65
decreases expression
EXP
bisphenol A results in decreased expression of TMEM65 mRNA
CTD
PMID:38866337
NCBI chr13:22,426,487...22,494,520
Ensembl chr13:22,426,793...22,494,520
G
TMEM69
transmembrane protein 69
decreases expression
EXP
bisphenol A results in decreased expression of TMEM69 mRNA
CTD
PMID:38866337
NCBI chr15:14,666,926...14,671,839
Ensembl chr15:14,667,231...14,671,622
G
TMEM97
transmembrane protein 97
increases expression
EXP
bisphenol A results in increased expression of TMEM97 mRNA
CTD
PMID:38866337
NCBI chr 9:42,572,855...42,581,012
Ensembl chr 9:42,572,889...42,579,947
G
TMSB10
thymosin beta 10
decreases expression
EXP
bisphenol A results in decreased expression of TMSB10 mRNA
CTD
PMID:38866337
NCBI chr17:40,048,823...40,049,508
Ensembl chr17:40,048,828...40,049,470
G
TMT1A
thiol methyltransferase 1A
increases expression
EXP
bisphenol A results in increased expression of METTL7A mRNA
CTD
PMID:38866337
NCBI chr27:3,858,792...3,866,350
Ensembl chr27:3,857,454...3,866,448
G
TMTC1
transmembrane O-mannosyltransferase targeting cadherins 1
increases expression
EXP
bisphenol A results in increased expression of TMTC1 mRNA
CTD
PMID:38866337
NCBI chr27:18,252,642...18,519,802
Ensembl chr27:18,191,118...18,518,974
G
TNFAIP8L3
TNF alpha induced protein 8 like 3
decreases expression
EXP
bisphenol A results in decreased expression of TNFAIP8L3 mRNA
CTD
PMID:38866337
NCBI chr30:16,822,069...16,840,284
Ensembl chr30:16,822,969...16,823,529
G
TNFRSF21
TNF receptor superfamily member 21
increases expression
EXP
bisphenol A results in increased expression of TNFRSF21 mRNA
CTD
PMID:38866337
NCBI chr12:15,343,953...15,408,230
G
TOGARAM1
TOG array regulator of axonemal microtubules 1
increases expression
EXP
bisphenol A results in increased expression of TOGARAM1 mRNA
CTD
PMID:38866337
NCBI chr 8:22,420,718...22,499,435
Ensembl chr 8:22,420,584...22,497,671
G
TOP2A
DNA topoisomerase II alpha
increases expression
EXP
bisphenol A results in increased expression of TOP2A mRNA
CTD
PMID:38866337
NCBI chr 9:22,207,501...22,237,497
Ensembl chr 9:22,207,638...22,237,496
G
TPI1
triosephosphate isomerase 1
decreases expression
EXP
bisphenol A results in decreased expression of TPI1 mRNA
CTD
PMID:38866337
NCBI chr27:38,154,519...38,157,900
Ensembl chr27:38,154,519...38,158,137
G
TPM2
tropomyosin 2
decreases expression
EXP
bisphenol A results in decreased expression of TPM2 mRNA
CTD
PMID:38866337
NCBI chr11:52,212,372...52,219,947
Ensembl chr11:52,212,401...52,219,923
G
TPM4
tropomyosin 4
decreases expression
EXP
bisphenol A results in decreased expression of TPM4 mRNA
CTD
PMID:38866337
NCBI chr20:46,354,808...46,376,489
Ensembl chr20:46,355,736...46,376,425
G
TPR
translocated promoter region, nuclear basket protein
increases expression
EXP
bisphenol A results in increased expression of TPR mRNA
CTD
PMID:38866337
NCBI chr 7:19,376,951...19,442,368
Ensembl chr 7:19,376,975...19,442,303
G
TRARG1
trafficking regulator of GLUT4 (SLC2A4) 1
increases expression
EXP
bisphenol A results in increased expression of TRARG1 mRNA
CTD
PMID:38866337
NCBI chr 9:44,560,962...44,577,418
Ensembl chr 9:44,563,419...44,576,972
G
TRIM63
tripartite motif containing 63
increases expression
EXP
bisphenol A results in increased expression of TRIM63 mRNA
CTD
PMID:38866337
NCBI chr 2:73,841,868...73,918,371
Ensembl chr 2:73,888,689...73,909,414
G
TRNAC-GCA
transfer RNA cysteine (anticodon GCA)
decreases expression
EXP
bisphenol A results in decreased expression of TRNAC-GCA mRNA
CTD
PMID:38866337
NCBI chr16:14,451,086...14,451,157
G
TROAP
trophinin associated protein
increases expression
EXP
bisphenol A results in increased expression of TROAP mRNA
CTD
PMID:38866337
NCBI chr27:5,282,495...5,289,106
Ensembl chr27:5,282,497...5,289,124
G
TRPC2
transient receptor potential cation channel subfamily C member 2
increases expression
EXP
bisphenol A results in increased expression of TRPC2 mRNA
CTD
PMID:38866337
NCBI chr21:26,163,641...26,202,938
G
TSC22D1
TSC22 domain family member 1
increases expression
EXP
bisphenol A results in increased expression of TSC22D1 mRNA
CTD
PMID:38866337
NCBI chr22:6,375,585...6,506,511
Ensembl chr22:6,375,577...6,505,672
G
TSC22D3
TSC22 domain family member 3
increases expression
EXP
bisphenol A results in increased expression of TSC22D3 mRNA
CTD
PMID:38866337
NCBI chr X:81,235,489...81,298,290
Ensembl chr X:81,235,809...81,298,192
G
TSHZ2
teashirt zinc finger homeobox 2
increases expression
EXP
bisphenol A results in increased expression of TSHZ2 mRNA
CTD
PMID:38866337
NCBI chr24:39,124,993...39,354,202
Ensembl chr24:38,995,063...39,346,728
G
TSNAXIP1
translin associated factor X interacting protein 1
decreases expression
EXP
bisphenol A results in decreased expression of TSNAXIP1 mRNA
CTD
PMID:38866337
NCBI chr 5:81,647,135...81,662,106
Ensembl chr 5:81,647,141...81,661,562
G
TTC21A
tetratricopeptide repeat domain 21A
increases expression
EXP
bisphenol A results in increased expression of TTC21A mRNA
CTD
PMID:38866337
NCBI chr23:8,776,252...8,812,480
Ensembl chr23:8,781,582...8,811,031
G
TTC9C
tetratricopeptide repeat domain 9C
increases expression
EXP
bisphenol A results in increased expression of TTC9C mRNA
CTD
PMID:38866337
NCBI chr18:53,928,236...53,941,410
Ensembl chr18:53,932,696...53,940,930
G
TTLL5
tubulin tyrosine ligase like 5
increases expression
EXP
bisphenol A results in increased expression of TTLL5 mRNA
CTD
PMID:38866337
NCBI chr 8:48,651,766...48,920,733
Ensembl chr 8:48,651,814...48,920,039
G
TUFT1
tuftelin 1
decreases expression
EXP
bisphenol A results in decreased expression of TUFT1 mRNA
CTD
PMID:38866337
NCBI chr17:60,580,032...60,628,422
Ensembl chr17:60,580,082...60,627,174
G
TUT4
terminal uridylyl transferase 4
increases expression
EXP
bisphenol A results in increased expression of TUT4 mRNA
CTD
PMID:38866337
NCBI chr15:8,832,208...8,958,136
Ensembl chr15:8,832,199...9,047,152
G
TXNIP
thioredoxin interacting protein
increases expression
EXP
bisphenol A results in increased expression of TXNIP mRNA
CTD
PMID:38866337
NCBI chr17:58,775,588...58,779,730
Ensembl chr17:58,776,871...58,779,531
G
UBE2C
ubiquitin conjugating enzyme E2 C
decreases expression
EXP
bisphenol A results in decreased expression of UBE2C mRNA
CTD
PMID:38866337
NCBI chr24:33,128,300...33,133,637
Ensembl chr24:33,128,335...33,132,023
G
UBE2E2
ubiquitin conjugating enzyme E2 E2
decreases expression
EXP
bisphenol A results in decreased expression of UBE2E2 mRNA
CTD
PMID:38866337
NCBI chr23:20,110,128...20,593,767
Ensembl chr23:20,130,230...20,486,399
G
UBR1
ubiquitin protein ligase E3 component n-recognin 1
increases expression
EXP
bisphenol A results in increased expression of UBR1 mRNA
CTD
PMID:38866337
NCBI chr30:9,869,769...10,006,994
Ensembl chr30:9,870,021...10,006,947
G
UPP1
uridine phosphorylase 1
decreases expression
EXP
bisphenol A results in decreased expression of UPP1 mRNA
CTD
PMID:38866337
NCBI chr18:108,215...120,213
G
USP13
ubiquitin specific peptidase 13
increases expression
EXP
bisphenol A results in increased expression of USP13 mRNA
CTD
PMID:38866337
NCBI chr34:13,059,099...13,175,980
Ensembl chr34:13,059,092...13,171,234
G
USP18
ubiquitin specific peptidase 18
decreases expression
EXP
bisphenol A results in decreased expression of USP18 mRNA
CTD
PMID:38866337
NCBI chr27:45,739,845...45,814,668
G
USP24
ubiquitin specific peptidase 24
increases expression
EXP
bisphenol A results in increased expression of USP24 mRNA
CTD
PMID:38866337
NCBI chr 5:54,086,685...54,192,761
Ensembl chr 5:54,086,685...54,190,164
G
USP25
ubiquitin specific peptidase 25
increases expression
EXP
bisphenol A results in increased expression of USP25 mRNA
CTD
PMID:38866337
NCBI chr31:12,555,614...12,692,765
Ensembl chr31:12,555,595...12,691,694
G
USP34
ubiquitin specific peptidase 34
increases expression
EXP
bisphenol A results in increased expression of USP34 mRNA
CTD
PMID:38866337
NCBI chr10:61,264,605...61,459,603
Ensembl chr10:61,267,478...61,511,347
G
USP39
ubiquitin specific peptidase 39
increases expression
EXP
bisphenol A results in increased expression of USP39 mRNA
CTD
PMID:38866337
NCBI chr17:39,437,908...39,470,579
Ensembl chr17:39,438,329...39,470,549
G
USP4
ubiquitin specific peptidase 4
increases expression
EXP
bisphenol A results in increased expression of USP4 mRNA
CTD
PMID:38866337
NCBI chr20:39,899,880...39,952,959
Ensembl chr20:39,899,897...39,952,420
G
UST
uronyl 2-sulfotransferase
decreases expression
EXP
bisphenol A results in decreased expression of UST mRNA
CTD
PMID:38866337
NCBI chr 1:39,633,276...39,922,361
Ensembl chr 1:39,633,501...39,921,289
G
UTP20
UTP20 small subunit processome component
increases expression
EXP
bisphenol A results in increased expression of UTP20 mRNA
CTD
PMID:38866337
NCBI chr15:40,291,344...40,387,200
Ensembl chr15:40,291,390...40,387,032
G
UTRN
utrophin
increases expression
EXP
bisphenol A results in increased expression of UTRN mRNA
CTD
PMID:38866337
NCBI chr 1:35,727,531...36,225,533
Ensembl chr 1:35,677,814...36,224,065
G
VAMP5
vesicle associated membrane protein 5
decreases expression
EXP
bisphenol A results in decreased expression of VAMP5 mRNA
CTD
PMID:38866337
NCBI chr17:39,488,877...39,495,795
Ensembl chr17:39,488,938...39,495,730
G
VAMP8
vesicle associated membrane protein 8
decreases expression
EXP
bisphenol A results in decreased expression of VAMP8 mRNA
CTD
PMID:38866337
NCBI chr17:39,497,628...39,501,734
Ensembl chr17:39,497,785...39,501,739
G
VDAC2
voltage dependent anion channel 2
decreases expression
EXP
bisphenol A results in decreased expression of VDAC2 mRNA
CTD
PMID:38866337
NCBI chr 4:25,449,926...25,462,147
Ensembl chr 4:25,449,442...25,462,335
G
VPS13B
vacuolar protein sorting 13 homolog B
increases expression
EXP
bisphenol A results in increased expression of VPS13B mRNA
CTD
PMID:38866337
NCBI chr13:1,101,226...1,834,933
Ensembl chr13:1,101,610...1,871,225
G
VRK3
VRK serine/threonine kinase 3
increases expression
EXP
bisphenol A results in increased expression of VRK3 mRNA
CTD
PMID:38866337
NCBI chr 1:106,564,151...106,601,321
Ensembl chr 1:106,564,110...106,598,332
G
VWA5A
von Willebrand factor A domain containing 5A
increases expression
EXP
bisphenol A results in increased expression of VWA5A mRNA
CTD
PMID:38866337
NCBI chr 5:10,337,879...10,362,299
Ensembl chr 5:10,325,266...10,362,641
G
VXN
vexin
decreases expression
EXP
bisphenol A results in decreased expression of VXN mRNA
CTD
PMID:38866337
NCBI chr29:16,078,154...16,101,873
Ensembl chr29:16,078,658...16,099,606
G
WASHC2C
WASH complex subunit 2C
decreases expression
EXP
bisphenol A results in decreased expression of WASHC2C mRNA
CTD
PMID:38866337
NCBI chr28:1,867,680...1,923,273
G
WDFY1
WD repeat and FYVE domain containing 1
increases expression
EXP
bisphenol A results in increased expression of WDFY1 mRNA
CTD
PMID:38866337
NCBI chr37:29,544,956...29,658,544
Ensembl chr37:29,444,082...29,677,312
G
WDR1
WD repeat domain 1
decreases expression
EXP
bisphenol A results in decreased expression of WDR1 mRNA
CTD
PMID:38866337
NCBI chr 3:69,305,731...69,348,183
Ensembl chr 3:69,305,731...69,348,177
G
WDR11
WD repeat domain 11
increases expression
EXP
bisphenol A results in increased expression of WDR11 mRNA
CTD
PMID:38866337
NCBI chr28:30,769,223...30,828,628
Ensembl chr28:30,769,219...30,828,049
G
WDR20
WD repeat domain 20
increases expression
EXP
bisphenol A results in increased expression of WDR20 mRNA
CTD
PMID:38866337
NCBI chr 8:70,150,090...70,208,683
Ensembl chr 8:70,146,967...70,199,975
G
WDR5
WD repeat domain 5
decreases expression
EXP
bisphenol A results in decreased expression of WDR5 mRNA
CTD
PMID:38866337
NCBI chr 9:50,352,600...50,371,224
Ensembl chr 9:50,352,472...50,371,236
G
WDR82
WD repeat domain 82
increases expression
EXP
bisphenol A results in increased expression of WDR82 mRNA
CTD
PMID:38866337
NCBI chr20:37,494,633...37,513,746
Ensembl chr20:37,355,494...37,511,125
G
XDH
xanthine dehydrogenase
increases expression
EXP
bisphenol A results in increased expression of XDH mRNA
CTD
PMID:38866337
NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
G
XRCC3
X-ray repair cross complementing 3
increases expression
EXP
bisphenol A results in increased expression of XRCC3 mRNA
CTD
PMID:38866337
NCBI chr 8:71,441,732...71,452,922
Ensembl chr 8:71,442,429...71,449,408
G
YIF1A
Yip1 interacting factor homolog A, membrane trafficking protein
decreases expression
EXP
bisphenol A results in decreased expression of YIF1A mRNA
CTD
PMID:38866337
NCBI chr18:51,015,575...51,019,909
Ensembl chr18:51,015,641...51,019,901
G
YIF1B
Yip1 interacting factor homolog B, membrane trafficking protein
decreases expression
EXP
bisphenol A results in decreased expression of YIF1B mRNA
CTD
PMID:38866337
NCBI chr 1:114,681,437...114,689,328
Ensembl chr 1:114,681,469...114,689,237
G
YPEL4
yippee like 4
increases expression
EXP
bisphenol A results in increased expression of YPEL4 mRNA
CTD
PMID:38866337
NCBI chr18:38,535,792...38,541,183
Ensembl chr18:38,539,190...38,540,303
G
ZAR1L
zygote arrest 1 like
increases expression
EXP
bisphenol A results in increased expression of ZAR1L mRNA
CTD
PMID:38866337
NCBI chr25:7,799,130...7,807,653
Ensembl chr25:7,799,615...7,856,230
G
ZC3H11A
zinc finger CCCH-type containing 11A
increases expression
EXP
bisphenol A results in increased expression of ZC3H11A mRNA
CTD
PMID:38866337
NCBI chr38:477,900...505,754
G
ZC3H12C
zinc finger CCCH-type containing 12C
decreases expression
EXP
bisphenol A results in decreased expression of ZC3H12C mRNA
CTD
PMID:38866337
NCBI chr 5:22,666,321...22,756,089
Ensembl chr 5:22,669,947...22,747,506
G
ZC3H6
zinc finger CCCH-type containing 6
increases expression
EXP
bisphenol A results in increased expression of ZC3H6 mRNA
CTD
PMID:38866337
NCBI chr17:36,620,959...36,688,438
Ensembl chr17:36,621,059...36,687,197
G
ZCCHC12
zinc finger CCHC-type containing 12
increases expression
EXP
bisphenol A results in increased expression of ZCCHC12 mRNA
CTD
PMID:38866337
NCBI chr X:91,004,777...91,008,019
G
ZCCHC9
zinc finger CCHC-type containing 9
decreases expression
EXP
bisphenol A results in decreased expression of ZCCHC9 mRNA
CTD
PMID:38866337
NCBI chr 3:25,973,874...25,983,132
Ensembl chr 3:25,963,700...25,983,062
G
ZDHHC15
zinc finger DHHC-type palmitoyltransferase 15
increases expression
EXP
bisphenol A results in increased expression of ZDHHC15 mRNA
CTD
PMID:38866337
NCBI chr X:58,641,182...58,812,671
Ensembl chr X:58,645,650...58,812,671
G
ZDHHC3
zinc finger DHHC-type palmitoyltransferase 3
increases expression
EXP
bisphenol A results in increased expression of ZDHHC3 mRNA
CTD
PMID:38866337
NCBI chr20:43,379,669...43,433,101
Ensembl chr20:43,379,722...43,431,414
G
ZFAND5
zinc finger AN1-type containing 5
increases expression
EXP
bisphenol A results in increased expression of ZFAND5 mRNA
CTD
PMID:38866337
NCBI chr 1:85,420,091...85,429,843
Ensembl chr 1:85,420,127...85,428,424
G
ZKSCAN2
zinc finger with KRAB and SCAN domains 2
increases expression
EXP
bisphenol A results in increased expression of ZKSCAN2 mRNA
CTD
PMID:38866337
NCBI chr 6:20,958,058...20,977,182
Ensembl chr 6:20,958,395...20,973,507
G
ZKSCAN8
zinc finger with KRAB and SCAN domains 8
increases expression
EXP
bisphenol A results in increased expression of ZKSCAN8 mRNA
CTD
PMID:38866337
NCBI chr35:25,305,821...25,321,830
Ensembl chr35:25,305,610...25,317,780
G
ZNF445
zinc finger protein 445
increases expression
EXP
bisphenol A results in increased expression of ZNF445 mRNA
CTD
PMID:38866337
NCBI chr23:1,906,958...1,940,340
Ensembl chr23:1,927,625...1,939,382
G
ZNF556
zinc finger protein 556
increases expression
EXP
bisphenol A results in increased expression of ZNF556 mRNA
CTD
PMID:38866337
NCBI chr20:56,333,136...56,357,075
Ensembl chr20:56,336,162...56,347,541
G
ZNF622
zinc finger protein 622
increases expression
EXP
bisphenol A results in increased expression of ZNF622 mRNA
CTD
PMID:38866337
NCBI chr 4:86,929,947...86,943,711
Ensembl chr 4:86,826,892...86,951,542
G
ZNF81
zinc finger protein 81
decreases expression
EXP
bisphenol A results in decreased expression of ZNF81 mRNA
CTD
PMID:38866337
NCBI chr X:41,353,241...41,460,082
Ensembl chr X:41,353,440...41,593,082
G
ZSCAN22
zinc finger and SCAN domain containing 22
increases expression
EXP
bisphenol A results in increased expression of ZSCAN22 mRNA
CTD
PMID:38866337
NCBI chr 1:99,608,190...99,621,256
Ensembl chr 1:99,611,104...99,620,356
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB11
ATP binding cassette subfamily B member 11
decreases localization
EXP
blebbistatin results in decreased localization of ABCB11 protein
CTD
PMID:15826951
NCBI chr36:13,742,895...13,835,312
Ensembl chr36:13,746,964...13,834,974
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Sulfobromophthalein results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of Sulfobromophthalein
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCHE
butyrylcholinesterase
increases hydrolysis multiple interactions
EXP
BCHE protein results in increased hydrolysis of butyrylcholine Succinylcholine inhibits the reaction [BCHE protein results in increased hydrolysis of butyrylcholine]
CTD
PMID:4631366 PMID:4985882
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCHE
butyrylcholinesterase
increases hydrolysis
EXP
BCHE protein results in increased hydrolysis of Butyrylthiocholine
CTD
PMID:22407886
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC1
ATP binding cassette subfamily C member 1
affects export
EXP
ABCC1 protein affects the export of calcein AM
CTD
PMID:12516967
NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCL2
BCL2 apoptosis regulator
affects expression
EXP
Calcitriol affects the expression of BCL2 protein
CTD
PMID:16080513
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP3
caspase 3
multiple interactions increases activity
EXP
Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP3 protein]
CTD
PMID:25446497
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP9
caspase 9
increases activity multiple interactions
EXP
Calcium Oxalate results in increased activity of CASP9 protein Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein]
CTD
PMID:25446497
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
G
TJP1
tight junction protein 1
multiple interactions decreases expression
EXP
Docetaxel inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein]; Phalloidine inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein]
CTD
PMID:34147488 PMID:36349591
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC8A1
solute carrier family 8 member A1
increases transport multiple interactions increases uptake
EXP
SLC8A1 protein results in increased transport of Calcium 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [SLC8A1 protein results in increased transport of Calcium]; 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [SLC8A1 protein results in increased uptake of Calcium]; SEA 0400 inhibits the reaction [SLC8A1 protein results in increased uptake of Calcium]
CTD
PMID:14660663 PMID:15375168
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
G
TRPM8
transient receptor potential cation channel subfamily M member 8
multiple interactions
EXP
[icilin results in increased activity of TRPM8 protein] which results in increased transport of Calcium; [Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium; [mustard oil results in increased activity of TRPM8 protein] which results in increased transport of Calcium; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[icilin results in increased activity of TRPM8 protein] which results in increased transport of Calcium]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[mustard oil results in increased activity of TRPM8 protein] which results in increased transport of Calcium]
CTD
PMID:16386244
NCBI chr25:45,261,092...45,357,560
Ensembl chr25:45,261,107...45,353,282
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CCL17
C-C motif chemokine ligand 17
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL17 promoter
CTD
PMID:33763461
NCBI chr 2:59,001,463...59,014,347
Ensembl chr 2:59,001,464...59,005,230
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL2 promoter
CTD
PMID:33763461
NCBI chr 9:39,008,187...39,009,932
G
IL13
interleukin 13
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
IL31
interleukin 31
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr26:7,173,151...7,175,195
Ensembl chr26:7,172,451...7,175,195
G
IL31RA
interleukin 31 receptor A
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of IL31RA promoter
CTD
PMID:33763461
NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293
G
IL4
interleukin 4
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
TSLP
thymic stromal lymphopoietin
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of TSLP promoter
CTD
PMID:33763461
NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HTR1B
5-hydroxytryptamine receptor 1B
multiple interactions
EXP
HTR1B protein promotes the reaction [donitriptan results in decreased susceptibility to Capsaicin]
CTD
PMID:16880765
NCBI chr12:38,659,088...38,659,546
G
TRPV1
transient receptor potential cation channel subfamily V member 1
multiple interactions increases activity
EXP
JYL 1421 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]
CTD
PMID:17392452
NCBI chr 9:47,404,987...47,443,871
Ensembl chr 9:47,404,972...47,431,926
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
MGMT
O-6-methylguanine-DNA methyltransferase
decreases response to substance multiple interactions
EXP
MGMT protein mutant form results in decreased susceptibility to Carmustine; MGMT protein results in decreased susceptibility to Carmustine MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]
CTD
PMID:14617759 PMID:15053863
NCBI chr28:38,204,611...38,427,482
Ensembl chr28:38,204,610...38,427,380
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HSP70
heat shock protein 70
multiple interactions
EXP
carvacrol promotes the reaction [sodium arsenite results in increased expression of HSP70 protein]
CTD
PMID:31940135
NCBI chr12:1,285,282...1,287,670
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP3
caspase 3
decreases activity
EXP
Carvedilol results in decreased activity of CASP3 protein
CTD
PMID:12875697
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
FAS
Fas cell surface death receptor
decreases expression
EXP
Carvedilol results in decreased expression of FAS
CTD
PMID:12875697
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
decreases expression
EXP
Carvedilol results in decreased expression of FASLG
CTD
PMID:12875697
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
NT5E
5'-nucleotidase ecto
increases activity
EXP
Carvedilol results in increased activity of NT5E protein
CTD
PMID:15148268
NCBI chr12:45,491,028...45,520,019
Ensembl chr12:45,491,733...45,518,405
G
RYR2
ryanodine receptor 2
multiple interactions
EXP
Carvedilol results in decreased oxidation of and results in increased stability of RYR2 protein
CTD
PMID:17448375
NCBI chr 4:2,371,868...2,908,132
Ensembl chr 4:2,373,114...2,907,875
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACE
angiotensin I converting enzyme
decreases activity
EXP
ceronapril results in decreased activity of ACE protein
CTD
PMID:1812274
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SCT
secretin
multiple interactions
EXP
[Ceruletide co-treated with SCT protein] results in increased abundance of Bicarbonates
CTD
PMID:3562434
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
cholanic acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AGT
angiotensinogen
decreases expression
EXP
Cilazapril results in decreased expression of AGT protein
CTD
PMID:2419701
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
REN
renin
increases activity
EXP
Cilazapril results in increased activity of REN protein
CTD
PMID:2419701
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
MYC
MYC proto-oncogene, bHLH transcription factor
decreases expression
EXP
Cilostazol results in decreased expression of MYC mRNA
CTD
PMID:19545562
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC22A2
solute carrier family 22 member 2
decreases activity
EXP
Cimetidine results in decreased activity of SLC22A2 protein
CTD
PMID:36669674
NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
KCNH2
potassium voltage-gated channel subfamily H member 2
multiple interactions
EXP
Cisapride binds to and results in decreased activity of KCNH2 protein
CTD
PMID:12388285
NCBI chr16:15,009,031...15,041,786
Ensembl chr16:15,009,031...15,041,504
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACAA2
acetyl-CoA acyltransferase 2
increases expression
EXP
Clofibrate results in increased expression of ACAA2 mRNA
CTD
PMID:19952500
NCBI chr 7:79,028,636...79,057,720
G
ACADVL
acyl-CoA dehydrogenase very long chain
increases expression
EXP
Clofibrate results in increased expression of ACADVL protein
CTD
PMID:19952500
NCBI chr 5:32,189,191...32,194,255
Ensembl chr 5:32,186,502...32,327,990
G
AGXT
alanine--glyoxylate and serine--pyruvate aminotransferase
decreases expression
EXP
Clofibrate results in decreased expression of AGXT protein
CTD
PMID:19952500
NCBI chr25:50,968,291...50,976,089
G
AHCY
adenosylhomocysteinase
decreases expression
EXP
Clofibrate results in decreased expression of AHCY protein
CTD
PMID:19952500
NCBI chr24:23,410,553...23,423,494
Ensembl chr24:23,411,140...23,419,767
G
ASL
argininosuccinate lyase
increases expression
EXP
Clofibrate results in increased expression of ASL protein
CTD
PMID:19952500
NCBI chr 6:768,522...779,144
Ensembl chr 6:730,358...779,424
G
ASS1
argininosuccinate synthase 1
decreases expression
EXP
Clofibrate results in decreased expression of ASS1 protein
CTD
PMID:19952500
NCBI chr 9:53,425,228...53,478,007
Ensembl chr 9:53,425,448...53,477,904
G
CPS1
carbamoyl-phosphate synthase 1
increases expression
EXP
Clofibrate results in increased expression of CPS1 protein
CTD
PMID:19952500
NCBI chr37:18,308,164...18,428,487
Ensembl chr37:18,143,986...18,427,697
G
CPT2
carnitine palmitoyltransferase 2
increases expression
EXP
Clofibrate results in increased expression of CPT2 mRNA
CTD
PMID:19952500
NCBI chr 5:55,718,209...55,786,175
Ensembl chr 5:55,718,510...55,744,809
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
decreases expression
EXP
Clofibrate results in decreased expression of CYP1A2 mRNA
CTD
PMID:19952500
NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
G
CYP2A13
cytochrome P450 family 2 subfamily A polypeptide 13
decreases expression
EXP
Clofibrate results in decreased expression of CYP2A13 mRNA
CTD
PMID:19952500
NCBI chr 1:112,932,246...112,938,248
Ensembl chr 1:112,931,985...112,938,350
G
CYP2B6
cytochrome P450 2B11
decreases expression
EXP
Clofibrate results in decreased expression of CYP2B6 mRNA
CTD
PMID:19952500
NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
G
CYP2C18
cytochrome P450 2C21
decreases expression
EXP
Clofibrate results in decreased expression of CYP2C18 mRNA
CTD
PMID:19952500
NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
increases expression
EXP
Clofibrate results in increased expression of CYP2E1 protein
CTD
PMID:19952500
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
G
CYP3A12
cytochrome P-450 3A12
decreases expression
EXP
Clofibrate results in decreased expression of CYP3A12 mRNA
CTD
PMID:19952500
G
CYP3A26
cytochrome P450 3A26
decreases expression
EXP
Clofibrate results in decreased expression of CYP3A26 mRNA
CTD
PMID:19952500
NCBI chr 6:9,777,663...9,815,345
Ensembl chr 6:9,777,659...9,869,352
G
CYP4A11
cytochrome P450, family 4, subfamily A, polypeptide 11
increases expression
EXP
Clofibrate results in increased expression of CYP4A11 mRNA
CTD
PMID:19952500
NCBI chr15:13,663,337...13,676,350
Ensembl chr15:13,604,130...13,676,344
G
DLST
dihydrolipoamide S-succinyltransferase
increases expression
EXP
Clofibrate results in increased expression of DLST protein
CTD
PMID:19952500
NCBI chr 8:48,003,730...48,025,001
Ensembl chr 8:48,002,211...48,024,999
G
ECHS1
enoyl-CoA hydratase, short chain 1
increases expression
EXP
Clofibrate results in increased expression of ECHS1 protein
CTD
PMID:19952500
NCBI chr28:40,939,856...40,947,694
Ensembl chr28:40,939,961...40,946,167
G
GDI1
GDP dissociation inhibitor 1
increases expression
EXP
Clofibrate results in increased expression of GDI1 protein
CTD
PMID:19952500
NCBI chr X:122,141,633...122,146,724
Ensembl chr X:122,141,566...122,146,824
G
GSTA4
glutathione S-transferase alpha 4
decreases expression
EXP
Clofibrate results in decreased expression of GSTA4 mRNA
CTD
PMID:19952500
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
G
GSTK1
glutathione S-transferase kappa 1
decreases expression
EXP
Clofibrate results in decreased expression of GSTK1 mRNA
CTD
PMID:19952500
NCBI chr16:6,411,678...6,416,135
G
GSTO1
glutathione S-transferase omega 1
decreases expression
EXP
Clofibrate results in decreased expression of GSTO1 mRNA
CTD
PMID:19952500
NCBI chr28:16,569,421...16,579,239
Ensembl chr28:16,569,066...16,619,880
G
HADH
hydroxyacyl-CoA dehydrogenase
increases expression
EXP
Clofibrate results in increased expression of HADH mRNA
CTD
PMID:19952500
NCBI chr32:28,460,445...28,506,141
Ensembl chr32:28,460,193...28,531,280
G
HSPD1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
Clofibrate results in increased expression of HSPD1 protein
CTD
PMID:19952500
NCBI chr37:7,010,421...7,025,912
G
KRT1
keratin 1
increases expression
EXP
Clofibrate results in increased expression of KRT1 protein
CTD
PMID:19952500
NCBI chr27:2,422,150...2,427,160
G
KRT18
keratin 18
decreases expression
EXP
Clofibrate results in decreased expression of KRT18 protein
CTD
PMID:19952500
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
G
LOC474938
glutathione S-transferase A2
decreases expression
EXP
Clofibrate results in decreased expression of GSTA3 mRNA; Clofibrate results in decreased expression of GSTA3 protein
CTD
PMID:19952500
NCBI chr12:20,349,133...20,365,023
G
LOC479912
glutathione S-transferase Mu 1
decreases expression
EXP
Clofibrate results in decreased expression of GSTM1 mRNA
CTD
PMID:19952500
NCBI chr 6:42,201,697...42,207,886
G
MGST1
microsomal glutathione S-transferase 1
increases expression
EXP
Clofibrate results in increased expression of MGST1 mRNA
CTD
PMID:19952500
NCBI chr27:30,370,588...30,391,898
Ensembl chr27:30,370,594...30,391,778
G
PC
pyruvate carboxylase
increases expression
EXP
Clofibrate results in increased expression of PC protein
CTD
PMID:19952500
NCBI chr18:50,406,994...50,507,677
Ensembl chr18:50,412,272...50,507,669
G
PCK2
phosphoenolpyruvate carboxykinase 2, mitochondrial
increases expression
EXP
Clofibrate results in increased expression of PCK2 protein
CTD
PMID:19952500
NCBI chr 8:4,099,016...4,107,870
Ensembl chr 8:4,098,671...4,107,865
G
PRDX6
peroxiredoxin 6
decreases expression
EXP
Clofibrate results in decreased expression of PRDX6 protein
CTD
PMID:19952500
NCBI chr 7:25,663,238...25,675,855
Ensembl chr 7:25,663,579...25,675,754
G
SELENBP1
selenium binding protein 1
decreases expression
EXP
Clofibrate results in decreased expression of SELENBP1 protein
CTD
PMID:19952500
NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
G
SHMT1
serine hydroxymethyltransferase 1
decreases expression
EXP
Clofibrate results in decreased expression of SHMT1 protein
CTD
PMID:19952500
NCBI chr 5:41,221,531...41,248,653
Ensembl chr 5:41,221,562...41,253,166
G
UGP2
UDP-glucose pyrophosphorylase 2
decreases expression
EXP
Clofibrate results in decreased expression of UGP2 protein
CTD
PMID:19952500
NCBI chr10:63,532,366...63,598,362
Ensembl chr10:63,533,171...63,597,452
G
UQCRC1
ubiquinol-cytochrome c reductase core protein 1
increases expression
EXP
Clofibrate results in increased expression of UQCRC1 protein
CTD
PMID:19952500
NCBI chr20:40,507,767...40,515,854
Ensembl chr20:40,506,907...40,520,110
G
UROC1
urocanate hydratase 1
decreases expression
EXP
Clofibrate results in decreased expression of UROC1 protein
CTD
PMID:19952500
NCBI chr20:676,624...717,109
Ensembl chr20:678,073...717,141
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRA2A
adrenoceptor alpha 2A
multiple interactions increases response to substance
EXP
Clonidine binds to and results in increased activity of ADRA2A protein ADRA2A protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
G
ADRA2C
adrenoceptor alpha 2C
increases response to substance
EXP
ADRA2C protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
G
GH1
growth hormone
increases secretion
EXP
Clonidine results in increased secretion of GH1 protein
CTD
PMID:6248808
NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
G
NISCH
nischarin
multiple interactions affects binding
EXP
Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein]
CTD
PMID:24120658
NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions increases activity
EXP
[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein]
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PRKCZ
protein kinase C zeta
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
REN
renin
multiple interactions decreases activity
EXP
Clonidine results in decreased secretion of and results in decreased activity of REN protein Clonidine results in decreased activity of REN protein
CTD
PMID:6248808 PMID:6991409
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRA2A
adrenoceptor alpha 2A
multiple interactions increases response to substance
EXP
Clonidine binds to and results in increased activity of ADRA2A protein ADRA2A protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
G
ADRA2C
adrenoceptor alpha 2C
increases response to substance
EXP
ADRA2C protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
G
GH1
growth hormone
increases secretion
EXP
Clonidine results in increased secretion of GH1 protein
CTD
PMID:6248808
NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
G
NISCH
nischarin
affects binding multiple interactions
EXP
Clonidine binds to NISCH protein Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein]
CTD
PMID:24120658
NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
increases activity multiple interactions
EXP
Clonidine results in increased activity of PIK3CG protein [Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein]
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PRKCZ
protein kinase C zeta
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
REN
renin
multiple interactions decreases activity
EXP
Clonidine results in decreased secretion of and results in decreased activity of REN protein Clonidine results in decreased activity of REN protein
CTD
PMID:6248808 PMID:6991409
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRA2A
adrenoceptor alpha 2A
multiple interactions increases response to substance
EXP
Clonidine binds to and results in increased activity of ADRA2A protein ADRA2A protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
G
ADRA2C
adrenoceptor alpha 2C
increases response to substance
EXP
ADRA2C protein results in increased susceptibility to Clonidine
CTD
PMID:16814767
NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
G
GH1
growth hormone
increases secretion
EXP
Clonidine results in increased secretion of GH1 protein
CTD
PMID:6248808
NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
G
NISCH
nischarin
affects binding multiple interactions
EXP
Clonidine binds to NISCH protein Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein]
CTD
PMID:24120658
NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions increases activity
EXP
[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein]
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PRKCZ
protein kinase C zeta
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
REN
renin
multiple interactions decreases activity
EXP
Clonidine results in decreased secretion of and results in decreased activity of REN protein Clonidine results in decreased activity of REN protein
CTD
PMID:6248808 PMID:6991409
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
INS
insulin
increases abundance
EXP
INS protein results in increased abundance of Adrenocorticotropic Hormone
CTD
PMID:1646414
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CRH
corticotropin releasing hormone
increases abundance
EXP
CRH protein results in increased abundance of Hydrocortisone
CTD
PMID:2831029
NCBI chr29:15,831,944...15,840,560
Ensembl chr29:15,831,944...15,834,384
G
INS
insulin
affects abundance multiple interactions
EXP
INS protein affects the abundance of Hydrocortisone Sodium affects the reaction [INS protein affects the abundance of Hydrocortisone]
CTD
PMID:1324617
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
POMC
proopiomelanocortin
increases abundance
EXP
POMC protein results in increased abundance of Hydrocortisone
CTD
PMID:2831029
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2B6
cytochrome P450 2B11
increases hydroxylation
EXP
CYP2B6 protein results in increased hydroxylation of Cyclophosphamide
CTD
PMID:16546968
NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
multiple interactions
EXP
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate
CTD
PMID:2579070
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
Sorbitol results in increased phosphorylation of MAPK1 protein
CTD
PMID:12639917
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
Sorbitol results in increased phosphorylation of MAPK3 protein
CTD
PMID:12639917
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CLDN4
claudin 4
increases expression
EXP
Mannitol results in increased expression of CLDN4 protein
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
decreases activity multiple interactions
EXP
delta-hexachlorocyclohexane results in decreased activity of CDIPT protein [delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate
CTD
PMID:2579070
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AGT
angiotensinogen
multiple interactions
EXP
Deferoxamine inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]
CTD
PMID:8021468
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2D15
cytochrome P450 family 2 subfamily D member 15
affects metabolic processing
EXP
CYP2D15 affects the metabolism of Desipramine
CTD
PMID:7786018
NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AVP
arginine vasopressin
decreases expression
EXP
Dexamethasone results in decreased expression of AVP protein
CTD
PMID:1934541
NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
EXP
Dexamethasone results in increased expression of HSD11B1 mRNA
CTD
PMID:21798686
NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897
G
NPPA
natriuretic peptide A
increases expression
EXP
Dexamethasone results in increased expression of NPPA protein
CTD
PMID:1934541
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase
decreases activity
EXP
Dichlorvos results in decreased activity of ACHE protein
CTD
PMID:89824 PMID:3627083
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
BCHE
butyrylcholinesterase
decreases activity
EXP
Dichlorvos results in decreased activity of BCHE protein
CTD
PMID:3627083 PMID:4631366
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing increases hydroxylation
EXP
CYP2C9 protein affects the metabolism of Diclofenac CYP2C19 protein results in increased hydroxylation of Diclofenac
CTD
PMID:15677349 PMID:15801540
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Diclofenac results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLCG1
phospholipase C gamma 1
multiple interactions increases activity
EXP
dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein] dipalmitoylphosphatidic acid results in increased activity of PLCG1 protein
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCHE
butyrylcholinesterase
decreases activity
EXP
Isoflurophate results in decreased activity of BCHE protein
CTD
PMID:4631366
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLCG1
phospholipase C gamma 1
increases activity
EXP
dimyristoylphosphatidic acid results in increased activity of PLCG1 protein
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PLCG1
phospholipase C gamma 1
increases activity
EXP
dioleoylphosphatidic acid results in increased activity of PLCG1 protein
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP3
caspase 3
multiple interactions
EXP
Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP3 protein]
CTD
PMID:25446497
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP9
caspase 9
multiple interactions
EXP
Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein]
CTD
PMID:25446497
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases expression affects response to substance multiple interactions
EXP
Doxorubicin results in increased expression of ABCB1 protein ABCB1 protein affects the susceptibility to Doxorubicin valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]; valspodar inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]
CTD
PMID:15492788 PMID:24975508 PMID:28093773
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
HGF
hepatocyte growth factor
decreases response to substance
EXP
HGF protein results in decreased susceptibility to Doxorubicin
CTD
PMID:15688034
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
TNNT2
troponin T2, cardiac type
affects expression
EXP
Doxorubicin affects the expression of TNNT2 protein
CTD
PMID:12322705
NCBI chr 7:1,598,306...1,620,531
Ensembl chr 7:1,598,306...1,613,741
G
VIP
vasoactive intestinal peptide
decreases expression
EXP
Doxorubicin results in decreased expression of VIP protein
CTD
PMID:3711722
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
G
XIAP
X-linked inhibitor of apoptosis
affects response to substance
EXP
XIAP affects the susceptibility to Doxorubicin
CTD
PMID:16953886
NCBI chr X:95,300,234...95,356,103
Ensembl chr X:95,331,827...95,351,582
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of Enkephalin, D-Penicillamine (2,5)-
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
affects response to substance
EXP
ABCB1 protein affects the susceptibility to emodepside
CTD
PMID:25660379
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
multiple interactions
EXP
[Ranolazine co-treated with Enalapril] affects the expression of ATP2A2 protein
CTD
PMID:18820026
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
G
EGR1
early growth response 1
multiple interactions
EXP
[Ranolazine co-treated with Enalapril] affects the expression of EGR1 protein
CTD
PMID:18820026
NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
G
GATA4
GATA binding protein 4
multiple interactions
EXP
[Ranolazine co-treated with Enalapril] affects the expression of GATA4 protein
CTD
PMID:18820026
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
G
KCND3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
Enalapril results in decreased expression of KCND3 mRNA
CTD
PMID:19732978
NCBI chr17:63,470,829...63,668,354
Ensembl chr17:63,470,415...63,668,035
G
NAB1
NGFI-A binding protein 1
multiple interactions
EXP
[Ranolazine co-treated with Enalapril] affects the expression of NAB1 protein
CTD
PMID:18820026
NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
G
NOS3
nitric oxide synthase 3
multiple interactions increases expression
EXP
FR 173657 inhibits the reaction [Enalapril results in increased expression of NOS3 mRNA]
CTD
PMID:12019275
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NPPA
natriuretic peptide A
decreases expression multiple interactions
EXP
Enalapril results in decreased expression of NPPA protein FR 173657 inhibits the reaction [Enalapril results in decreased expression of NPPA protein]
CTD
PMID:12019275
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
REN
renin
increases activity multiple interactions
EXP
Enalapril results in increased activity of REN protein [Enalapril co-treated with FR 173657] results in increased activity of REN protein
CTD
PMID:12019275
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
SLC8A1
solute carrier family 8 member A1
multiple interactions
EXP
[Ranolazine co-treated with Enalapril] affects the expression of SLC8A1 protein
CTD
PMID:18820026
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AR
androgen receptor
multiple interactions
EXP
Eplerenone binds to and results in decreased activity of AR protein
CTD
PMID:23242577
NCBI chr24:34,713,390...34,731,461 NCBI chr X:51,969,785...52,167,450
Ensembl chr X:51,969,785...52,151,912
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ALPI
alkaline phosphatase, intestinal
increases chemical synthesis
EXP
ALPI protein results in increased chemical synthesis of Estrone
CTD
PMID:1495895
NCBI chr25:44,107,418...44,110,947
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of estrone sulfate
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
Etodolac results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC1
ATP binding cassette subfamily C member 1
decreases response to substance
EXP
ABCC1 protein results in decreased susceptibility to Etoposide
CTD
PMID:12516967
NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Felodipine results in increased activity of NR1I2 protein
CTD
PMID:27732639
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
EDN1
endothelin 1
increases activity
EXP
Fenfluramine results in increased activity of EDN1 protein
CTD
PMID:9918753
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Flufenamic Acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
EXP
Fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene]
CTD
PMID:8592870
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
multiple interactions affects activity
EXP
[Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate
CTD
PMID:2579070
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
GNAQ
G protein subunit alpha q
multiple interactions
EXP
G(M1) Ganglioside inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein]
CTD
PMID:21671308
NCBI chr 1:80,733,530...80,928,065
Ensembl chr 1:80,715,366...80,928,065
G
HEXB
hexosaminidase subunit beta
multiple interactions
EXP
G(M1) Ganglioside inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; G(M1) Ganglioside inhibits the reaction [Wasp Venoms results in increased secretion of HEXB protein]
CTD
PMID:21334356 PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CFTR
CF transmembrane conductance regulator
decreases activity
EXP
Genistein results in decreased activity of CFTR protein
CTD
PMID:15496164
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Genistein results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CCL2
C-C motif chemokine ligand 2
increases expression
EXP
Gentamicins results in increased expression of CCL2 protein
CTD
PMID:33290828
NCBI chr 9:39,008,187...39,009,932
G
CLU
clusterin
increases expression
EXP
Gentamicins results in increased expression of CLU mRNA; Gentamicins results in increased expression of CLU protein
CTD
PMID:25034533 PMID:33290828
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
LCN2
lipocalin 2
increases expression
EXP
Gentamicins results in increased expression of LCN2 mRNA; Gentamicins results in increased expression of LCN2 protein
CTD
PMID:25034533 PMID:33290828
NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
G
LOC607874
cystatin-C-like
increases expression
EXP
Gentamicins results in increased expression of CST3 protein
CTD
PMID:33290828
NCBI chr23:49,562...53,618
G
MIR15B
microRNA mir-15b
affects expression
EXP
Gentamicins affects the expression of MIR15B mRNA
CTD
PMID:33290828
NCBI chr34:26,460,663...26,460,722
Ensembl chr34:26,460,645...26,460,741
G
MIR30A
microRNA mir-30a
increases expression
EXP
Gentamicins results in increased expression of MIR30A mRNA
CTD
PMID:33290828
NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
G
SPP1
secreted phosphoprotein 1
increases expression
EXP
Gentamicins results in increased expression of SPP1 protein
CTD
PMID:33290828
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CLDN4
claudin 4
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23816505
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23816505
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]
CTD
PMID:23816505
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]
CTD
PMID:23816505
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CFTR
CF transmembrane conductance regulator
decreases activity
EXP
Glyburide results in decreased activity of CFTR protein
CTD
PMID:15496164
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC47A1
solute carrier family 47 member 1
decreases activity
EXP
hexaconazole results in decreased activity of SLC47A1 protein
CTD
PMID:36669674
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
G
SLC47A2
solute carrier family 47 member 2
decreases activity
EXP
hexaconazole results in decreased activity of SLC47A2 protein
CTD
PMID:36669674
NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ATP5F1B
ATP synthase F1 subunit beta
multiple interactions decreases expression
EXP
[Hydrochloric Acid co-treated with Bile Acids and Salts] results in decreased expression of ATP5F1B mRNA Hydrochloric Acid results in decreased expression of ATP5F1B mRNA
CTD
PMID:15883737
NCBI chr10:870,405...876,937
Ensembl chr10:870,392...909,161
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression multiple interactions
EXP
Hydrochloric Acid results in increased expression of CXCL8 protein Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of CXCL8 protein]
CTD
PMID:18339021
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
FGF7
fibroblast growth factor 7
increases expression
EXP
Hydrochloric Acid results in increased expression of FGF7 mRNA
CTD
PMID:15883737
NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
G
FGFR2
fibroblast growth factor receptor 2
increases expression
EXP
Hydrochloric Acid results in increased expression of FGFR2 mRNA
CTD
PMID:15883737
NCBI chr28:31,303,882...31,411,015
Ensembl chr28:31,303,894...31,411,621
G
MMP2
matrix metallopeptidase 2
increases expression multiple interactions
EXP
Hydrochloric Acid results in increased expression of MMP2 protein Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP2 protein]
CTD
PMID:18339021
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP9
matrix metallopeptidase 9
increases expression multiple interactions
EXP
Hydrochloric Acid results in increased expression of MMP9 protein Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein]
CTD
PMID:18339021
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
NOS2
nitric oxide synthase 2
increases activity
EXP
Hydrochloric Acid results in increased activity of NOS2 protein
CTD
PMID:14621274
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases transport
EXP
ABCB1 protein results in increased transport of hypaconitine
CTD
PMID:23200901
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ABCG2
ATP binding cassette subfamily G member 2
multiple interactions
EXP
[3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of hypaconitine
CTD
PMID:23200901
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Ibuprofen results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Ibuprofen results in increased expression of PTGS2 protein
CTD
PMID:16105799
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NOS3
nitric oxide synthase 3
increases activity
EXP
icariin results in increased activity of NOS3 protein
CTD
PMID:17438405
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HEXB
hexosaminidase subunit beta
multiple interactions
EXP
Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein]
CTD
PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Indomethacin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC22A6
solute carrier family 22 member 6
multiple interactions
EXP
[Lansoprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican; [Omeprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican; [Pantoprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican
CTD
PMID:36243147
NCBI chr18:53,736,669...53,745,001
Ensembl chr18:53,736,959...53,744,396
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDIPT
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
multiple interactions
EXP
[Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate; Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]
CTD
PMID:2579070
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[iprodione binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein
CTD
PMID:24389113
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
EXP
[iprodione binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein
CTD
PMID:24389113
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
multiple interactions increases activity
EXP
Atenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Pindolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; xibenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]
CTD
PMID:6103674
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
kaempferol results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
decreases expression multiple interactions decreases activity
EXP
Ketoconazole results in decreased expression of ABCB1 mRNA [Ketoconazole results in decreased activity of ABCB1 protein] which results in decreased transport of Technetium Tc 99m Sestamibi
CTD
PMID:19754906 PMID:22620706
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
CYP3A12
cytochrome P-450 3A12
multiple interactions decreases activity
EXP
Ketoconazole inhibits the reaction [CYP3A12 protein results in increased hydroxylation of Diazepam] Ketoconazole results in decreased activity of CYP3A12 protein
CTD
PMID:15677349
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Dithiothreitol metabolite results in increased expression of HSPA5 protein
CTD
PMID:17416481
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC1
ATP binding cassette subfamily C member 1
affects transport
EXP
ABCC1 protein affects the transport of Leukotriene C4
CTD
PMID:12516967
NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport
EXP
ABCC2 protein affects the transport of Leukotriene C4
CTD
PMID:15507541
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Lithocholic Acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
affects response to substance increases export
EXP
ABCB1 protein affects the susceptibility to Loperamide ABCB1 protein results in increased export of Loperamide
CTD
PMID:25660379 PMID:28093773
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP3
caspase 3
increases activity
EXP
Loratadine results in increased activity of CASP3 protein
CTD
PMID:20570632
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CCL17
C-C motif chemokine ligand 17
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL17 promoter
CTD
PMID:33763461
NCBI chr 2:59,001,463...59,014,347
Ensembl chr 2:59,001,464...59,005,230
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL2 promoter
CTD
PMID:33763461
NCBI chr 9:39,008,187...39,009,932
G
IL13
interleukin 13
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
IL31
interleukin 31
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr26:7,173,151...7,175,195
Ensembl chr26:7,172,451...7,175,195
G
IL31RA
interleukin 31 receptor A
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of IL31RA promoter
CTD
PMID:33763461
NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293
G
IL4
interleukin 4
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]
CTD
PMID:33763461
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
TSLP
thymic stromal lymphopoietin
multiple interactions
EXP
[Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of TSLP promoter
CTD
PMID:33763461
NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASP8
caspase 8
multiple interactions increases expression
EXP
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA]
CTD
PMID:31005593
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
FADD
Fas associated via death domain
increases expression
EXP
marbofloxacin results in increased expression of FADD mRNA
CTD
PMID:31005593
NCBI chr18:48,087,447...48,094,497
G
TNF
tumor necrosis factor
increases expression
EXP
marbofloxacin results in increased expression of TNF mRNA; marbofloxacin results in increased expression of TNF protein
CTD
PMID:31005593
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF1A
TNF receptor superfamily member 1A
multiple interactions increases expression
EXP
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA] marbofloxacin results in increased expression of TNFRSF1A mRNA; marbofloxacin results in increased expression of TNFRSF1A protein
CTD
PMID:31005593
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TRADD
TNFRSF1A associated via death domain
multiple interactions increases expression
EXP
TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA]
CTD
PMID:31005593
NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCA5
ATP binding cassette subfamily A member 5
increases expression
EXP
masitinib results in increased expression of ABCA5 mRNA
CTD
PMID:22747577
NCBI chr 9:15,708,070...15,781,100
Ensembl chr 9:15,420,835...15,783,045
G
ABHD14A
abhydrolase domain containing 14A
increases expression
EXP
masitinib results in increased expression of ABHD14A mRNA
CTD
PMID:22747577
NCBI chr20:37,738,500...37,744,689
G
ABITRAM
actin binding transcription modulator
decreases expression
EXP
masitinib results in decreased expression of ABITRAM mRNA
CTD
PMID:22747577
NCBI chr11:64,094,653...64,100,078
Ensembl chr11:64,094,721...64,109,421
G
ABLIM1
actin binding LIM protein 1
increases expression
EXP
masitinib results in increased expression of ABLIM1 mRNA
CTD
PMID:22747577
NCBI chr28:25,260,323...25,543,369
Ensembl chr28:25,260,873...25,545,304
G
ACAT2
acetyl-CoA acetyltransferase 2
decreases expression
EXP
masitinib results in decreased expression of ACAT2 mRNA
CTD
PMID:22747577
NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327
G
ACSM3
acyl-CoA synthetase medium chain family member 3
increases expression
EXP
masitinib results in increased expression of ACSM3 mRNA
CTD
PMID:22747577
NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728
G
ACTL7A
actin like 7A
increases expression
EXP
masitinib results in increased expression of ACTL7A mRNA
CTD
PMID:22747577
NCBI chr11:64,031,305...64,033,908
Ensembl chr11:64,032,358...64,033,788
G
ACTR2
actin related protein 2
decreases expression
EXP
masitinib results in decreased expression of ACTR2 protein
CTD
PMID:22747577
NCBI chr10:64,696,068...64,733,027
Ensembl chr10:64,696,111...64,730,553
G
ADPRH
ADP-ribosylarginine hydrolase
increases expression
EXP
masitinib results in increased expression of ADPRH mRNA
CTD
PMID:22747577
NCBI chr33:23,218,633...23,226,844
Ensembl chr33:23,218,101...23,224,667
G
AGA
aspartylglucosaminidase
increases expression
EXP
masitinib results in increased expression of AGA mRNA
CTD
PMID:22747577
NCBI chr16:52,314,860...52,324,879
Ensembl chr16:52,314,535...52,324,894
G
AGO2
argonaute RISC catalytic component 2
decreases expression
EXP
masitinib results in decreased expression of AGO2 mRNA
CTD
PMID:22747577
NCBI chr13:35,169,243...35,230,252
Ensembl chr13:35,180,912...35,268,577
G
AGRN
agrin
increases expression
EXP
masitinib results in increased expression of AGRN mRNA
CTD
PMID:22747577
NCBI chr 5:56,239,621...56,273,679
Ensembl chr 5:56,239,701...56,272,745
G
AIG1
androgen induced 1
increases expression
EXP
masitinib results in increased expression of AIG1 mRNA
CTD
PMID:22747577
NCBI chr 1:34,643,994...34,884,445
Ensembl chr 1:34,643,764...34,884,119
G
ALAS2
5'-aminolevulinate synthase 2
increases expression
EXP
masitinib results in increased expression of ALAS2 mRNA
CTD
PMID:22747577
NCBI chr X:46,703,477...46,731,767
Ensembl chr X:46,703,477...46,723,529
G
ALDH5A1
aldehyde dehydrogenase 5 family member A1
decreases expression
EXP
masitinib results in decreased expression of ALDH5A1 mRNA
CTD
PMID:22747577
NCBI chr35:22,560,005...22,590,996
Ensembl chr35:22,560,008...22,587,875
G
AMN1
antagonist of mitotic exit network 1 homolog
increases expression
EXP
masitinib results in increased expression of AMN1 mRNA
CTD
PMID:22747577
NCBI chr27:17,044,301...17,100,444
Ensembl chr27:17,044,309...17,361,570
G
ANKRD26
ankyrin repeat domain containing 26
increases expression
EXP
masitinib results in increased expression of ANKRD26 mRNA
CTD
PMID:22747577
NCBI chr 2:6,230,466...6,402,360
G
ANP32E
acidic nuclear phosphoprotein 32 family member E
decreases expression
EXP
masitinib results in decreased expression of ANP32E mRNA
CTD
PMID:22747577
NCBI chr17:59,460,864...59,482,467
Ensembl chr17:59,462,766...59,477,936
G
ANXA1
annexin A1
increases expression
EXP
masitinib results in increased expression of ANXA1 protein
CTD
PMID:22747577
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
G
ANXA6
annexin A6
increases expression
EXP
masitinib results in increased expression of ANXA6 protein
CTD
PMID:22747577
NCBI chr 4:58,091,186...58,140,102
Ensembl chr 4:58,091,251...58,139,372
G
ARMC12
armadillo repeat containing 12
increases expression
EXP
masitinib results in increased expression of ARMC12 mRNA
CTD
PMID:22747577
NCBI chr12:4,868,831...4,879,801
Ensembl chr12:4,869,774...4,879,793
G
ASCC1
activating signal cointegrator 1 complex subunit 1
decreases expression
EXP
masitinib results in decreased expression of ASCC1 mRNA
CTD
PMID:22747577
NCBI chr 4:22,779,644...22,876,434
Ensembl chr 4:22,779,781...22,874,215
G
B4GALT7
beta-1,4-galactosyltransferase 7
increases expression
EXP
masitinib results in increased expression of B4GALT7 mRNA
CTD
PMID:22747577
NCBI chr11:3,497,860...3,507,513
Ensembl chr11:3,498,153...3,505,034
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
masitinib results in decreased expression of BIRC5 mRNA
CTD
PMID:22747577
NCBI chr 9:2,930,308...2,959,307
G
BTBD3
BTB domain containing 3
decreases expression
EXP
masitinib results in decreased expression of BTBD3 mRNA
CTD
PMID:22747577
NCBI chr24:10,478,635...10,512,773
Ensembl chr24:10,479,900...10,512,185
G
CA2
carbonic anhydrase 2
decreases expression
EXP
masitinib results in decreased expression of CA2 mRNA
CTD
PMID:22747577
NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579
G
CAMK2G
calcium/calmodulin dependent protein kinase II gamma
increases expression
EXP
masitinib results in increased expression of CAMK2G mRNA
CTD
PMID:22747577
NCBI chr 4:24,244,063...24,299,362
Ensembl chr 4:24,245,960...24,299,357
G
CAPG
capping actin protein, gelsolin like
increases expression
EXP
masitinib results in increased expression of CAPG protein
CTD
PMID:22747577
NCBI chr17:39,619,429...39,640,944
Ensembl chr17:39,619,248...39,640,942
G
CCT2
chaperonin containing TCP1 subunit 2
decreases expression
EXP
masitinib results in decreased expression of CCT2 protein
CTD
PMID:22747577
NCBI chr10:11,560,287...11,586,559
Ensembl chr10:11,560,396...11,578,433
G
CD5L
CD5 molecule like
increases expression
EXP
masitinib results in increased expression of CD5L mRNA
CTD
PMID:22747577
NCBI chr 7:40,516,190...40,526,528
Ensembl chr 7:40,516,190...40,526,528
G
CDADC1
cytidine and dCMP deaminase domain containing 1
increases expression
EXP
masitinib results in increased expression of CDADC1 mRNA
CTD
PMID:22747577
NCBI chr22:2,443,459...2,489,147
Ensembl chr22:2,436,206...2,489,016
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
EXP
masitinib results in increased expression of CDKN1A mRNA
CTD
PMID:22747577
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CIAPIN1
cytokine induced apoptosis inhibitor 1
decreases expression
EXP
masitinib results in decreased expression of CIAPIN1 mRNA
CTD
PMID:22747577
NCBI chr 2:58,977,592...58,992,785
Ensembl chr 2:58,977,676...58,992,581
G
CIRBP
cold inducible RNA binding protein
increases expression
EXP
masitinib results in increased expression of CIRBP mRNA
CTD
PMID:22747577
NCBI chr20:57,521,609...57,526,526
Ensembl chr20:57,519,119...57,526,435
G
CLEC2B
C-type lectin domain family 2 member B
decreases expression
EXP
masitinib results in decreased expression of CLEC2B mRNA
CTD
PMID:22747577
NCBI chr27:36,088,754...36,143,581
Ensembl chr27:36,120,134...36,143,040
G
CMTM7
CKLF like MARVEL transmembrane domain containing 7
increases expression
EXP
masitinib results in increased expression of CMTM7 mRNA
CTD
PMID:22747577
NCBI chr23:12,317,636...12,382,836
Ensembl chr23:12,328,303...12,382,837
G
CORO1A
coronin 1A
increases expression
EXP
masitinib results in increased expression of CORO1A protein
CTD
PMID:22747577
NCBI chr 6:18,161,850...18,167,915
Ensembl chr 6:18,160,601...18,167,818
G
CPNE1
copine 1
increases expression
EXP
masitinib results in increased expression of CPNE1 mRNA
CTD
PMID:22747577
NCBI chr24:24,554,636...24,589,748
Ensembl chr24:24,554,636...24,589,731
G
CTSK
cathepsin K
increases expression
EXP
masitinib results in increased expression of CTSK mRNA
CTD
PMID:22747577
NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507
G
DHRS4
hydrogenase/reductase 4
increases expression
EXP
masitinib results in increased expression of DHRS4 mRNA
CTD
PMID:22747577
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
DLA-12
MHC class I DLA-12
increases expression
EXP
masitinib results in increased expression of DLA-12 mRNA
CTD
PMID:22747577
NCBI chr12:933,321...936,671
Ensembl chr12:932,613...987,561
G
DLA-64
MHC class I DLA-64
increases expression
EXP
masitinib results in increased expression of DLA-64 mRNA
CTD
PMID:22747577
NCBI chr12:983,573...986,969
G
DLGAP1
DLG associated protein 1
decreases expression
EXP
masitinib results in decreased expression of DLGAP1 mRNA
CTD
PMID:22747577
NCBI chr 7:70,082,563...70,949,116
Ensembl chr 7:70,081,885...70,406,213
G
DLGAP5
DLG associated protein 5
decreases expression
EXP
masitinib results in decreased expression of DLGAP5 mRNA
CTD
PMID:22747577
NCBI chr 8:30,998,806...31,038,614
Ensembl chr 8:30,994,402...31,036,540
G
DPCD
deleted in primary ciliary dyskinesia homolog
decreases expression
EXP
masitinib results in decreased expression of DPCD mRNA
CTD
PMID:22747577
NCBI chr28:14,201,302...14,219,121
Ensembl chr28:14,201,351...14,219,121
G
DPYSL3
dihydropyrimidinase like 3
decreases expression
EXP
masitinib results in decreased expression of DPYSL3 mRNA
CTD
PMID:22747577
NCBI chr 2:41,687,725...41,809,402
Ensembl chr 2:41,690,845...41,802,376
G
EBPL
EBP like
increases expression
EXP
masitinib results in increased expression of EBPL mRNA
CTD
PMID:22747577
NCBI chr22:2,116,588...2,137,935
Ensembl chr22:2,116,131...2,182,633
G
EDEM2
ER degradation enhancing alpha-mannosidase like protein 2
increases expression
EXP
masitinib results in increased expression of EDEM2 mRNA
CTD
PMID:22747577
NCBI chr24:24,137,228...24,165,995
Ensembl chr24:24,137,228...24,165,968
G
EIF3A
eukaryotic translation initiation factor 3 subunit A
decreases expression
EXP
masitinib results in decreased expression of EIF3A protein
CTD
PMID:22747577
NCBI chr28:29,290,668...29,326,851
Ensembl chr28:29,291,422...29,326,701
G
EIF4A1
eukaryotic translation initiation factor 4A1
decreases expression
EXP
masitinib results in decreased expression of EIF4A1 protein
CTD
PMID:22747577
NCBI chr 5:32,495,606...32,500,805
Ensembl chr 5:32,484,572...32,500,805
G
EIF5A2
eukaryotic translation initiation factor 5A2
decreases expression
EXP
masitinib results in decreased expression of EIF5A2 mRNA
CTD
PMID:22747577
NCBI chr34:35,309,812...35,322,382
Ensembl chr34:35,314,172...35,322,392
G
ELSPBP1
epididymal sperm binding protein 1
increases expression
EXP
masitinib results in increased expression of ELSPBP1 mRNA
CTD
PMID:22747577
NCBI chr 1:108,159,609...108,187,224
Ensembl chr 1:108,159,611...108,188,076
G
ETFDH
electron transfer flavoprotein dehydrogenase
decreases expression
EXP
masitinib results in decreased expression of ETFDH mRNA
CTD
PMID:22747577
NCBI chr15:55,752,170...55,781,118
Ensembl chr15:55,752,200...55,792,105
G
GGT1
gamma-glutamyltransferase 1
increases expression
EXP
masitinib results in increased expression of GGT1 mRNA
CTD
PMID:22747577
NCBI chr26:28,301,455...28,315,029
G
GKN1
gastrokine 1
increases expression
EXP
masitinib results in increased expression of GKN1 mRNA
CTD
PMID:22747577
NCBI chr10:67,788,329...67,793,445
Ensembl chr10:67,788,110...67,793,589
G
GMFB
glia maturation factor beta
decreases expression
EXP
masitinib results in decreased expression of GMFB mRNA
CTD
PMID:22747577
NCBI chr 8:30,394,020...30,408,408
Ensembl chr 8:30,359,499...30,408,357
G
GSTA4
glutathione S-transferase alpha 4
increases expression
EXP
masitinib results in increased expression of GSTA4 mRNA
CTD
PMID:22747577
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
G
GXYLT1
glucoside xylosyltransferase 1
decreases expression
EXP
masitinib results in decreased expression of GXYLT1 mRNA
CTD
PMID:22747577
NCBI chr27:11,754,609...11,810,245
Ensembl chr27:11,765,072...11,807,787
G
HEBP2
heme binding protein 2
decreases expression
EXP
masitinib results in decreased expression of HEBP2 mRNA
CTD
PMID:22747577
NCBI chr 1:30,716,395...30,724,814
Ensembl chr 1:30,716,606...30,724,613
G
HERPUD1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
masitinib results in increased expression of HERPUD1 mRNA
CTD
PMID:22747577
NCBI chr 2:59,388,492...59,400,028
Ensembl chr 2:59,388,494...59,400,003
G
HSP90B1
heat shock protein 90 beta family member 1
increases expression
EXP
masitinib results in increased expression of HSP90B1 protein
CTD
PMID:22747577
NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311
G
HTR2B
5-hydroxytryptamine receptor 2B
increases expression
EXP
masitinib results in increased expression of HTR2B mRNA
CTD
PMID:22747577
NCBI chr25:43,042,306...43,056,361
Ensembl chr25:43,042,173...43,056,612
G
HYAL3
hyaluronidase 3
increases expression
EXP
masitinib results in increased expression of HYAL3 mRNA
CTD
PMID:22747577
NCBI chr20:39,041,940...39,047,388
Ensembl chr20:39,042,070...39,047,365
G
IGFBP7
insulin like growth factor binding protein 7
increases expression
EXP
masitinib results in increased expression of IGFBP7 mRNA
CTD
PMID:22747577
NCBI chr13:49,138,406...49,207,235
Ensembl chr13:49,138,402...49,207,394
G
IL13
interleukin 13
increases expression
EXP
masitinib results in increased expression of IL13 mRNA
CTD
PMID:22747577
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
IMMP2L
inner mitochondrial membrane peptidase subunit 2
increases expression
EXP
masitinib results in increased expression of IMMP2L mRNA
CTD
PMID:22747577
NCBI chr14:50,487,679...51,336,906
G
IRX6
iroquois homeobox 6
increases expression
EXP
masitinib results in increased expression of IRX6 protein
CTD
PMID:22747577
NCBI chr 2:60,630,688...60,636,285
Ensembl chr 2:60,630,447...60,636,416
G
ITGA6
integrin subunit alpha 6
decreases expression
EXP
masitinib results in decreased expression of ITGA6 mRNA
CTD
PMID:22747577
NCBI chr36:16,777,363...16,858,725
Ensembl chr36:16,776,863...16,855,449
G
JAML
junction adhesion molecule like
decreases expression
EXP
masitinib results in decreased expression of JAML mRNA
CTD
PMID:22747577
NCBI chr 5:15,485,378...15,513,457
Ensembl chr 5:15,476,582...15,513,075
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
masitinib results in increased expression of JUN mRNA
CTD
PMID:22747577
NCBI chr 5:50,966,698...50,968,939
G
KCTD19
potassium channel tetramerization domain containing 19
increases expression
EXP
masitinib results in increased expression of KCTD19 mRNA
CTD
PMID:22747577
NCBI chr 5:82,060,946...82,093,248
Ensembl chr 5:82,061,449...82,093,246
G
KLHL5
kelch like family member 5
increases expression
EXP
masitinib results in increased expression of KLHL5 mRNA
CTD
PMID:22747577
NCBI chr 3:73,258,925...73,347,262
Ensembl chr 3:73,262,895...73,344,879
G
LBX2
ladybird homeobox 2
increases expression
EXP
masitinib results in increased expression of LBX2 mRNA
CTD
PMID:22747577
NCBI chr17:48,641,630...48,643,411
Ensembl chr17:48,641,674...48,643,239
G
LIN7C
lin-7 homolog C, crumbs cell polarity complex component
decreases expression
EXP
masitinib results in decreased expression of LIN7C mRNA
CTD
PMID:22747577
NCBI chr21:48,061,446...48,071,458
Ensembl chr21:48,064,929...48,071,429
G
LOC474850
heat shock 70 kDa protein 1-like
increases expression
EXP
masitinib results in increased expression of HSPA1L mRNA
CTD
PMID:22747577
NCBI chr12:1,281,164...1,285,010
Ensembl chr12:1,281,472...1,285,440
G
LOC475707
GPN-loop GTPase 1
decreases expression
EXP
masitinib results in decreased expression of GPN1 mRNA
CTD
PMID:22747577
NCBI chr17:21,654,516...21,678,435
Ensembl chr17:21,545,673...21,673,157
G
LOC478000
phytanoyl-CoA hydroxylase-like
increases expression
EXP
masitinib results in increased expression of PHYH mRNA
CTD
PMID:22747577
NCBI chr 2:23,185,901...23,206,719
Ensembl chr 2:23,185,782...23,253,497
G
LOC609402
hemoglobin subunit beta-like
increases expression
EXP
masitinib results in increased expression of HBG1 mRNA
CTD
PMID:22747577
NCBI chr21:28,187,535...28,188,991
G
LONRF1
LON peptidase N-terminal domain and ring finger 1
increases expression
EXP
masitinib results in increased expression of LONRF1 mRNA
CTD
PMID:22747577
NCBI chr16:36,220,324...36,256,896
Ensembl chr16:36,221,156...36,256,897
G
LRP1
LDL receptor related protein 1
increases expression
EXP
masitinib results in increased expression of LRP1 mRNA
CTD
PMID:22747577
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
G
LRP8
LDL receptor related protein 8
decreases expression
EXP
masitinib results in decreased expression of LRP8 mRNA
CTD
PMID:22747577
NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736
G
LYRM1
LYR motif containing 1
increases expression
EXP
masitinib results in increased expression of LYRM1 mRNA
CTD
PMID:22747577
NCBI chr 6:24,428,461...24,460,291
Ensembl chr 6:24,441,307...24,460,331
G
MAGEF1
MAGE family member F1
decreases expression
EXP
masitinib results in decreased expression of MAGEF1 mRNA
CTD
PMID:22747577
NCBI chr34:17,543,381...17,545,089
Ensembl chr34:17,543,906...17,544,868
G
MOB1B
MOB kinase activator 1B
decreases expression
EXP
masitinib results in decreased expression of MOB1B mRNA
CTD
PMID:22747577
NCBI chr13:60,145,168...60,197,916
Ensembl chr13:60,145,366...60,195,463
G
MPDZ
multiple PDZ domain crumbs cell polarity complex component
increases expression
EXP
masitinib results in increased expression of MPDZ mRNA
CTD
PMID:22747577
NCBI chr11:33,691,434...33,826,500
Ensembl chr11:33,692,296...33,826,437
G
MYOZ1
myozenin 1
increases expression
EXP
masitinib results in increased expression of MYOZ1 mRNA
CTD
PMID:22747577
NCBI chr 4:24,158,532...24,165,416
Ensembl chr 4:24,158,720...24,165,392
G
NAPG
NSF attachment protein gamma
decreases expression
EXP
masitinib results in decreased expression of NAPG mRNA
CTD
PMID:22747577
NCBI chr 7:76,403,561...76,424,994
Ensembl chr 7:76,403,595...76,423,170
G
NDUFS1
NADH:ubiquinone oxidoreductase core subunit S1
decreases expression
EXP
masitinib results in decreased expression of NDUFS1 mRNA
CTD
PMID:22747577
NCBI chr37:14,680,908...14,713,838
Ensembl chr37:14,683,083...14,713,754
G
NFKBIA
NFKB inhibitor alpha
increases expression
EXP
masitinib results in increased expression of NFKBIA mRNA
CTD
PMID:22747577
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
NRAS
NRAS proto-oncogene, GTPase
decreases expression
EXP
masitinib results in decreased expression of NRAS mRNA
CTD
PMID:22747577
NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
G
NSG1
neuronal vesicle trafficking associated 1
decreases expression
EXP
masitinib results in decreased expression of NSG1 mRNA
CTD
PMID:22747577
NCBI chr 3:69,805,646...69,831,200
Ensembl chr 3:69,805,592...69,831,194
G
NTRK1
neurotrophic receptor tyrosine kinase 1
increases expression
EXP
masitinib results in increased expression of NTRK1 mRNA
CTD
PMID:22747577
NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
G
OCA2
OCA2 melanosomal transmembrane protein
decreases expression
EXP
masitinib results in decreased expression of OCA2 mRNA
CTD
PMID:22747577
NCBI chr 3:32,361,825...32,713,631
Ensembl chr 3:32,361,517...32,713,572
G
OGT
O-linked N-acetylglucosamine (GlcNAc) transferase
increases expression
EXP
masitinib results in increased expression of OGT mRNA
CTD
PMID:22747577
NCBI chr X:55,821,227...55,857,597
Ensembl chr X:55,821,234...55,855,502
G
OXCT1
3-oxoacid CoA-transferase 1
increases expression
EXP
masitinib results in increased expression of OXCT1 protein
CTD
PMID:22747577
NCBI chr 4:67,709,846...67,841,737
Ensembl chr 4:67,527,531...67,841,518
G
PARP14
poly(ADP-ribose) polymerase family member 14
increases expression
EXP
masitinib results in increased expression of PARP14 mRNA
CTD
PMID:22747577
NCBI chr33:25,763,282...25,798,284
Ensembl chr33:25,763,255...25,798,198
G
PCM1
pericentriolar material 1
increases expression
EXP
masitinib results in increased expression of PCM1 mRNA
CTD
PMID:22747577
NCBI chr16:41,212,733...41,291,654
Ensembl chr16:41,214,417...41,291,376
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
decreases expression
EXP
masitinib results in decreased expression of PCOLCE2 mRNA
CTD
PMID:22747577
NCBI chr23:38,424,408...38,486,800
Ensembl chr23:38,426,216...38,487,252
G
PDE6H
phosphodiesterase 6H
increases expression
EXP
masitinib results in increased expression of PDE6H mRNA
CTD
PMID:22747577
NCBI chr27:31,640,731...31,664,494
Ensembl chr27:31,640,737...31,664,401
G
PDHA1
pyruvate dehydrogenase E1 subunit alpha 1
decreases expression
EXP
masitinib results in decreased expression of PDHA1 mRNA
CTD
PMID:22747577
NCBI chr X:15,338,364...15,354,011
Ensembl chr X:15,338,202...15,387,458
G
PDIA3
protein disulfide isomerase family A member 3
increases expression
EXP
masitinib results in increased expression of PDIA3 protein
CTD
PMID:22747577
NCBI chr30:10,487,926...10,513,437
Ensembl chr30:10,487,921...10,513,397
G
PEBP4
phosphatidylethanolamine binding protein 4
increases expression
EXP
masitinib results in increased expression of PEBP4 mRNA
CTD
PMID:22747577
NCBI chr25:34,329,160...34,574,086
Ensembl chr25:34,317,421...34,574,066
G
PECAM1
platelet and endothelial cell adhesion molecule 1
increases expression
EXP
masitinib results in increased expression of PECAM1 mRNA
CTD
PMID:22747577
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PHF10
PHD finger protein 10
increases expression
EXP
masitinib results in increased expression of PHF10 mRNA
CTD
PMID:22747577
NCBI chr12:71,955,354...71,998,283
Ensembl chr12:71,787,082...71,998,243
G
POMT1
protein O-mannosyltransferase 1
decreases expression
EXP
masitinib results in decreased expression of POMT1 mRNA
CTD
PMID:22747577
NCBI chr 9:52,615,349...52,631,538
Ensembl chr 9:52,615,655...52,630,836
G
POR
cytochrome p450 oxidoreductase
increases expression
EXP
masitinib results in increased expression of POR mRNA
CTD
PMID:22747577
NCBI chr 6:7,247,780...7,316,282
Ensembl chr 6:7,263,574...7,316,297
G
PPA1
inorganic pyrophosphatase 1
decreases expression
EXP
masitinib results in decreased expression of PPA1 protein
CTD
PMID:22747577
NCBI chr 4:21,145,547...21,189,985
Ensembl chr 4:21,145,547...21,182,748
G
PRPS2
phosphoribosyl pyrophosphate synthetase 2
decreases expression
EXP
masitinib results in decreased expression of PRPS2 mRNA
CTD
PMID:22747577
NCBI chr X:9,281,686...9,326,551
Ensembl chr X:9,281,730...9,418,289
G
PSMB9
proteasome 20S subunit beta 9
increases expression
EXP
masitinib results in increased expression of PSMB9 mRNA
CTD
PMID:22747577
NCBI chr12:2,432,287...2,438,920
Ensembl chr12:2,432,505...2,438,069
G
PSMD6
proteasome 26S subunit, non-ATPase 6
decreases expression
EXP
masitinib results in decreased expression of PSMD6 protein
CTD
PMID:22747577
NCBI chr20:27,206,801...27,220,059
G
PSMD9
proteasome 26S subunit, non-ATPase 9
decreases expression
EXP
masitinib results in decreased expression of PSMD9 mRNA
CTD
PMID:22747577
NCBI chr26:7,376,154...7,400,655
Ensembl chr26:7,377,413...7,400,573
G
PTH
parathyroid hormone
increases expression
EXP
masitinib results in increased expression of PTH mRNA
CTD
PMID:22747577
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
G
PXYLP1
2-phosphoxylose phosphatase 1
decreases expression
EXP
masitinib results in decreased expression of ACPL2 mRNA
CTD
PMID:22747577
NCBI chr23:37,145,065...37,197,808
Ensembl chr23:37,145,086...37,196,427
G
R3HDM2
R3H domain containing 2
increases expression
EXP
masitinib results in increased expression of R3HDM2 mRNA
CTD
PMID:22747577
NCBI chr10:1,377,664...1,504,008
Ensembl chr10:1,370,350...1,504,017
G
RAB44
RAB44, member RAS oncogene family
increases expression
EXP
masitinib results in increased expression of RAB44 mRNA
CTD
PMID:22747577
NCBI chr12:5,769,056...5,804,963
Ensembl chr12:5,770,882...5,804,949
G
RASGRP2
RAS guanyl releasing protein 2
increases expression
EXP
masitinib results in increased expression of RASGRP2 mRNA
CTD
PMID:22747577
NCBI chr18:52,412,331...52,426,910
Ensembl chr18:52,412,367...52,426,916
G
RCAN1
regulator of calcineurin 1
increases expression
EXP
masitinib results in increased expression of RCAN1 mRNA
CTD
PMID:22747577
NCBI chr31:29,908,046...30,002,412
Ensembl chr31:29,909,388...30,002,418
G
RGS13
regulator of G protein signaling 13
decreases expression
EXP
masitinib results in decreased expression of RGS13 mRNA
CTD
PMID:22747577
NCBI chr38:6,291,146...6,316,662
Ensembl chr38:6,291,182...6,315,198
G
SAR1B
secretion associated Ras related GTPase 1B
decreases expression
EXP
masitinib results in decreased expression of SAR1A mRNA
CTD
PMID:22747577
NCBI chr11:22,713,459...22,743,190
Ensembl chr11:22,717,942...22,743,124
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
masitinib results in decreased expression of SCD mRNA
CTD
PMID:22747577
NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
G
SELENBP1
selenium binding protein 1
increases expression
EXP
masitinib results in increased expression of SELENBP1 protein
CTD
PMID:22747577
NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
G
SERPINE2
serpin family E member 2
increases expression
EXP
masitinib results in increased expression of SERPINE2 mRNA
CTD
PMID:22747577
NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228
G
SFT2D2
SFT2 domain containing 2
decreases expression
EXP
masitinib results in decreased expression of SFT2D2 mRNA
CTD
PMID:22747577
NCBI chr 7:30,258,748...30,281,371
G
SLA
Src like adaptor
increases expression
EXP
masitinib results in increased expression of SLA mRNA
CTD
PMID:22747577
NCBI chr13:29,503,304...29,590,679
Ensembl chr13:29,504,867...29,569,773
G
SLC25A12
solute carrier family 25 member 12
decreases expression
EXP
masitinib results in decreased expression of SLC25A12 mRNA
CTD
PMID:22747577
NCBI chr36:16,185,011...16,391,080
Ensembl chr36:16,185,649...16,483,016
G
SMC5
structural maintenance of chromosomes 5
decreases expression
EXP
masitinib results in decreased expression of SMC5 mRNA
CTD
PMID:22747577
NCBI chr 1:87,192,988...87,285,678
Ensembl chr 1:87,194,867...87,285,606
G
SRR
serine racemase
increases expression
EXP
masitinib results in increased expression of SRR mRNA
CTD
PMID:22747577
G
STING1
stimulator of interferon response cGAMP interactor 1
increases expression
EXP
masitinib results in increased expression of TMEM173 mRNA
CTD
PMID:22747577
NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072
G
STOX1
storkhead box 1
increases expression
EXP
masitinib results in increased expression of STOX1 mRNA
CTD
PMID:22747577
NCBI chr 4:20,013,893...20,065,480
Ensembl chr 4:20,014,007...20,060,394
G
STX16
syntaxin 16
increases expression
EXP
masitinib results in increased expression of STX16 mRNA
CTD
PMID:22747577
NCBI chr24:43,425,719...43,451,828
Ensembl chr24:43,426,470...43,449,077
G
STYXL1
serine/threonine/tyrosine interacting like 1
increases expression
EXP
masitinib results in increased expression of STYXL1 mRNA
CTD
PMID:22747577
NCBI chr 6:7,323,911...7,389,878
Ensembl chr 6:7,316,477...7,389,842
G
TARDBP
TAR DNA binding protein
decreases expression
EXP
masitinib results in decreased expression of TARDBP protein
CTD
PMID:22747577
NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593
G
TBC1D14
TBC1 domain family member 14
decreases expression
EXP
masitinib results in decreased expression of TBC1D14 mRNA
CTD
PMID:22747577
NCBI chr 3:58,992,743...59,097,581
Ensembl chr 3:58,926,237...59,097,621
G
TCN2
transcobalamin 2
increases expression
EXP
masitinib results in increased expression of TCN2 mRNA
CTD
PMID:22747577
NCBI chr26:23,693,664...23,710,342
Ensembl chr26:23,693,773...23,709,832
G
TCP1
t-complex 1
decreases expression
EXP
masitinib results in decreased expression of TCP1 protein
CTD
PMID:22747577
NCBI chr 1:49,029,260...49,038,023
Ensembl chr 1:49,029,282...49,038,020
G
TEAD4
TEA domain transcription factor 4
increases expression
EXP
masitinib results in increased expression of TEAD4 mRNA
CTD
PMID:22747577
NCBI chr27:41,744,100...41,783,223
Ensembl chr27:41,748,871...41,803,556
G
THEMIS2
thymocyte selection associated family member 2
decreases expression
EXP
masitinib results in decreased expression of THEMIS2 mRNA
CTD
PMID:22747577
NCBI chr 2:72,465,719...72,501,962
Ensembl chr 2:72,464,026...72,502,928
G
TM2D2
TM2 domain containing 2
increases expression
EXP
masitinib results in increased expression of TM2D2 mRNA
CTD
PMID:22747577
NCBI chr16:26,551,563...26,557,554
Ensembl chr16:26,551,628...26,556,285
G
TMEM108
transmembrane protein 108
increases expression
EXP
masitinib results in increased expression of TMEM108 mRNA
CTD
PMID:22747577
NCBI chr23:29,992,038...30,331,791
Ensembl chr23:29,992,021...30,396,840
G
TMEM260
transmembrane protein 260
increases expression
EXP
masitinib results in increased expression of TMEM260 mRNA
CTD
PMID:22747577
NCBI chr 8:32,238,992...32,309,320
Ensembl chr 8:32,238,988...32,306,317
G
TNFSF10
TNF superfamily member 10
increases expression
EXP
masitinib results in increased expression of TNFSF10 mRNA
CTD
PMID:22747577
NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
G
TNPO1
transportin 1
decreases expression
EXP
masitinib results in decreased expression of TNPO1 mRNA
CTD
PMID:22747577
NCBI chr 2:55,795,737...55,859,366
Ensembl chr 2:55,799,907...55,851,213
G
TNS1
tensin 1
decreases expression
EXP
masitinib results in decreased expression of TNS1 mRNA
CTD
PMID:22747577
NCBI chr37:24,578,855...24,776,153
Ensembl chr37:24,581,806...24,808,049
G
TOX
thymocyte selection associated high mobility group box
increases expression
EXP
masitinib results in increased expression of TOX mRNA
CTD
PMID:22747577
NCBI chr29:9,542,471...9,841,759
Ensembl chr29:9,544,561...9,842,034
G
TSHB
thyroid stimulating hormone subunit beta
increases expression
EXP
masitinib results in increased expression of TSHB mRNA
CTD
PMID:22747577
NCBI chr17:52,659,137...52,685,388
Ensembl chr17:52,681,357...52,685,390
G
TSPAN2
tetraspanin 2
increases expression
EXP
masitinib results in increased expression of TSPAN2 mRNA
CTD
PMID:22747577
NCBI chr17:52,692,744...52,749,048
Ensembl chr17:52,694,603...52,744,276
G
TTC38
tetratricopeptide repeat domain 38
increases expression
EXP
masitinib results in increased expression of TTC38 protein
CTD
PMID:22747577
NCBI chr10:19,887,285...19,910,347
Ensembl chr10:19,773,373...19,910,683
G
TTLL1
TTL family tubulin polyglutamylase complex subunit L1
decreases expression
EXP
masitinib results in decreased expression of TTLL1 mRNA
CTD
PMID:22747577
NCBI chr10:22,456,150...22,492,375
Ensembl chr10:22,456,146...22,488,505
G
UCHL3
ubiquitin C-terminal hydrolase L3
increases expression
EXP
masitinib results in increased expression of UCHL3 protein
CTD
PMID:22747577
NCBI chr22:29,348,962...29,397,944
Ensembl chr22:29,348,706...29,407,965
G
UQCC1
ubiquinol-cytochrome c reductase complex assembly factor 1
decreases expression
EXP
masitinib results in decreased expression of UQCC1 mRNA
CTD
PMID:22747577
NCBI chr24:24,285,147...24,381,819
Ensembl chr24:24,286,320...24,381,699
G
UROD
uroporphyrinogen decarboxylase
increases expression
EXP
masitinib results in increased expression of UROD protein
CTD
PMID:22747577
NCBI chr15:15,313,808...15,317,130
Ensembl chr15:15,312,674...15,320,010
G
UROS
uroporphyrinogen III synthase
increases expression
EXP
masitinib results in increased expression of UROS mRNA
CTD
PMID:22747577
NCBI chr28:34,952,074...34,983,532
Ensembl chr28:34,948,003...34,983,532
G
VCPKMT
valosin containing protein lysine methyltransferase
decreases expression
EXP
masitinib results in decreased expression of VCPKMT mRNA
CTD
PMID:22747577
NCBI chr 8:26,611,333...26,636,700
Ensembl chr 8:26,625,677...26,636,316
G
WAPL
WAPL cohesin release factor
decreases expression
EXP
masitinib results in decreased expression of WAPAL mRNA
CTD
PMID:22747577
NCBI chr 4:34,219,644...34,297,456
Ensembl chr 4:34,219,645...34,302,839
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
increases expression
EXP
masitinib results in increased expression of YWHAZ protein
CTD
PMID:22747577
NCBI chr13:2,729,404...2,764,422
G
ZNF23
zinc finger protein 23
increases expression
EXP
masitinib results in increased expression of ZNF23 mRNA
CTD
PMID:22747577
NCBI chr 5:77,246,374...77,260,761
Ensembl chr 5:77,246,667...77,260,350
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
GNAQ
G protein subunit alpha q
multiple interactions
EXP
G(M1) Ganglioside inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein]; ganglioside, GD1a inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein]; mastoparan results in increased activity of and affects the localization of GNAQ protein
CTD
PMID:21671308
NCBI chr 1:80,733,530...80,928,065
Ensembl chr 1:80,715,366...80,928,065
G
HEXB
hexosaminidase subunit beta
multiple interactions increases secretion
EXP
G(M1) Ganglioside inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; ganglioside, GD1a inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein]; methyl-beta-cyclodextrin promotes the reaction [mastoparan results in increased secretion of HEXB protein]; Pertussis Toxin inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; Quinacrine promotes the reaction [mastoparan results in increased secretion of HEXB protein]; YM-254890 inhibits the reaction [mastoparan results in increased secretion of HEXB protein]
CTD
PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HEXB
hexosaminidase subunit beta
multiple interactions increases secretion
EXP
G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; sialogangliosides inhibits the reaction [Melitten results in increased secretion of HEXB protein]; trisialoganglioside GT1 inhibits the reaction [Melitten results in increased secretion of HEXB protein]
CTD
PMID:21334356
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases transport
EXP
ABCB1 protein results in increased transport of mesaconitine
CTD
PMID:23200901
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ABCG2
ATP binding cassette subfamily G member 2
multiple interactions
EXP
[3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of mesaconitine
CTD
PMID:23200901
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Dipyrone results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
multiple interactions
EXP
[Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein
CTD
PMID:18820026
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
G
CYP2D15
cytochrome P450 family 2 subfamily D member 15
affects metabolic processing
EXP
CYP2D15 affects the metabolism of Metoprolol
CTD
PMID:7786018
NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
G
EGR1
early growth response 1
multiple interactions
EXP
[Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein
CTD
PMID:18820026
NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
G
GATA4
GATA binding protein 4
multiple interactions
EXP
[Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein
CTD
PMID:18820026
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
G
NAB1
NGFI-A binding protein 1
multiple interactions
EXP
[Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein
CTD
PMID:18820026
NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
G
SLC8A1
solute carrier family 8 member A1
multiple interactions
EXP
[Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein
CTD
PMID:18820026
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases response to substance
EXP
ABCB1 mutant form results in increased susceptibility to Mexiletine
CTD
PMID:16594604
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin]
CTD
PMID:20510202
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
MYLK
myosin light chain kinase
multiple interactions
EXP
[ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin]
CTD
PMID:20510202
NCBI chr33:26,663,991...26,867,370
Ensembl chr33:26,664,800...26,843,181
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AKAP12
A-kinase anchoring protein 12
increases expression
EXP
mocetinostat results in increased expression of AKAP12 mRNA
CTD
PMID:27255383
NCBI chr 1:41,614,893...41,712,350
Ensembl chr 1:41,614,714...41,709,798
G
ANK1
ankyrin 1
decreases expression
EXP
mocetinostat results in decreased expression of ANK1 mRNA
CTD
PMID:27255383
NCBI chr16:23,858,299...23,966,181
Ensembl chr16:23,766,193...23,964,226
G
ANK3
ankyrin 3
increases expression
EXP
mocetinostat results in increased expression of ANK3 mRNA
CTD
PMID:27255383
NCBI chr 4:12,166,275...12,827,175
Ensembl chr 4:12,167,550...12,827,037
G
AP2M1
adaptor related protein complex 2 subunit mu 1
decreases expression
EXP
mocetinostat results in decreased expression of AP2M1 mRNA
CTD
PMID:27255383
NCBI chr34:17,071,199...17,080,445
Ensembl chr34:17,071,235...17,080,445
G
AP2S1
adaptor related protein complex 2 subunit sigma 1
decreases expression
EXP
mocetinostat results in decreased expression of AP2S1 mRNA
CTD
PMID:27255383
NCBI chr 1:109,094,098...109,105,233
Ensembl chr 1:109,082,221...109,105,230
G
AP3S1
adaptor related protein complex 3 subunit sigma 1
increases expression
EXP
mocetinostat results in increased expression of AP3S1 mRNA
CTD
PMID:27255383
NCBI chr11:5,543,140...5,611,322
Ensembl chr11:5,543,222...5,610,930
G
ARF4
ADP ribosylation factor 4
increases expression
EXP
mocetinostat results in increased expression of ARF4 mRNA
CTD
PMID:27255383
NCBI chr20:32,849,725...32,871,127
Ensembl chr20:32,849,757...32,870,721
G
ATG4D
autophagy related 4D cysteine peptidase
decreases expression
EXP
mocetinostat results in decreased expression of ATG4D mRNA
CTD
PMID:27255383
NCBI chr20:50,618,458...50,623,703
Ensembl chr20:50,618,459...50,624,179
G
ATG7
autophagy related 7
decreases expression
EXP
mocetinostat results in decreased expression of ATG7 mRNA
CTD
PMID:27255383
NCBI chr20:6,916,354...7,154,849
Ensembl chr20:6,916,515...7,154,800
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
increases expression
EXP
mocetinostat results in increased expression of ATP1A1 mRNA
CTD
PMID:27255383
NCBI chr17:53,828,482...53,847,043
Ensembl chr17:53,813,976...53,847,167
G
BCAP29
B cell receptor associated protein 29
increases expression
EXP
mocetinostat results in increased expression of BCAP29 mRNA
CTD
PMID:27255383
NCBI chr18:12,969,594...13,021,948
Ensembl chr18:12,970,411...13,022,022
G
BLOC1S1
biogenesis of lysosomal organelles complex 1 subunit 1
decreases expression
EXP
mocetinostat results in decreased expression of BLOC1S1 mRNA
CTD
PMID:27255383
NCBI chr10:116,993...120,244
G
BNIP1
BCL2 interacting protein 1
decreases expression
EXP
mocetinostat results in decreased expression of BNIP1 mRNA
CTD
PMID:27255383
NCBI chr 4:39,255,685...39,303,485
Ensembl chr 4:39,289,776...39,303,430
G
CACNB3
calcium voltage-gated channel auxiliary subunit beta 3
increases expression
EXP
mocetinostat results in increased expression of CACNB3 mRNA
CTD
PMID:27255383
NCBI chr27:5,705,587...5,714,620
Ensembl chr27:5,706,064...5,717,647
G
CAMK1D
calcium/calmodulin dependent protein kinase ID
increases expression
EXP
mocetinostat results in increased expression of CAMK1D mRNA
CTD
PMID:27255383
NCBI chr 2:23,680,395...24,113,922
Ensembl chr 2:23,685,672...24,114,084
G
CASK
calcium/calmodulin dependent serine protein kinase
increases expression
EXP
mocetinostat results in increased expression of CASK mRNA
CTD
PMID:27255383
NCBI chr X:35,939,117...36,296,438
Ensembl chr X:35,940,647...36,297,014
G
CAV1
caveolin 1
increases expression
EXP
mocetinostat results in increased expression of CAV1 mRNA
CTD
PMID:27255383
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
G
CBY1
chibby 1, beta catenin antagonist
decreases expression
EXP
mocetinostat results in decreased expression of CBY1 mRNA
CTD
PMID:27255383
NCBI chr10:26,125,064...26,134,693
Ensembl chr10:26,125,189...26,128,285
G
CHMP4B
charged multivesicular body protein 4B
decreases expression
EXP
mocetinostat results in decreased expression of CHMP4B mRNA
CTD
PMID:27255383
NCBI chr24:22,995,677...23,050,084
Ensembl chr24:22,995,672...23,049,287
G
CHMP5
charged multivesicular body protein 5
decreases expression
EXP
mocetinostat results in decreased expression of CHMP5 mRNA
CTD
PMID:27255383
NCBI chr11:50,363,488...50,376,081
G
CHMP6
charged multivesicular body protein 6
decreases expression
EXP
mocetinostat results in decreased expression of CHMP6 mRNA
CTD
PMID:27255383
NCBI chr 9:997,951...1,001,659
Ensembl chr 9:998,653...1,002,538
G
CLTCL1
clathrin heavy chain like 1
increases expression
EXP
mocetinostat results in increased expression of CLTCL1 mRNA
CTD
PMID:27255383
NCBI chr26:29,907,235...30,002,136
Ensembl chr26:29,906,278...30,002,128
G
COPB1
COPI coat complex subunit beta 1
increases expression
EXP
mocetinostat results in increased expression of COPB1 mRNA
CTD
PMID:27255383
NCBI chr21:37,186,380...37,224,549
Ensembl chr21:37,186,424...37,224,519
G
COPB2
COPI coat complex subunit beta 2
decreases expression
EXP
mocetinostat results in decreased expression of COPB2 mRNA
CTD
PMID:27255383
NCBI chr23:35,536,520...35,604,708
Ensembl chr23:35,536,615...35,566,569
G
COPG1
COPI coat complex subunit gamma 1
decreases expression
EXP
mocetinostat results in decreased expression of COPG1 mRNA
CTD
PMID:27255383
NCBI chr20:2,832,150...2,860,356
Ensembl chr20:2,832,198...2,860,320
G
DERL2
derlin 2
decreases expression
EXP
mocetinostat results in decreased expression of DERL2 mRNA
CTD
PMID:27255383
NCBI chr 5:31,319,660...31,330,846
Ensembl chr 5:31,319,717...31,330,841
G
DNM1L
dynamin 1 like
decreases expression
EXP
mocetinostat results in decreased expression of DNM1L mRNA
CTD
PMID:27255383
NCBI chr27:16,161,855...16,211,983
Ensembl chr27:16,163,357...16,211,957
G
GPAA1
glycosylphosphatidylinositol anchor attachment 1
decreases expression
EXP
mocetinostat results in decreased expression of GPAA1 mRNA
CTD
PMID:27255383
NCBI chr13:37,577,162...37,580,346
Ensembl chr13:37,576,354...37,580,345
G
HPS4
HPS4 biogenesis of lysosomal organelles complex 3 subunit 2
decreases expression
EXP
mocetinostat results in decreased expression of HPS4 mRNA
CTD
PMID:27255383
NCBI chr26:20,131,658...20,157,532
Ensembl chr26:19,933,281...20,157,058
G
HRC
histidine rich calcium binding protein
decreases expression
EXP
mocetinostat results in decreased expression of HRC mRNA
CTD
PMID:27255383
NCBI chr 1:107,304,718...107,308,741
Ensembl chr 1:107,304,924...107,308,740
G
KCNK1
potassium two pore domain channel subfamily K member 1
increases expression
EXP
mocetinostat results in increased expression of KCNK1 mRNA
CTD
PMID:27255383
NCBI chr 4:6,117,406...6,139,390
Ensembl chr 4:6,118,373...6,122,093
G
KCNMB4
potassium calcium-activated channel subfamily M regulatory beta subunit 4
increases expression
EXP
mocetinostat results in increased expression of KCNMB4 mRNA
CTD
PMID:27255383
NCBI chr10:12,211,372...12,251,739
G
KCNS3
potassium voltage-gated channel modifier subfamily S member 3
increases expression
EXP
mocetinostat results in increased expression of KCNS3 mRNA
CTD
PMID:27255383
NCBI chr17:13,297,242...13,338,319
Ensembl chr17:13,336,374...13,337,849
G
KIF5A
kinesin family member 5A
increases expression
EXP
mocetinostat results in increased expression of KIF5A mRNA
CTD
PMID:27255383
NCBI chr10:1,637,007...1,666,790
Ensembl chr10:1,636,932...1,664,767
G
KIF5B
kinesin family member 5B
decreases expression
EXP
mocetinostat results in decreased expression of KIF5B mRNA
CTD
PMID:27255383
NCBI chr 2:14,835,906...14,880,896
Ensembl chr 2:14,835,901...14,878,251
G
KIF5C
kinesin family member 5C
increases expression
EXP
mocetinostat results in increased expression of KIF5C mRNA
CTD
PMID:27255383
NCBI chr19:50,535,622...50,684,485
Ensembl chr19:50,535,456...50,668,738
G
LAMTOR1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
decreases expression
EXP
mocetinostat results in decreased expression of LAMTOR1 mRNA
CTD
PMID:27255383
NCBI chr21:25,981,170...25,986,942
Ensembl chr21:25,981,254...25,996,432
G
LAMTOR2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
decreases expression
EXP
mocetinostat results in decreased expression of LAMTOR2 mRNA
CTD
PMID:27255383
NCBI chr 7:41,760,632...41,764,926
Ensembl chr 7:41,760,638...41,763,299
G
LOC478702
tubulin beta-2B chain
increases expression
EXP
mocetinostat results in increased expression of TUBB2B mRNA
CTD
PMID:27255383
NCBI chr35:3,494,982...3,498,274
Ensembl chr35:3,495,277...3,498,248
G
MAL2
mal, T cell differentiation protein 2
increases expression
EXP
mocetinostat results in increased expression of MAL2 mRNA
CTD
PMID:27255383
NCBI chr13:18,404,979...18,422,076
Ensembl chr13:18,406,633...18,420,469
G
MICAL1
microtubule associated monooxygenase, calponin and LIM domain containing 1
increases expression
EXP
mocetinostat results in increased expression of MICAL1 mRNA
CTD
PMID:27255383
NCBI chr12:66,350,459...66,358,391
Ensembl chr12:66,350,427...66,360,615
G
MYPN
myopalladin
decreases expression
EXP
mocetinostat results in decreased expression of MYPN mRNA
CTD
PMID:27255383
NCBI chr 4:19,364,146...19,468,827
Ensembl chr 4:19,381,416...19,465,995
G
PEX19
peroxisomal biogenesis factor 19
decreases expression
EXP
mocetinostat results in decreased expression of PEX19 mRNA
CTD
PMID:27255383
NCBI chr38:21,939,054...21,945,281
Ensembl chr38:21,939,018...21,944,602
G
POLE2
DNA polymerase epsilon 2, accessory subunit
increases expression
EXP
mocetinostat results in increased expression of DNAAF2 mRNA
CTD
PMID:27255383
NCBI chr 8:26,264,220...26,295,089
Ensembl chr 8:26,251,160...26,295,317
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
increases expression
EXP
mocetinostat results in increased expression of PPP3CA mRNA
CTD
PMID:27255383
NCBI chr32:22,688,141...22,996,693
Ensembl chr32:22,688,143...22,996,688
G
RAB27A
RAB27A, member RAS oncogene family
increases expression
EXP
mocetinostat results in increased expression of RAB27A mRNA
CTD
PMID:27255383
NCBI chr30:20,633,576...20,706,240
Ensembl chr30:20,635,400...20,690,521
G
RAB31
RAB31, member RAS oncogene family
increases expression
EXP
mocetinostat results in increased expression of RAB31 mRNA
CTD
PMID:27255383
NCBI chr 7:75,678,896...75,807,716
Ensembl chr 7:75,678,908...75,817,426
G
RAB3IP
RAB3A interacting protein
increases expression
EXP
mocetinostat results in increased expression of RAB3IP mRNA
CTD
PMID:27255383
NCBI chr10:11,673,749...11,714,282
Ensembl chr10:11,673,777...11,714,281
G
RABEPK
Rab9 effector protein with kelch motifs
increases expression
EXP
mocetinostat results in increased expression of RABEPK mRNA
CTD
PMID:27255383
NCBI chr 9:57,857,269...57,877,333
Ensembl chr 9:57,857,269...57,883,761
G
SCAMP3
secretory carrier membrane protein 3
decreases expression
EXP
mocetinostat results in decreased expression of SCAMP3 mRNA
CTD
PMID:27255383
NCBI chr 7:42,294,764...42,299,097
G
SCN10A
sodium voltage-gated channel alpha subunit 10
increases expression
EXP
mocetinostat results in increased expression of SCN10A mRNA
CTD
PMID:27255383
NCBI chr23:8,420,468...8,527,414
Ensembl chr23:8,420,472...8,527,383
G
SDCBP
syndecan binding protein
increases expression
EXP
mocetinostat results in increased expression of SDCBP mRNA
CTD
PMID:27255383
NCBI chr29:9,331,876...9,370,489
G
SEC24B
SEC24 homolog B, COPII coat complex component
increases expression
EXP
mocetinostat results in increased expression of SEC24B mRNA
CTD
PMID:27255383
NCBI chr32:29,671,702...29,766,628
Ensembl chr32:29,671,738...29,772,192
G
SEC24D
SEC24 homolog D, COPII coat complex component
increases expression
EXP
mocetinostat results in increased expression of SEC24D mRNA
CTD
PMID:27255383
NCBI chr32:37,690,158...37,795,762
Ensembl chr32:37,690,399...37,924,252
G
SEC63
SEC63 homolog, protein translocation regulator
increases expression
EXP
mocetinostat results in increased expression of SEC63 mRNA
CTD
PMID:27255383
NCBI chr12:64,983,442...65,028,573
G
SFT2D1
SFT2 domain containing 1
decreases expression
EXP
mocetinostat results in decreased expression of SFT2D1 mRNA
CTD
PMID:27255383
NCBI chr 1:54,335,832...54,354,199
Ensembl chr 1:54,336,005...54,354,137
G
SMTN
smoothelin
decreases expression
EXP
mocetinostat results in decreased expression of SMTN mRNA
CTD
PMID:27255383
NCBI chr26:24,085,356...24,108,005
Ensembl chr26:24,085,382...24,108,540
G
SNAP23
synaptosome associated protein 23
increases expression
EXP
mocetinostat results in increased expression of SNAP23 mRNA
CTD
PMID:27255383
NCBI chr30:9,453,931...9,493,506
Ensembl chr30:9,456,084...9,492,329
G
SNAPIN
SNAP associated protein
decreases expression
EXP
mocetinostat results in decreased expression of SNAPIN mRNA
CTD
PMID:27255383
NCBI chr 7:43,410,554...43,411,929
Ensembl chr 7:43,410,998...43,412,323
G
SNX15
sorting nexin 15
decreases expression
EXP
mocetinostat results in decreased expression of SNX15 mRNA
CTD
PMID:27255383
NCBI chr18:52,152,562...52,165,081
Ensembl chr18:52,152,561...52,165,048
G
SNX16
sorting nexin 16
increases expression
EXP
mocetinostat results in increased expression of SNX16 mRNA
CTD
PMID:27255383
NCBI chr29:28,882,768...28,922,713
Ensembl chr29:28,884,426...28,920,797
G
SNX17
sorting nexin 17
decreases expression
EXP
mocetinostat results in decreased expression of SNX17 mRNA
CTD
PMID:27255383
NCBI chr17:21,326,496...21,332,170
Ensembl chr17:21,326,503...21,331,857
G
SNX24
sorting nexin 24
increases expression
EXP
mocetinostat results in increased expression of SNX24 mRNA
CTD
PMID:27255383
NCBI chr11:12,776,934...12,869,304
Ensembl chr11:12,708,712...12,888,165
G
SNX7
sorting nexin 7
increases expression
EXP
mocetinostat results in increased expression of SNX7 mRNA
CTD
PMID:27255383
NCBI chr 6:51,004,307...51,388,283
Ensembl chr 6:51,025,203...51,094,539
G
SPTBN1
spectrin beta, non-erythrocytic 1
increases expression
EXP
mocetinostat results in increased expression of SPTBN1 mRNA
CTD
PMID:27255383
NCBI chr10:55,429,989...55,571,917
Ensembl chr10:55,429,940...55,571,916
G
STAM2
signal transducing adaptor molecule 2
decreases expression
EXP
mocetinostat results in decreased expression of STAM2 mRNA
CTD
PMID:27255383
NCBI chr19:53,213,904...53,256,711
Ensembl chr19:53,216,274...53,256,756 Ensembl chr19:53,216,274...53,256,756
G
STON1
stonin 1
increases expression
EXP
mocetinostat results in increased expression of STON1 mRNA
CTD
PMID:27255383
NCBI chr10:50,421,635...50,470,302
Ensembl chr10:50,436,715...50,467,878
G
STX4
syntaxin 4
decreases expression
EXP
mocetinostat results in decreased expression of STX4 mRNA
CTD
PMID:27255383
NCBI chr 6:17,184,044...17,189,481
Ensembl chr 6:17,184,399...17,189,370
G
SYTL1
synaptotagmin like 1
increases expression
EXP
mocetinostat results in increased expression of SYTL1 mRNA
CTD
PMID:27255383
NCBI chr 2:72,916,445...72,925,219
Ensembl chr 2:72,916,445...72,925,147
G
SYTL4
synaptotagmin like 4
increases expression
EXP
mocetinostat results in increased expression of SYTL4 mRNA
CTD
PMID:27255383
NCBI chr X:74,537,937...74,617,580
Ensembl chr X:74,539,183...74,565,753
G
TFRC
transferrin receptor
decreases expression
EXP
mocetinostat results in decreased expression of TFRC mRNA
CTD
PMID:27255383
NCBI chr33:29,206,024...29,237,221
Ensembl chr33:29,208,609...29,238,242
G
TMED1
transmembrane p24 trafficking protein 1
decreases expression
EXP
mocetinostat results in decreased expression of TMED1 mRNA
CTD
PMID:27255383
NCBI chr20:50,395,862...50,399,118
Ensembl chr20:50,396,005...50,407,535
G
TMED2
transmembrane p24 trafficking protein 2
decreases expression
EXP
mocetinostat results in decreased expression of TMED2 mRNA
CTD
PMID:27255383
NCBI chr26:6,039,046...6,047,490
Ensembl chr26:6,039,405...6,047,459
G
TRIM54
tripartite motif containing 54
decreases expression
EXP
mocetinostat results in decreased expression of TRIM54 mRNA
CTD
PMID:27255383
NCBI chr17:21,257,660...21,278,410
Ensembl chr17:21,257,706...21,278,274
G
TSG101
tumor susceptibility 101
decreases expression
EXP
mocetinostat results in decreased expression of TSG101 mRNA
CTD
PMID:27255383
NCBI chr21:40,910,870...40,952,922
Ensembl chr21:40,910,874...40,952,808
G
TTN
titin
decreases expression
EXP
mocetinostat results in decreased expression of TTN mRNA
CTD
PMID:27255383
NCBI chr36:22,146,870...22,417,858
Ensembl chr36:22,147,824...22,417,826
G
TUBA4A
tubulin alpha 4a
decreases expression
EXP
mocetinostat results in decreased expression of TUBA4A mRNA
CTD
PMID:27255383
NCBI chr37:25,799,075...25,803,257
Ensembl chr37:25,796,107...25,802,892
G
TUBG1
tubulin, gamma 1
decreases expression
EXP
mocetinostat results in decreased expression of TUBG1 mRNA
CTD
PMID:27255383
NCBI chr 9:20,358,683...20,363,455
Ensembl chr 9:20,322,253...20,363,455
G
USO1
USO1 vesicle transport factor
decreases expression
EXP
mocetinostat results in decreased expression of USO1 mRNA
CTD
PMID:27255383
NCBI chr32:305,895...395,113
Ensembl chr32:305,935...394,896
G
VPS13B
vacuolar protein sorting 13 homolog B
decreases expression
EXP
mocetinostat results in decreased expression of VPS13B mRNA
CTD
PMID:27255383
NCBI chr13:1,101,226...1,834,933
Ensembl chr13:1,101,610...1,871,225
G
VPS16
VPS16 core subunit of CORVET and HOPS complexes
decreases expression
EXP
mocetinostat results in decreased expression of VPS16 mRNA
CTD
PMID:27255383
NCBI chr24:18,401,440...18,424,605
Ensembl chr24:18,399,572...18,424,510
G
VPS26A
VPS26, retromer complex component A
decreases expression
EXP
mocetinostat results in decreased expression of VPS26A mRNA
CTD
PMID:27255383
NCBI chr 4:20,265,120...20,296,125
Ensembl chr 4:20,264,905...20,294,674
G
VPS29
VPS29 retromer complex component
decreases expression
EXP
mocetinostat results in decreased expression of VPS29 mRNA
CTD
PMID:27255383
NCBI chr26:8,301,699...8,309,364
Ensembl chr26:8,301,699...8,309,364
G
VPS33A
VPS33A core subunit of CORVET and HOPS complexes
decreases expression
EXP
mocetinostat results in decreased expression of VPS33A mRNA
CTD
PMID:27255383
NCBI chr26:7,090,669...7,119,913
G
VPS33B
VPS33B late endosome and lysosome associated
decreases expression
EXP
mocetinostat results in decreased expression of VPS33B mRNA
CTD
PMID:27255383
NCBI chr 3:53,220,199...53,239,738
Ensembl chr 3:53,220,194...53,239,732
G
VPS35
VPS35 retromer complex component
decreases expression
EXP
mocetinostat results in decreased expression of VPS35 mRNA
CTD
PMID:27255383
NCBI chr15:8,428,073...8,454,601
Ensembl chr15:8,428,172...8,454,049
G
VPS41
VPS41 subunit of HOPS complex
decreases expression
EXP
mocetinostat results in decreased expression of VPS41 mRNA
CTD
PMID:27255383
NCBI chr18:10,788,846...10,956,207
Ensembl chr18:10,788,891...10,955,645
G
VPS52
VPS52 subunit of GARP complex
decreases expression
EXP
mocetinostat results in decreased expression of VPS52 mRNA
CTD
PMID:27255383
NCBI chr12:2,697,508...2,712,831
Ensembl chr12:2,697,508...2,712,831
G
VPS54
VPS54 subunit of GARP complex
increases expression
EXP
mocetinostat results in increased expression of VPS54 mRNA
CTD
PMID:27255383
NCBI chr10:63,598,373...63,676,753
Ensembl chr10:63,599,229...63,676,747
G
VTI1B
vesicle transport through interaction with t-SNAREs 1B
decreases expression
EXP
mocetinostat results in decreased expression of VTI1B mRNA
CTD
PMID:27255383
NCBI chr 8:41,619,365...41,650,389
Ensembl chr29:19,153,616...19,154,245 Ensembl chr 8:19,153,616...19,154,245
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC6A9
solute carrier family 6 member 9
affects localization multiple interactions
EXP
Monensin affects the localization of SLC6A9 protein Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein]
CTD
PMID:19473961
NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
IL6
interleukin 6
multiple interactions decreases expression
EXP
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein] N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of IL6 protein
CTD
PMID:24105867
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
multiple interactions
EXP
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein]
CTD
PMID:24105867
NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CLDN4
claudin 4
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23816505
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23816505
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]
CTD
PMID:23816505
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]
CTD
PMID:23816505
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SOD1
superoxide dismutase 1
affects response to substance
EXP
SOD1 protein affects the susceptibility to Nafenopin
CTD
PMID:6333936
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
POMC
proopiomelanocortin
increases expression
EXP
Naloxone results in increased expression of POMC protein
CTD
PMID:8277081
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS2
prostaglandin-endoperoxide synthase 2
affects expression increases expression
EXP
nefiracetam affects the expression of PTGS2 mRNA nefiracetam results in increased expression of PTGS2 protein
CTD
PMID:16105799
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PPARG
peroxisome proliferator activated receptor gamma
increases expression multiple interactions
EXP
Niacinamide results in increased expression of PPARG protein Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]
CTD
PMID:22539994
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
RUNX2
RUNX family transcription factor 2
increases acetylation multiple interactions decreases expression
EXP
Niacinamide results in increased acetylation of RUNX2 protein Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein]
CTD
PMID:22539994
NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785 Ensembl chr12:13,628,539...13,840,785
G
SIRT1
sirtuin 1
decreases expression multiple interactions
EXP
Niacinamide results in decreased expression of SIRT1 protein Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein]
CTD
PMID:22539994
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
IL1B
interleukin 1 beta
decreases expression
EXP
nimesulide results in decreased expression of IL1B mRNA
CTD
PMID:19638440
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
nimesulide results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
KNG1
kininogen 1
increases chemical synthesis
EXP
KNG1 protein modified form results in increased chemical synthesis of Nitrites
CTD
PMID:17644579
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
decreases activity
EXP
Nitroglycerin results in decreased activity of REN protein
CTD
PMID:8640982
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 mRNA; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 protein
CTD
PMID:12857884 PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
decreases localization
EXP
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased localization of RELA protein
CTD
PMID:12857884
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
affects metabolic processing
EXP
CYP2E1 protein affects the metabolism of 2-cresol
CTD
PMID:8592870
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACTA2
actin alpha 2, smooth muscle
multiple interactions increases expression
EXP
CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of ACTA2 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] ochratoxin A results in increased expression of ACTA2 mRNA; ochratoxin A results in increased expression of ACTA2 protein
CTD
PMID:33543323
NCBI chr26:38,700,434...38,714,915
Ensembl chr26:38,700,480...38,711,753
G
B9D2
B9 domain containing 2
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of TGFB1 mRNA; ochratoxin A results in increased expression of TGFB1 protein CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of TGFB1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]
CTD
PMID:33543323
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
CASP4
caspase 4, apoptosis-related cysteine peptidase
increases cleavage increases expression multiple interactions
EXP
ochratoxin A results in increased cleavage of CASP1 protein ochratoxin A results in increased expression of CASP1 mRNA CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]
CTD
PMID:33543323
NCBI chr 5:27,133,778...27,147,954
Ensembl chr 5:27,132,565...27,149,736
G
GSDMD
gasdermin D
multiple interactions increases expression
EXP
CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein] ochratoxin A results in increased expression of GSDMD mRNA; ochratoxin A results in increased expression of GSDMD protein
CTD
PMID:33543323
NCBI chr13:37,221,219...37,226,912
Ensembl chr13:37,193,022...37,228,360
G
IL18
interleukin 18
multiple interactions increases expression
EXP
CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL18 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]
CTD
PMID:33543323
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL1B
interleukin 1 beta
multiple interactions increases expression
EXP
CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein] ochratoxin A results in increased expression of IL1B mRNA; ochratoxin A results in increased expression of IL1B protein
CTD
PMID:33543323
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL6
interleukin 6
increases secretion increases expression
EXP
ochratoxin A results in increased secretion of IL6 protein ochratoxin A results in increased expression of IL6 mRNA
CTD
PMID:33543323
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions increases expression
EXP
N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of VIM protein] ochratoxin A results in increased expression of NLRP3 mRNA; ochratoxin A results in increased expression of NLRP3 protein
CTD
PMID:33543323
NCBI chr 8:251,776...313,290
Ensembl chr 8:253,407...313,059
G
PYCARD
PYD and CARD domain containing
increases expression multiple interactions
EXP
ochratoxin A results in increased expression of PYCARD mRNA; ochratoxin A results in increased expression of PYCARD protein N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD protein]
CTD
PMID:33543323
NCBI chr 6:17,049,352...17,051,348
Ensembl chr 6:17,049,705...17,051,240
G
TNF
tumor necrosis factor
increases secretion increases expression
EXP
ochratoxin A results in increased secretion of TNF protein ochratoxin A results in increased expression of TNF mRNA
CTD
PMID:33543323
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
VIM
vimentin
multiple interactions increases expression
EXP
CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of VIM protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of VIM protein] ochratoxin A results in increased expression of VIM mRNA; ochratoxin A results in increased expression of VIM protein
CTD
PMID:33543323
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CAPN1
calpain 1
increases expression
EXP
Ofloxacin results in increased expression of CAPN1 mRNA
CTD
PMID:24582689
NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757
G
CASP12
caspase 12
increases expression
EXP
Ofloxacin results in increased expression of CASP12 mRNA; Ofloxacin results in increased expression of CASP12 protein
CTD
PMID:24582689
NCBI chr 5:27,162,840...27,176,964
Ensembl chr 5:27,161,700...27,177,683
G
CASP8
caspase 8
multiple interactions increases expression
EXP
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA]
CTD
PMID:24582689
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
G
DDIT3
DNA damage inducible transcript 3
increases expression
EXP
Ofloxacin results in increased expression of DDIT3 mRNA
CTD
PMID:24582689
NCBI chr10:1,606,693...1,612,410
Ensembl chr10:1,606,693...1,611,303
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Ofloxacin results in increased expression of HSPA5 mRNA
CTD
PMID:24582689
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
G
TNF
tumor necrosis factor
increases expression
EXP
Ofloxacin results in increased expression of TNF mRNA; Ofloxacin results in increased expression of TNF protein
CTD
PMID:24582689
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF1A
TNF receptor superfamily member 1A
multiple interactions increases expression
EXP
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA] Ofloxacin results in increased expression of TNFRSF1A mRNA; Ofloxacin results in increased expression of TNFRSF1A protein
CTD
PMID:24582689
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TRADD
TNFRSF1A associated via death domain
multiple interactions increases expression
EXP
TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA]
CTD
PMID:24582689
NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
decreases secretion multiple interactions
EXP
Ouabain results in decreased secretion of REN protein Vanadates inhibits the reaction [Ouabain results in decreased secretion of REN protein]
CTD
PMID:6093556
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing
EXP
CYP2C11 protein affects the metabolism of 4-cresol
CTD
PMID:8592870
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
affects metabolic processing
EXP
CYP2E1 protein affects the metabolism of 4-cresol
CTD
PMID:8592870
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
TRPM8
transient receptor potential cation channel subfamily M member 8
increases activity multiple interactions
EXP
Menthol results in increased activity of TRPM8 protein [Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium]
CTD
PMID:16386244
NCBI chr25:45,261,092...45,357,560
Ensembl chr25:45,261,107...45,353,282
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Acetaminophen results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
UGT1A6
UDP glucuronosyltransferase 1 family, polypeptide A6
increases glucuronidation
EXP
UGT1A6 protein results in increased glucuronidation of Acetaminophen
CTD
PMID:11903872
NCBI chr25:45,081,655...45,161,584
Ensembl chr25:45,032,130...45,160,941
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCHE
butyrylcholinesterase
decreases activity
EXP
Paraoxon results in decreased activity of BCHE protein
CTD
PMID:4631366
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
increases reduction
EXP
DHRS4 protein results in increased reduction of 2,3-pentanedione
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
TJP1
tight junction protein 1
multiple interactions
EXP
Phalloidine inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein]
CTD
PMID:34147488
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
affects metabolic processing
EXP
CYP1A2 protein affects the metabolism of Phenacetin
CTD
PMID:15801540
NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Phenacetin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRA1A
adrenoceptor alpha 1A
multiple interactions
EXP
Phenylephrine binds to and results in increased activity of ADRA1A protein; silodosin inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:19371927
NCBI chr25:30,690,959...30,801,484
Ensembl chr25:30,693,571...30,801,486
G
ADRA1D
adrenoceptor alpha 1D
multiple interactions
EXP
BMY 7378 inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1D protein]; naftopidil inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1D protein]; Phenylephrine binds to and results in increased activity of ADRA1D protein
CTD
PMID:19371927
NCBI chr24:17,231,771...17,239,110
Ensembl chr24:17,213,643...17,214,761 Ensembl chr24:17,213,643...17,214,761
G
REN
renin
increases secretion
EXP
Phenylephrine results in increased secretion of REN protein
CTD
PMID:6347479
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
increases reduction
EXP
DHRS4 protein results in increased reduction of phenylglyoxylic acid
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
INS
insulin
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein
CTD
PMID:12639917
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein
CTD
PMID:12639917
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein
CTD
PMID:12639917
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
SLC6A9
solute carrier family 6 member 9
multiple interactions affects localization
EXP
Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein] Tetradecanoylphorbol Acetate affects the localization of SLC6A9 protein
CTD
PMID:19473961
NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
G
SOD1
superoxide dismutase 1
affects response to substance
EXP
SOD1 protein affects the susceptibility to Tetradecanoylphorbol Acetate
CTD
PMID:6333936
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; [Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; [Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
multiple interactions
EXP
Pindolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]
CTD
PMID:6103674
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NCF1
neutrophil cytosolic factor 1
decreases expression
EXP
pitavastatin results in decreased expression of NCF1 mRNA
CTD
PMID:15502390
NCBI chr 6:5,702,222...5,719,515
Ensembl chr 6:5,605,694...5,719,458
G
NOS3
nitric oxide synthase 3
increases activity increases expression
EXP
pitavastatin results in increased activity of NOS3 protein pitavastatin results in increased expression of NOS3 mRNA
CTD
PMID:15502390
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NOX4
NADPH oxidase 4
decreases expression
EXP
pitavastatin results in decreased expression of NOX4 mRNA
CTD
PMID:15502390
NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz
CTD
PMID:24389113
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
EXP
[prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein
CTD
PMID:24389113
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ESR1
estrogen receptor 1
affects expression
EXP
Progesterone affects the expression of ESR1 protein
CTD
PMID:16483645
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
PGR
progesterone receptor
affects binding
EXP
Progesterone binds to PGR protein
CTD
PMID:16054490
NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRB2
adrenoceptor beta 2
multiple interactions
EXP
[Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine
CTD
PMID:2884805
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
NPPA
natriuretic peptide A
increases expression
EXP
Propranolol results in increased expression of NPPA protein
CTD
PMID:2566282
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
REN
renin
multiple interactions decreases activity
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased activity of REN protein] Propranolol results in decreased activity of REN protein
CTD
PMID:2566282 PMID:6103674
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
VIP
vasoactive intestinal peptide
decreases expression
EXP
Propranolol results in decreased expression of VIP protein
CTD
PMID:2566282
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
increases expression
EXP
Dinoprostone results in increased expression of REN protein
CTD
PMID:495730
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Quercetin results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
HSP70
heat shock protein 70
decreases expression
EXP
Quercetin results in decreased expression of HSP70 protein
CTD
PMID:17009600
NCBI chr12:1,285,282...1,287,670
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HEXB
hexosaminidase subunit beta
multiple interactions
EXP
Quinacrine promotes the reaction [mastoparan results in increased secretion of HEXB protein]
CTD
PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SCT
secretin
decreases abundance
EXP
SCT protein results in decreased abundance of Lactic Acid
CTD
PMID:2418308
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
affects expression multiple interactions
EXP
Ranolazine affects the expression of ATP2A2 protein [Ranolazine co-treated with Enalapril] affects the expression of ATP2A2 protein; [Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein
CTD
PMID:18820026
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
G
EGR1
early growth response 1
multiple interactions affects expression
EXP
[Ranolazine co-treated with Enalapril] affects the expression of EGR1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein Ranolazine affects the expression of EGR1 protein
CTD
PMID:18820026
NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
G
GATA4
GATA binding protein 4
affects expression multiple interactions
EXP
Ranolazine affects the expression of GATA4 protein [Ranolazine co-treated with Enalapril] affects the expression of GATA4 protein; [Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein
CTD
PMID:18820026
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
G
NAB1
NGFI-A binding protein 1
affects expression multiple interactions
EXP
Ranolazine affects the expression of NAB1 protein [Ranolazine co-treated with Enalapril] affects the expression of NAB1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein
CTD
PMID:18820026
NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
G
SLC8A1
solute carrier family 8 member A1
affects expression multiple interactions
EXP
Ranolazine affects the expression of SLC8A1 protein [Ranolazine co-treated with Enalapril] affects the expression of SLC8A1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein
CTD
PMID:18820026
NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACP5
acid phosphatase 5, tartrate resistant
multiple interactions
EXP
Resveratrol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]
CTD
PMID:21239502
NCBI chr20:49,812,444...49,816,262
Ensembl chr20:49,814,032...49,816,260
G
EP300
E1A binding protein p300
multiple interactions
EXP
[[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]
CTD
PMID:21239502
NCBI chr10:24,076,538...24,156,708
Ensembl chr10:24,077,971...24,156,396
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
EXP
Resveratrol inhibits the reaction [TNFSF11 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:21239502
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions
EXP
Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]
CTD
PMID:22539994
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
[[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased localization of and results in increased activity of RELA protein]
CTD
PMID:21239502
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RUNX2
RUNX family transcription factor 2
multiple interactions decreases acetylation increases expression
EXP
[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of RUNX2 protein]; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased acetylation of RUNX2 protein] Resveratrol results in increased expression of RUNX2 protein
CTD
PMID:21239502 PMID:22539994
NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785 Ensembl chr12:13,628,539...13,840,785
G
SIRT1
sirtuin 1
increases expression multiple interactions increases activity
EXP
Resveratrol results in increased expression of SIRT1 protein [[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein; [Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of SIRT1 protein]; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased acetylation of RUNX2 protein]
CTD
PMID:21239502 PMID:22539994
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
TNFSF11
TNF superfamily member 11
multiple interactions decreases response to substance
EXP
[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] Resveratrol results in decreased susceptibility to TNFSF11 protein
CTD
PMID:21239502
NCBI chr22:8,226,931...8,257,926
Ensembl chr22:8,227,555...8,258,645
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases expression
EXP
Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein
CTD
PMID:22620706
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Rifampin results in increased activity of NR1I2 protein
CTD
PMID:27732639
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
REN
renin
decreases activity
EXP
Rilmenidine results in decreased activity of REN protein
CTD
PMID:2866274
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
allicin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Ritonavir results in increased activity of NR1I2 protein
CTD
PMID:27732639
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin
CTD
PMID:24389113
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport
EXP
ABCC2 protein affects the transport of Saquinavir
CTD
PMID:12702717
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]; valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Vincristine]; valspodar inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]
CTD
PMID:15492788 PMID:24975508
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AGT
angiotensinogen
increases response to substance multiple interactions
EXP
AGT protein modified form results in increased susceptibility to Serotonin Deferoxamine inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]; Reactive Oxygen Species inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]
CTD
PMID:8021468
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
EDN1
endothelin 1
increases activity
EXP
Serotonin results in increased activity of EDN1 protein
CTD
PMID:9918753
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADRA1A
adrenoceptor alpha 1A
multiple interactions
EXP
silodosin binds to and results in decreased activity of ADRA1A protein; silodosin inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:19371927
NCBI chr25:30,690,959...30,801,484
Ensembl chr25:30,693,571...30,801,486
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NOS3
nitric oxide synthase 3
increases expression decreases expression
EXP
Simvastatin results in increased expression of NOS3 protein Simvastatin results in decreased expression of NOS3 mRNA
CTD
PMID:11087217
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of Sincalide
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
GSR
glutathione-disulfide reductase
multiple interactions decreases activity
EXP
[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:18163546
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
HSP70
heat shock protein 70
increases expression multiple interactions
EXP
sodium arsenite results in increased expression of HSP70 protein carvacrol promotes the reaction [sodium arsenite results in increased expression of HSP70 protein]; leucinostatin A promotes the reaction [sodium arsenite results in increased expression of HSP70 protein]
CTD
PMID:31940135
NCBI chr12:1,285,282...1,287,670
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CLDN4
claudin 4
increases expression multiple interactions
EXP
Sodium Chloride results in increased expression of CLDN4 protein Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
EXP
Sodium Chloride results in increased expression of JUN protein pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]; U 0126 inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]
CTD
PMID:23816505
NCBI chr 5:50,966,698...50,968,939
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation multiple interactions
EXP
Sodium Chloride results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23816505
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation multiple interactions
EXP
Sodium Chloride results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23816505
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
EXP
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]
CTD
PMID:23816505
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
EXP
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]
CTD
PMID:23816505
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
G
SOD2
superoxide dismutase 2
increases expression
EXP
Sodium Chloride results in increased expression of SOD2 protein
CTD
PMID:22718889
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SP1
Sp1 transcription factor
multiple interactions increases expression
EXP
pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of SP1 protein]; Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]; U 0126 inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; U 0126 inhibits the reaction [Sodium Chloride results in increased expression of SP1 protein]
CTD
PMID:23816505
NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase
multiple interactions decreases activity
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
BCHE
butyrylcholinesterase
decreases activity
EXP
Soman results in decreased activity of BCHE protein
CTD
PMID:16915560
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CNR2
cannabinoid receptor 2
multiple interactions
EXP
SR 144528 binds to and results in decreased activity of CNR2 protein
CTD
PMID:21871882
NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP3A12
cytochrome P-450 3A12
multiple interactions
EXP
CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide]
CTD
PMID:12051674
G
EPHX1
epoxide hydrolase 1
multiple interactions
EXP
CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide]
CTD
PMID:12051674
NCBI chr 7:38,964,319...39,004,902
Ensembl chr 7:38,964,338...38,999,238
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
GSR
glutathione-disulfide reductase
multiple interactions
EXP
[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:18163546
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BCHE
butyrylcholinesterase
increases hydrolysis multiple interactions
EXP
BCHE protein results in increased hydrolysis of Succinylcholine Succinylcholine inhibits the reaction [BCHE protein results in increased hydrolysis of butyrylcholine]
CTD
PMID:4985882
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
Sulindac results in decreased expression of PTGS2 protein
CTD
PMID:12857884
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
decreases localization
EXP
Sulindac results in decreased localization of RELA protein
CTD
PMID:12857884
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of Taurocholic Acid
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC22A2
solute carrier family 22 member 2
decreases activity
EXP
tebuconazole results in decreased activity of SLC22A2 protein
CTD
PMID:36669674
NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
G
SLC22A5
solute carrier family 22 member 5
decreases activity
EXP
tebuconazole results in decreased activity of SLC22A5 protein
CTD
PMID:36669674
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
G
SLC47A1
solute carrier family 47 member 1
decreases activity
EXP
tebuconazole results in decreased activity of SLC47A1 protein
CTD
PMID:36669674
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
G
SLC47A2
solute carrier family 47 member 2
decreases activity
EXP
tebuconazole results in decreased activity of SLC47A2 protein
CTD
PMID:36669674
NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport
EXP
ABCC2 protein affects the transport of temocaprilat
CTD
PMID:15507541
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CDKN2A
cyclin dependent kinase inhibitor 2A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDKN2A protein
CTD
PMID:14729356
NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression decreases expression
EXP
tert-Butylhydroperoxide results in increased expression of GADD45A protein tert-Butylhydroperoxide results in decreased expression of GADD45A protein
CTD
PMID:14729356
NCBI chr 6:77,393,026...77,396,473
Ensembl chr 6:77,393,036...77,396,618
G
TERT
telomerase reverse transcriptase
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of TERT protein
CTD
PMID:14729356
NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
B9D2
B9 domain containing 2
increases expression
EXP
Testosterone results in increased expression of TGFB1 mRNA
CTD
PMID:17157324
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
KCND3
potassium voltage-gated channel subfamily D member 3
increases expression
EXP
Testosterone results in increased expression of KCND3 protein
CTD
PMID:17054656
NCBI chr17:63,470,829...63,668,354
Ensembl chr17:63,470,415...63,668,035
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
increases expression
EXP
Testosterone results in increased expression of KCNJ2 protein
CTD
PMID:17054656
NCBI chr 9:16,468,938...16,475,722
Ensembl chr 9:16,468,938...16,475,722
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Myristic Acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Thapsigargin results in increased expression of HSPA5 protein
CTD
PMID:17416481
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
tolfenamic acid results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing
EXP
CYP2C11 protein affects the metabolism of Toluene
CTD
PMID:8592870
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions affects metabolic processing
EXP
Ditiocarb inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene]; Fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene]
CTD
PMID:8592870
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
toosendanin results in increased expression of BAX mRNA; toosendanin results in increased expression of BAX protein
CTD
PMID:36809669
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
toosendanin results in decreased expression of BCL2 mRNA; toosendanin results in decreased expression of BCL2 protein
CTD
PMID:36809669
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
CASP3
caspase 3
increases cleavage
EXP
toosendanin results in increased cleavage of CASP3 protein
CTD
PMID:36809669
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP9
caspase 9
increases cleavage
EXP
toosendanin results in increased cleavage of CASP9 protein
CTD
PMID:36809669
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
G
CYCS
cytochrome c, somatic
multiple interactions
EXP
toosendanin results in increased expression of and affects the localization of CYCS protein
CTD
PMID:36809669
NCBI chr14:38,579,446...38,581,983
Ensembl chr14:38,579,446...38,581,983
G
TP53
tumor protein p53
increases expression
EXP
toosendanin results in increased expression of TP53 mRNA; toosendanin results in increased expression of TP53 protein
CTD
PMID:36809669
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC22A5
solute carrier family 22 member 5
decreases activity
EXP
triticonazole results in decreased activity of SLC22A5 protein
CTD
PMID:36669674
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
G
SLC47A1
solute carrier family 47 member 1
decreases activity
EXP
triticonazole results in decreased activity of SLC47A1 protein
CTD
PMID:36669674
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Troleandomycin results in increased activity of NR1I2 protein
CTD
PMID:27732639
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase
multiple interactions
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
SCT
secretin
multiple interactions
EXP
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates]
CTD
PMID:3562434
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
SLC22A5
solute carrier family 22 member 5
decreases activity
EXP
uniconazole results in decreased activity of SLC22A5 protein
CTD
PMID:36669674
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
G
SLC47A1
solute carrier family 47 member 1
decreases activity
EXP
uniconazole results in decreased activity of SLC47A1 protein
CTD
PMID:36669674
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CLDN4
claudin 4
increases expression
EXP
Urea results in increased expression of CLDN4 protein
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
SOD2
superoxide dismutase 2
increases expression
EXP
Urea results in increased expression of SOD2 protein
CTD
PMID:22718889
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
P2RY2
purinergic receptor P2Y2
multiple interactions increases activity
EXP
[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid; [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP]
CTD
PMID:10604969
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
DHRS4
hydrogenase/reductase 4
decreases activity
EXP
Valproic Acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
INS
insulin
multiple interactions
EXP
INS protein promotes the reaction [Sodium results in increased abundance of Vasopressins]
CTD
PMID:1324617
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin
CTD
PMID:20510202
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCB1
ATP binding cassette subfamily B member 1
increases export multiple interactions affects response to substance
EXP
ABCB1 protein results in increased export of Vincristine valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Vincristine]
CTD
PMID:24975508 PMID:28093773
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ABCC1
ATP binding cassette subfamily C member 1
decreases response to substance
EXP
ABCC1 protein results in decreased susceptibility to Vincristine
CTD
PMID:12516967
NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
TNF
tumor necrosis factor
multiple interactions
EXP
Vitamin E inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]
CTD
PMID:14973143
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CASQ1
calsequestrin 1
decreases expression
EXP
Vorinostat results in decreased expression of CASQ1 mRNA
CTD
PMID:27255383
NCBI chr38:22,012,060...22,020,430
Ensembl chr38:22,011,060...22,020,383
G
HSP70
heat shock protein 70
decreases expression
EXP
Vorinostat results in decreased expression of HSP70 mRNA
CTD
PMID:27255383
NCBI chr12:1,285,282...1,287,670
G
TNNI3K
TNNI3 interacting kinase
decreases expression
EXP
Vorinostat results in decreased expression of TNNI3K mRNA
CTD
PMID:27255383
NCBI chr 6:71,825,853...72,107,832
Ensembl chr 6:71,815,734...72,119,476
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase
multiple interactions decreases activity
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
BCHE
butyrylcholinesterase
decreases activity
EXP
VX-agent results in decreased activity of BCHE protein
CTD
PMID:16915560
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
CNR2
cannabinoid receptor 2
affects binding
EXP
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to CNR2 protein
CTD
PMID:21871882
NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HEXB
hexosaminidase subunit beta
multiple interactions
EXP
YM-254890 inhibits the reaction [mastoparan results in increased secretion of HEXB protein]
CTD
PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions
EXP
Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein]
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PRKCZ
protein kinase C zeta
multiple interactions
EXP
Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ABCG2
ATP binding cassette subfamily G member 2
increases transport
EXP
ABCG2 protein results in increased transport of Zearalenone
CTD
PMID:30576553
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ALOX5
arachidonate 5-lipoxygenase
decreases activity
EXP
zileuton results in decreased activity of ALOX5 protein
CTD
PMID:1618819
NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all